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 Abstract 
Abstract 
i 
 
Helicobacter pylori is a gastric pathogen which infects ~50% of the global 
population and can lead to the development of gastritis, gastric and duodenal ulcers 
and carcinoma. Genome sequencing of H. pylori revealed high levels of genetic 
variability; this pathogen is known for its adaptability due to mechanisms including 
phase variation, recombination and horizontal gene transfer. Motility is essential for 
efficient colonisation by H. pylori. The flagellum is a complex nanomachine which 
has been studied in detail in E. coli and Salmonella. In H. pylori, key differences 
have been identified in the regulation of flagellum biogenesis, warranting further 
investigation. 
In this study, the genomes of two H. pylori strains (CCUG 17874 and P79) were 
sequenced and published as draft genome sequences. Comparative studies identified 
the potential role of restriction modification systems and the comB locus in 
transformation efficiency differences between these strains. Core genome analysis of 
43 H. pylori strains including 17874 and P79 defined a more refined core genome for 
the species than previously published. Comparative analysis of the genome 
sequences of strains isolated from individuals suffering from H. pylori-related 
diseases resulted in the identification of “disease-specific” genes. 
Structure-function analysis of the essential motility protein HP0958 was 
performed to elucidate its role during flagellum assembly in H. pylori. The 
previously reported HP0958-FliH interaction could not be substantiated in this study 
and appears to be a false positive. Site-directed mutagenesis confirmed that the 
coiled-coil domain of HP0958 is involved in the interaction with RpoN (74-284), 
while the Zn-finger domain is required for direct interaction with the full length flaA 
mRNA transcript. Complementation of a non-motile hp0958-null derivative strain of 
P79 with site-directed mutant alleles of hp0958 resulted in cells producing flagellar-
type extrusions from non-polar positions. Thus, HP0958 may have a novel function 
in spatial localisation of flagella in H. pylori. 
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1 Helicobacter pylori 
 1.1 Discovery of H. pylori 
Helicobacter pylori is a Gram negative micro-aerophilic member of the ε-
proteobacteria, order Campylobacterales, family Helicobacteriaceae (Goodwin et 
al., 1989). The spiral cells of this organism have been observed in samples from 
animals and humans since the late 19
th
 century but were not isolated until relatively 
recently due to their fastidious growth requirements (Marshall and Warren, 1984; 
Warren and Marshall, 1983). H. pylori is a human gastric pathogen, isolated by 
Marshall and Warren in 1982 (Marshall and Warren, 1984), which colonises the 
mucosal lining of the stomach. It is motile because of multiple polar sheathed 
flagella, which are vital for colonisation and persistence in the host (Eaton et al., 
1992; Yoshiyama and Nakazawa, 2000). 
H. pylori was first identified as a member of the Campylobacter genus, originally 
named Campylobacter pyloridis (Goodwin et al., 1986). However, when differences 
in 5S and 16S rRNA, cellular fatty acid composition and ultrastructure were 
identified, it was reclassified under the new genus, Helicobacter (Goodwin et al., 
1989). In 2002, Fox reported 24 named Helicobacter members (Fox, 2002) and today 
there are over 200 members of the genus listed (NCBI, 2013), with new species 
being isolated regularly, e.g. H. macacae (Fox et al., 2007) and new H. pylori strains 
(Blanchard et al., 2013). Helicobacter pylori was the first species to have the genome 
of more than one strain sequenced, with that of H. pylori 26695 completed in 1997 
(Tomb et al., 1997) followed by J99, facilitating comparative analyses (Alm and 
Trust, 1999). 
The genus can be sub-divided into gastric and enterohepatic Helicobacter species. 
The former primarily occupy the antrum of the stomach, e.g. H. heilmannii and 
H. felis, while the latter occupy the intestinal crypts of their host, e.g. H. pullorum 
and H. cinaedi (Fox, 2002; Rossi and Hänninen, 2012; Smet et al., 2011). 
Helicobacter species have been isolated from 142 vertebrate host species where they 
are associated with a wide range of disease types (Table 1) (Smet et al., 2011). 
Animal models used to study H. pylori include mouse, gnotobiotic piglet, 
Mongolian gerbil and guinea pig (Kusters et al., 2006). Recently, the teleost fish 
Danio rerio (zebrafish) has been successfully used as a model organism for 
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investigation of the H. pylori CagA virulence factor (Neal et al., 2013). A novel ex-
vivo three-dimensional system, termed an “organoid”, has been developed from 
gastric stem cells, an exciting alternative to conventional 2-dimensional mammalian 
tissue culture systems (Wroblewski et al., 2013). 
  
Table 1 Features of H. pylori species 
Species Mammalian hosts Pathology or clinical presentation Reference 
H. pylori Human, primate Gastritis, peptic ulcer disease, gastric 
adenocarcinoma, MALT lymphoma 
(Blaser, 1990; Dorer et al., 2009; Nagini, 
2012) 
H. felis Cat, dog, mouse, human Gastritis in natural host; may cause peptic ulcers 
or gastric adenocarcinoma in mouse 
(Fox et al., 2002; Haesebrouck et al., 2009; 
Lee et al., 1988; Trebesius et al., 2001) 
H. mustelae Ferret Gastritis, peptic ulcer disease, gastric 
adenocarcinoma, MALT lymphoma 
(Fox, 2002, 1994; Fox et al., 1997) 
H. acinonychis Cheetah, tiger Gastritis, peptic ulcer disease (Cattoli et al., 2000; Eaton et al., 1993) 
H. heilmannii Human, dog, cat, monkey, 
cheetah, rat 
Gastritis, dyspeptic symptoms, MALT 
lymphoma 
(Andersen et al., 1999; Stolte et al., 997; 
Trebesius et al., 2001) 
H. hepaticus Mouse, other rodents Proliferative typhlocolitis, hepatitis, 
hepatocellular carcinoma 
(Fox et al., 1994; Ward et al., 1994) 
H. anseris Goose  (Fox et al., 2006) 
H. suis Pig, human Gastritis, dyspepsia (De Groote et al., 1999; Joosten et al., 2013) 
H. bilis Mouse, human Bacteremia, cellulitis (Fox et al., 1995; Turvey et al., 2012) 
H. cinaedi Human, monkey Bacteremia, cellulitis (Fox et al., 2001; Kikuchi et al., 2012) 
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 1.2 Morphology and Physiology 
Helicobacter pylori cells are generally 2 - 5 µm long and 0.5 - 1 µm wide (Figure 
1). H. pylori is motile via its 2 - 6 unipolar, sheathed flagella (Geis et al., 1993; 
Yoshiyama and Nakazawa, 2000). On solid media, cells form small translucent 
colonies of ~3 mm (Dunn et al., 1997). The flagella are ~3 µm in length and often 
possess a bulb at the distal end (Goodwin et al., 1985). It is hypothesised that the 
sheath may aid host colonization by protecting the flagellar filament from 
degradation by the acidic human stomach (Jones and Curry, 1989; Luket and Penn, 
1995). Flagella-associated autotransporter protein, FaaA, is a VacA-like protein. It 
has been shown to localise to the flagellar sheath. An isogenic faaA mutant exhibits 
decreased motility and an impaired ability to colonise the stomach of mice, 
indicating its important role in motility and host colonisation (Radin et al., 2013). 
The bacterium is spiral in vivo, but assumes a rod-shaped or coccoid form when 
cultured in vitro (Benaissa et al., 1996). Conflicting arguments suggested this 
coccoid form could indicate cell death, while others indicated it may be a dormant 
stage still capable of infection (Benaissa et al., 1996; Catrenich and Makin, 1991; 
Kusters et al., 1997). It has since been shown that the coccoid form can be sub-
divided into two types: a viable coccoid form and a non-viable, degenerative coccoid 
form (Azevedo et al., 2007; Saitoa et al., 2003; Willén et al., 2000). Induced coccoid 
forms of H. pylori are still capable of expression of cagE and babA, indicating that 
cells with this morphology are still possibly capable of infection (Poursina et al., 
2013). 
Motility is a key feature of this organism, which is necessary for efficient 
colonisation of the host (Ottemann and Lowenthal, 2002). Motility and chemotaxis 
play a dual role in infection, because motile but che-negative derivative strains of 
H. pylori exhibit reduced host colonisation (Foynes et al., 2000; Terry et al., 2005). 
H. pylori can swim with curvilinear velocities of ~25 µm/s (Karim et al., 1998). 
Motility appears more rapid than that of rod-shaped E. coli in a viscous solution 
indicating its ability to swim through the viscous mucosal lining of the stomach 
(Hazell et al., 1986). Celli et al. showed that the mechanism by which H. pylori can 
move so rapidly through this mucus relates to the viscoelastic properties of mucin, a 
major component of the gastric mucosa (Section 2.4). 
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Figure 1 Helicobacter pylori spiral cells with polar sheathed flagella. 
Electron microscopy image of H. pylori (Yoshiyama and Nakazawa, 2000). 
 
H. pylori is catalase, oxidase and urease positive (Goodwin et al., 1989; Kusters et 
al., 2006). Superoxide dismutase and catalase production have a protective role for 
the bacterium against oxidation by phagocytes (Handa et al., 2010). As H. pylori is 
acid-sensitive, the production of urease is a key virulence factor which aids infection 
and colonisation of the acidic human stomach (Hazell et al., 1986). H. pylori is 
capable of biofilm formation, a feature used by pathogenic bacteria to aid in infection 
and survival in the host (Yonezawa et al., 2010). Its biofilm extracellular polymeric 
substance (EPS) matrix includes polysaccharides and extracellular DNA, possibly 
providing an environment which promotes inter-strain recombination events (Grande 
et al., 2011, 2012).  
H. pylori is a fastidious organism which requires complex medium for growth. It 
is routinely grown on Columbia Agar Base or in Brucella broth or Brain Heart 
Infusion broth. Supplements include horse blood, activated charcoal, cornstarch, β-
cyclodextrins or foetal calf serum (Buck et al., 1987; Kusters et al., 2006; Morgan et 
al., 1987). In the presence of antibiotics used for primary culture on selective agar, 
inhibited growth of the bacteria can be circumvented through the addition of ferrous 
sulphate, sodium pyruvate, and mucin (Jiang and Doyle, 2000). Several amino acids 
are generally required for growth: leucine, valine, phenylalanine, methionine, 
arginine, and histidine (Nedenskov, 1994). Some amino acids can also serve as an 
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energy source: serine, alanine, proline and aspartate (Tomb et al., 1997). It grows 
well in the pH range 5.5 – 8 (Morgan et al., 1987). 
Optimal culture conditions include a microaerobic environment of 5 - 15% O2 and 
5% CO2 (Goodwin and Armstrong, 1990) and a temperature of 33 - 40.5°C 
(Goodwin et al., 1986). H. pylori is a capnophile, i.e. it thrives in the presence of 
CO2, which has been found to be more sensitive to aerobic environments when at 
low cell densities (Bury-Moné et al., 2006). Thin-layered liquid culture of H. pylori 
facilitates efficient gas transfer and hence growth in a microaerobic environment (Joo 
et al., 2010). Microaerobic conditions can be achieved using hypoxia chamber, CO2-
regulated incubator and CampyGen gas pack. 
 1.3 Genetics 
There are now over 200 named members of the Helicobacter genus (Smet et al., 
2011). Today, the complete genomes of 52 H. pylori strains have been sequenced 
and annotated; these are available on the NCBI Genome web resource (NCBI, 2013). 
The draft genome sequences of a further 228 strains are also available, though some 
lack annotation. Typically, the complete genome of H pylori has an average size of 
1.6 - 1.7 Mbp, a GC content of 35 - 39%; some strains possess bacteriophage DNA 
and approximately 50% carry cryptic plasmids (Alm and Trust, 1999; Baltrus et al., 
2009; Farnbacher et al., 2010; Penfold et al., 1988; Uchiyama et al., 2012). Current 
sequencing information has identified that H. pylori has an open pan-genome, with 
~1,200 core genes, and a coding density of 89 - 92% (Farnbacher et al., 2010; 
Fischer et al., 2010; Lara-Ramírez et al., 2011). The gene content can differ by >10% 
between two given strains of H. pylori (Farnbacher et al., 2010; Fischer et al., 2010). 
Identical strains of H. pylori have only been isolated from family members, 
indicating intrafamilial transmission and highlighting the genetic variability of this 
organism (Achtman et al., 1999; Linz et al., 2007; Raymond et al., 2008). 
Comparative analysis of the genomes of H. pylori 26695 and J99 in 1997 
indicated that H. pylori genomes display high levels of genetic recombination (Alm 
and Trust, 1999). The identification of transposable elements, repeat sequences and a 
large number of single nucleotide polymorphisms (SNPs) throughout the genome 
indicated a species with a high level of genomic plasticity. H pylori genomes have 
characteristic regions of high variability known as “plasticity zones” and 
pathogenicity islands (PAI) which encode key virulence genes e.g. cagA (see below) 
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and a large number of genes of unknown function. A large proportion of the genetic 
variation between strains can be localised to these regions which have a different GC 
content to the rest of the genome (Alm et al., 1999; Kersulyte et al., 2009). The cag 
PAI contains genes which encode components of a type IV secretion system, 
facilitating injection of this strain-specific virulence factor into host cells (TFSS) 
(Akopyants et al., 1998; Censini et al., 1996; Duncan et al., 2013; Furuta et al., 
2011). Sequential sequencing of the genomes of H. pylori isolates from chronically 
infected subjects revealed genome evolution during infection. The high rate of 
recombination occurred at non-random sites throughout the genome; Kennemann et 
al. suggest that H. pylori initially imports long DNA fragments and these are 
subsequently fragmented and distributed to different locations (Kennemann et al., 
2011). Genes with a high recombination rate include those encoding outer membrane 
proteins and proteins involved in lipopolysaccharide synthesis (Yahara et al., 2012). 
Helicobacter pylori is naturally competent for the uptake of exogenous DNA 
(Nedenskov-Sorensen et al., 1990). H. pylori is unique amongst naturally competent 
bacteria as it is the only known species which does not use pilus proteins during 
transformation. The proposed mechanism by which natural transformation is 
regulated involves the Type IV secretion system, ComB and is localised to cell poles 
(Hofreuter et al., 2001; Stingl et al., 2010). ComB facilitates DNA uptake through 
the outer membrane, while ComEC is required for the passage of DNA through the 
inner membrane (Stingl et al., 2010). H. pylori can also transfer plasmids and 
chromosomal DNA between cells by conjugation (Fischer et al., 2010; Heuermann 
and Haas, 1998; Kuipers et al., 1998). Recently, the ComB system has also been 
identified as playing a role in DNaseI-resistant plasmid transfer. A novel T4SS-
independent pathway termed the alternate DNaseI-Resistant pathway (ADR) has 
been identified, highlighting the important role of horizontal gene transfer in the 
genome flux of H. pylori (Rohrer et al., 2012). Bacteriophage also contribute to this 
genetic variability through DNA transduction (Luo et al., 2012). 
Restriction modification (RM) systems are a protective strategy used by bacteria 
to prevent invasion of foreign DNA through the activity of restriction endonucleases. 
H. pylori strains possess RM systems that are strain-specific (Alm & Trust, 1999; 
Ando et al., 2000; Tomb et al., 1997). RM systems can be classified as types I - IV. 
Type II systems are the best understood of these, involving restriction 
endonuclease/DNA methyltransferase pairs of enzymes that have opposing 
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intracellular activities to cleave/methylate DNA at specific recognition sites, 
respectively (Xu et al., 2000). There is a complex interplay of factors which 
ultimately determine the capacity of a given strain of H. pylori for horizontal gene 
transfer e.g. nucT, dprB and ruvC (Humbert and Salama, 2008; Humbert et al., 
2011). 
.
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2 Pathogenesis of Helicobacter pylori 
 2.1 Epidemiology 
Helicobacter pylori has had an intimate association with humans for ~100,000 
years (Moodley et al., 2012). The movement of anatomically modern humans from 
Africa ~60,000 years ago matches the divergence of H. pylori, thereby indicating that 
H. pylori migrated throughout the globe with its human host (Linz et al., 2007). 
H. pylori can be subdivided into 7 populations: hpAfrica1, hpAfrica2, hpNEAfrica, 
hpAsia2, hpEastAsia, hpSahul and hpEurope (Moodley et al., 2009, 2012). 
Although there is a high global incidence of Helicobacter pylori, infection has 
been shown to vary locally due to factors including geographical location, age, race, 
and socioeconomic status (Khalifa et al., 2010). Levels of infection are generally 
higher in developing countries, with infection occurring often in early childhood 
(Figure 2) (Perez-Perez et al., 2004; Pounder and Ng, 1995). Industrialised countries 
show lower rates of infection in children (Fiedorik et al., 1991). In Western countries 
e.g. Germany and USA, the prevalence of infection is low in children and higher 
amongst those above the age of 50 (Prinz et al., 2006). In China and Japan, the 
proportion of infected individuals is high (~60% of young members of the population 
and 80 - 90% of older members) (Dorji et al., 2013; Inoue and Tsugane, 2005; Prinz 
et al., 2006). Black and Hispanic ethnicities are associated with higher risk of 
infection, though different ethnicities can be broadly linked with differing social 
classes and hygiene standards (reviewed in (Brown, 2000)). 
Chapter 1 
~ 11 ~ 
 
 
Figure 2 Prevalence of H. pylori infection in studies published during 2012. 
Bar chart representation of data overviewed by (Calvet et al., 2013). 
 
 2.2 Transmission 
Approximately half the worldwide population harbours H. pylori (Hunt et al., 
2011; The Eurogast Study Group, 1993) and hence, eradication of this pathogenic 
bacteria is of global concern. However, because H. pylori can persist in the host for 
years before symptoms develop, it is often difficult to determine the point of 
infection, likely during childhood (Brown, 2000; Malaty et al., 2002; Salama et al., 
2013). H. pylori is generally accepted to be acquired from close personal contact i.e. 
between family members (Fialho et al., 2010; Raymond et al., 2008). 
There are several proposed routes of transmission of H. pylori: oral-oral, faecal-
oral, gastro-oral and iatrogenic. The oral-oral route of transmission has been 
substantiated, with several studies isolating the pathogen from saliva, dental plaques 
and the oesophagus (Cellini et al., 2010; Silva et al., 2010; Zou and Li, 2011), while 
others suggest a link between pre-mastication of young infants’ food and infection 
(Clemens et al., 1996; Frenck and Clemens, 2003). The faecal-oral route is possibly 
another dominant mode of transmission, as DNA and viable H. pylori cells have been 
isolated from the faeces of infected hosts (Momtaz et al., 2012; Parsonnet et al., 
1999). Improvement in sanitation standards in the United States achieved in the latter 
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half of the 19
th
 century correlated with a reduction in the transmission of rates of 
H. pylori, supporting the likelihood of a predominantly oral/faecal-oral transmission 
route (Rupnow et al., 2000). 
Iatrogenic transmission has been found to occur through use of compromised 
medical equipment e.g. endoscopes (Brown, 2000). Transmission associated with 
gastroesophageal reflux and contact with vomitus has also been reported (Parsonnet 
et al., 1999). Water has been suggested as a reservoir for H. pylori in the 
environment, both in freshwater streams and off-shore marine waters (reviewed in 
(Bellack et al., 2006), (Twing et al., 2011)). H. pylori has been isolated from a 
variety of non-human hosts including primates and domestic cats (Fox, 1995; Handt 
et al., 1994). Other non-pylori Helicobacters have been isolated from humans, 
though this is not their primary host e.g. H. suis and H. pullorum (Table 1) 
(Haesebrouck et al., 2009; Joosten et al., 2013). Thus, the possibility of zoonotic 
transmission of this gastric pathogen, perhaps through close human contact, must 
also be considered. 
 2.3 Infection and Inflammation 
Unlike the alkaline lumen of the bowel, the extremely acidic (pH 1 - 2) gastric 
lumen is a much more hostile environment for bacteria. Therefore, gastric colonisers 
such as H. pylori find their niche in the thick mucosal lining of the stomach and next 
to the epithelial cell surface (Hazell et al., 1986). Urease secretion, motility through 
the use of its multiple polar flagella and a range of virulence factors facilitate 
H. pylori persistence and infection e.g. catalase and superoxide dismutase 
(Section 2.4, Figure 3). 
Control of the local pH of the bacteria’s environment is key to the survival of the 
bacteria in the stomach long enough to establish infection. Secretion of urease alters 
the pH of the gastric lumen by hydrolysing urea to produce ammonia and carbon 
dioxide. H. pylori activates cytoplasmic urease through a pH-controlled channel, 
UreI (Weeks, 2000). Unperturbed by this otherwise hostile environment, the motile 
bacteria can then swim to, and interact with, host epithelial cells, thereby eliciting 
inflammation (Ottemann and Lowenthal, 2002). H. pylori localises in the gastric 
antrum, where there are few acid-producing parietal cells (McNulty and Watson, 
1984). It is also found deep in the mucosal layer of the corpus (Kuipers et al., 1995). 
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H. pylori motility is inhibited by active pepsin, a peptidase which is active at low 
pH levels. Postprandial occurrences associated with bouts of luminal neutralisation 
could provide an opportunity for H. pylori infection (Schreiber et al., 2005). This 
may help to explain why infection tends to occur during childhood as opposed to 
adulthood. In infants, this neutralising effect lasts for ~1 hr, while in adults it is as 
short as a few minutes. Thus, in infants and young children there is an extended 
postprandial period during which H. pylori can swim from the lumen to the gastric 
mucus and epithelial cells (Agunod et al., 1969; Bücker et al., 2012; Mitchell et al., 
2001). 
 
 
Figure 3 Pathogen-host interaction during infection. 
Overview of the various points of bacterial-host interaction during H. pylori infection and 
host responses (Suerbaum & Michetti 2002). 
 
Infection induces a host response which ultimately leads to inflammation and 
tissue damage, but not destruction of the invading pathogen. Upon reaching the 
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epithelial cells, host recognition of H. pylori peptidoglycan by NOD1 receptors 
initiates a cascade which activates NFκB (Viala et al., 2004). Injection of the 
H. pylori CagA effector protein into host cells illicits an NFκB and Fas-mediated 
pro-inflammatory response (Lamb et al., 2009). Recognition of H. pylori triggers a T 
helper type 1 (Th1) mucosal cell response which may induce gastritis by up-
regulation of IL18, interferon-γ (INF-γ) and caspase 1 (Ghosh et al., 2002; Tomita et 
al., 2001). Infection is also associated with increased levels of caspase 3 which 
induces apoptosis of host cells, contributing to the development of gastric ulcers and 
cancers (Shimada et al., 2008). Chemotaxis contributes to apoptosis induction 
through regulation of Th17 cells. Che
-
 mutant strains of H. pylori trigger less 
inflammation and apoptosis, despite colonising to a similar extent when compared 
with wild type infections of a mouse model (Rolig et al., 2011). Recently, a novel 
virulence factor, JHP940, has been described which activates an NFκB response 
through its activity as a eukaryotic-type Ser/Thr kinase (Kim et al., 2010). H. pylori 
mediates life-long low-level inflammation in the host by altering these immune 
response pathways, leading to a number of clinical conditions. 
 2.4 Virulence Factors 
A variety of virulence factors contribute to the pathogenicity of Helicobacter 
pylori (Backert and Clyne, 2011). These include urease, motility, cag PAI, VacA, 
adhesins and lipopolysaccharide (LPS). Urease production and motility are key 
virulence factors which work in tandem to enable Helicobacter pylori infection and 
persistence in the host. Urease is a nickel-containing metalloenzyme composed of 
two subunits, UreA and UreB. The active form of urease hydrolyzes urea to produce 
ammonia and carbon dioxide, which raises the pH. H. pylori is not an acidophile, and 
hence, activity of this enzyme is essential for survival in the gastric lumen which has 
a pH of ~2. Cytoplasmic urease allows the bacteria to maintain a neutral internal pH 
(Stingl et al., 2001). There is also evidence of altruistic autolysis of H. pylori making 
urease available for outer membrane association (Phadnis et al., 1996). Urease-
deficient H. pylori are unable to colonise the stomachs of gnotobiotic piglets. 
Surprisingly, urease-deficient H. pylori are out-competed by urease-producing 
H. pylori in co-infection experiments of achlorhydric piglets, indicating another role 
for this enzyme beyond pH neutralisation (Eaton and Krakowka, 1994). 
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It was suggested that urease has a dual function as an adhesin, but this was later 
disproven (Clyne et al., 1996). A study using the gerbil model of infection indicated 
that H. pylori spatial orientation in the gastric mucosa is dependent on pH gradient 
(Bahari et al., 1982; Schreiber et al., 2004). Ammonia and bicarbonate produced by 
the enzyme may also cause pathological effects including cytotoxicity and 
suppression of host bactericidal activity (Kuwahara et al., 2000). Urease promotes 
survival of H. pylori engulfed by macrophages and inhibits opsonisation (Rokita et 
al., 1998; Schwartz and Allen, 2006). It also indirectly disrupts the tight junctions of 
gastric epithelial cells, contributing to virulence (Wroblewski and Peek, 2011; 
Wroblewski et al., 2009). 
Urease activity, chemotaxis and motility are closely associated in their 
contribution to the virulence of H. pylori. Motility is essential for H. pylori infection 
and persistence in the host (Eaton et al., 1992; Ottemann and Lowenthal, 2002). 
Motility enables the bacterium to travel to, and remain in, the host gastric mucosal 
layer and to interact with host epithelial cells through adhesins and other factors (see 
above). A number of flagellar proteins (FliQ, FliM and FliS) participate in adherence 
to AGS cells (Zhang et al., 2002). Chemotactic sensing enables the bacteria to swim 
away from an acidic environment, i.e. the lumen, through membrane-bound or 
cytoplasmic chemoreceptors e.g. TlpD (Croxen et al., 2006). In Salmonella enterica 
serovar Typhimurium the phosphorylated form of CheY interacts with flagellar 
switch protein FliM to initiate clockwise flagellar rotation resulting in tumbling and 
change of direction (Lowenthal et al., 2009). Bacterial urease activity raises the local 
pH of the mucus, which is associated with a reduction in mucin viscosity. This 
altered rheology allows the bacteria to move more freely through the mucosal layer 
(Celli et al., 2009). Cell shape contributes to H. pylori motility and colonisation 
ability. Cells lacking the characteristic helical twist of H. pylori display impaired 
motility in gel-like mucin at low pH and reduced colonisation capabilities (Sycuro et 
al., 2010, 2012). H. pylori is known to interact with gastric mucins, glycosylated 
extracellular proteins which function in homeostasis and host protection (Van de 
Bovenkamp et al., 2003). H. pylori reduces the rate of mucin production in a mouse 
model (Navabi et al., 2013). An in vitro study using human gastric cancer cell lines 
also found that urease and flagellin can alter the expression profile of mucins (Perrais 
et al., 2013). The flagellar-type secretion system is not exclusively used for flagellum 
biogenesis. Virulence proteins have been identified which are secreted through the 
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flagellar lumen e.g. YplA in Yersinia enterocolitica and CiaB in Campylobacter 
(Christensen et al., 2009; Young et al., 1999).Therefore, the importance of flagella 
and motility as an important virulence and colonisation factor should not be 
underestimated. 
H. pylori strains are subdivided into two subsets on the basis of their Cytotoxin-
associated gene A (cagA) status: Class I strains are cagA positive and are associated 
with increased virulence, Class II are cagA negative (Covacci et al., 1993; Xiang et 
al., 1995). CagA is a highly immunogenic protein which is injected into host 
epithelial cells via a Type IV secretion system (Covacci et al., 1993). The cagA gene 
is present on a 40 kb PAI alongside genes for approximately 30 proteins (Figure 4) 
(Censini et al., 1996). This includes the genes encoding a complete T4SS (Kutter et 
al., 2008). The content of this PAI varies considerably between strains as it quite 
unstable and is subject to frequent inversion and deletion events (Akopyants et al., 
1998; Kauser et al., 2004). Other genes in this PAI encode proteins with homology to 
several virulence-associated proteins, e.g. conjugative plasmids and heat shock 
proteins, thus highlighting its multifaceted role in H. pylori virulence (Akopyants et 
al., 1998) (Akopyants et al., 1998). 
CagA is the first identified bacterial oncoprotein that functions in mammalian 
hosts (Ohnishi et al., 2008). CagA-positive strains of H. pylori are associated with 
increased inflammation and development of more severe conditions such as gastric 
adenocarcinoma and B cell mucosa-associated lymphoid tissue (MALT) lymphoma 
(Murata-Kamiya, 2011; Wroblewski et al., 2010). Exposed CagA on the bacterial 
surface triggers externalisation of host plasma membrane phosphatidylserine to 
which CagA binds and initiates entry into host cells (Murata-Kamiya et al., 2010). 
CagA undergoes tyrosine phosphorylation by Src kinase or Abelson murine leukemia 
viral oncogene homolog 1 (ABL) kinase (Poppe et al., 2007; Selbach et al., 2002). 
Phosphorylated CagA can then bind to and activate SRC homology 2 domain-
containing phosphatase (SHP-2) (Higashi et al., 2002). This activity causes 
elongation of cells known as the hummingbird phenotype (Segal et al., 1999). CagA 
interacts with PAR1/MARK to disrupt tight junctions and induce loss of cell polarity 
(Saadat et al., 2007). It has also been found to destabilise the tight junction complex 
E-cadherin/β-catenin and promote cell migration (Bagnoli et al., 2005; Murata-
Kamiya et al., 2007). Furthermore, CagA increases IL-8 expression, enhancing the 
inflammatory response to infection (Crabtree et al., 1994). 
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Figure 4 The cag pathogenicity island. 
Overview of the components of the cag PAI in H. pylori adapted from (Suerbaum & 
Michetti, 2002). 
 
Vacuolating cytotoxin (VacA) is a multifactorial secreted cytotoxin which has 
been extensively studied in H. pylori. VacA was identified soon after H. pylori was 
first isolated as a toxin which induces vacuolation of host epithelial cells (Leunk et 
al., 1988). All strains possess the vacA gene but it is subject to extreme diversity. The 
preprotoxin is ~193 kDa and contains three variable regions which are the site of 
polymorphisms: signal sequence (s), mid (m) and intermediate (i) regions (Atherton 
et al., 1995; Rhead et al., 2007). The vacA allele harboured by a given strain is a 
determinant for pathogenicity. The s1/m1 genotype was considered the most virulent 
form but evidence suggests the i-region variant may be a better predictor of more 
severe clinical outcomes (Chung et al., 2010; Miehlke et al., 2000; Rhead et al., 
2007). 
The pre-protoxin consists of an N-terminal signal sequence for transport across 
the inner membrane, a passenger domain and a C-terminal auto-transporter domain 
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which enables Type 5 secretion. The passenger domain is composed of p33 and p55 
subunits which are cleaved to produce an 88 kDa toxin (Lupetti et al., 1996; Telford 
et al., 1994). p33 has a role in cell binding, while p55 is central to vacuolation, 
membrane depolarisation and internalisation (Torres et al., 2005). The p33 subunit 
targets VacA to the mitochondrial inner membrane, resulting in apoptosis as 
indicated by the release of cytochrome c and activation of caspase 3 (Galmiche et al., 
2000; Willhite and Blanke, 2004). VacA forms endosomal membrane anion channels 
which inhibit antigen presentation, procathepsin D maturation and destruction of 
epidermal growth factor (EGF) (Molinari et al., 1998; Satin et al., 1997; Tombola et 
al., 1999). This potent cytotoxin also inhibits T-cell proliferation and activation, 
enabling H. pylori to alter and evade the host adaptive immune response to infection 
(Gebert et al., 2003; Sundrud et al., 2004). Salama et al. showed that wild type 
H. pylori out-compete vacA-negative mutants in a murine gastric model, indicating 
an additional role in initial host colonisation for this toxin (Salama et al., 2001). 
LPS is a component of the outer membrane and the flagellar sheath (Jones and 
Curry, 1989). It is composed of lipid A, core oligosaccharide and an O-antigen 
domain. In H. pylori, LPS exerts a low level of pro-inflammatory activity compared 
with LPS of other enterobacteria, including E. coli and Salmonella (Muotiala et al., 
1992). Altered lipid A backbone phosphorylation allows LPS to evade TLR2 
recognition, contributing to persistence of this pathogen (Cullen et al., 2011). 
H. pylori exerts molecular mimicry through the O-chain of LPS which can present 
structures similar to host Lewis blood group antigens (Wirth et al., 1997). Lewis X-
induced autoantibodies are associated with colonisation ability and adhesion of 
H. pylori to AGS cells (Sheu et al., 2007). LPS possibly exhibits its endotoxic 
activity through up-regulation of inducible nitric oxide expression which leads to 
impairment of host DNA repair machinery, as studied in human colon carcinoma cell 
lines (Cavallo et al., 2011). A link between LPS production and flagellar assembly 
has been identified in C. jejuni. Cj0256 is a phosphoethanolamine transferase which 
post-translationally modifies both lipid A and flagellar rod protein, FlgG. Cj0256 is 
essential for motility in C. jejuni, as deletion of this gene results in aflagellate cells 
(Cullen and Trent, 2010). 
H. pylori peptidoglycan is transported to host epithelial cells either by the cagPAI 
T4SS or bacterial outer membrane vesicles (Kaparakis et al., 2010; Viala et al., 
2004). There, it binds to NOD1 receptors, triggering an NFκB/IL-8-mediated 
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inflammatory response (Girardin et al., 2003; Viala et al., 2004). Many H. pylori 
adhesins are surface proteins which bind host epithelial glycoproteins. Blood group 
antigen-binding protein (BabA) is an adhesin that binds Lewis-b blood group antigen 
(Borén et al., 1993). Presence of the babA2 gene has been suggested as a marker of 
increased risk to H. pylori-associated diseases including duodenal ulcer and 
adenocarcinoma (Gerhard et al., 1999; Mizushima et al., 2001). Sialic acid-binding 
adhesin (SabA) binds sialated Lewis-X (Mahdavi et al., 2002). This adhesin 
facilitates binding of H. pylori to mucosal epithelial cells where it then illicits 
activation of neutrophils and inflammation (Petersson et al., 2006; Unemo et al., 
2005). This strong response can be dampened by neutrophil activating protein (HP-
NAP) to aid H. pylori persistence (Unemo et al., 2005; Wang et al., 2006). Outer 
inflammatory protein A (OipA) is an adhesin which illicits a pro-inflammatory host 
response through the activation of Il-8 (Yamaoka et al., 2000). Additionally, OipA is 
involved in focal adhesion kinase (FAK) phosphorylation and activation, affecting 
actin stress fiber formation and cell motility (Tabassam et al., 2008). 
Catalase, superoxide dismutase and HP-NAP also function to neutralise reactive 
oxygen species, an oxidative stress response contributing to virulence (Bauerfeind et 
al., 1997; Seyler et al., 2001; Wang et al., 2006). Duodenal ulcer promoting protein 
A (DupA) was identified in 2005 as an adhesin associated with IL-8 and IL-12 
induction and inflammation in mononuclear cells (Hussein et al., 2010; Lu et al., 
2005). H. pylori produces a pore-forming cytolysin orthologue, TlyA, which confers 
haemolytic activity (Lata et al., 2014; Martino et al., 2001). The outer membrane 
phospholipase A (PldA) has also been shown to mediate haemolysis and contribute 
to host colonisation (Dorrell et al., 1999; Sitaraman et al., 2012). Sphingomyelinase 
(SMase) activity results in haemolysis of blood lymphocytes as well as activation of 
mitogen-activated protein (MAP) kinases and apoptosis in AGS cells (Chan et al., 
2000; Tseng et al., 2004). The capacity of H. pylori for horizontal gene transfer in 
vitro is indicative of its ability to adapt to and persist in its host (Blaser and Atherton, 
2004; Nedenskov-Sorensen et al., 1990). Toller et al. hypothesize that double-strand 
DNA breakages induced by H. pylori infection may be a contributing factor in the 
development of gastric carcinoma. Persistent infection may lead to mutations 
generated during DNA repair, thereby increasing the risk for cancer development 
(Toller et al., 2011). Thus, H. pylori has a diverse armoury of virulence factors at its 
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disposal to aid in host infection and persistence while evading removal by the host 
immune system. 
 2.5 Disease 
The association between Helicobacter pylori and chronic gastritis and peptic 
ulceration was noted by Marshall and Warren (Marshall and Warren, 1984; Warren 
and Marshall, 1983). In fact, Marshall ingested H. pylori to confirm Koch’s 
postulates identifying H. pylori as a causative agent of gastritis (Marshall et al., 
1985). It is now accepted that almost all subjects infected with H. pylori develop 
chronic gastritis (Kusters et al., 2006). However, only a minority develop the more 
severe pathological effects of infection, including peptic ulcer, non-ulcer dyspepsia, 
gastric carcinoma and MALT lymphoma (Figure 5). An association has also been 
made between H. pylori infection and sudden infant death syndrome (Kerr, 2000). 
In most cases, acute gastritis does not progress further, but it can develop into 
gastric/duodenal ulcer disease (Cave and Goddard, 1999). H. pylori infection is also 
associated with dyspepsia (Harvey et al., 2010). Gastric ulcers occur in the region of 
the stomach where the corpus mucosa meets the antrum mucosa, whereas duodenal 
ulcers are associated with the duodenal bulb (Kusters et al., 2006). H. pylori is a 
major causative agent of gastric ulcers. Complications can arise from ulceration 
including bleeding and stricture formation. 
The more severe disease types associated with H. pylori infection include gastric 
adenocarcinoma and MALT lymphoma. In 1994, Helicobacter pylori was classified 
as a human carcinogen (International Agency for Research on Cancer, 1994). 
Atrophic gastritis and intestinal metaplasia can result from chronic gastritis-
associated inflammation (Kuipers et al., 1995). These features can increase the risk 
of development of gastric cancer (Uemura et al., 2001). Gastric cancer is the third 
most common form of cancer in men, and fifth in women (Jemal et al., 2011; 
Society, 2011). Approximately 50% of gastric cancer occurrences can be attributed 
to H. pylori infection, illustrating the global burden of H. pylori infection (Parkin, 
2006). In a Swedish cohort, H. pylori was associated with ~70% of all noncardia 
adenocarcinomas (Ekström et al., 2001). Clinical studies show that a high percentage 
of MALT lymphoma patients test positive for H. pylori and its eradication has been 
linked with disease remission (Eidt et al., 1994; Fischbach et al., 2009). 
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Figure 5 Clinical outcomes of H. pylori infection. 
Adapted from (Kim et al., 2011). 
 
 2.6 Diagnostics 
A broad range of diagnostic tests have been established for H. pylori infection. 
These can be classified as either invasive (endoscopy, histology) or non-invasive 
(serological tests, urine, stool antigen assays, breath etc.). Results of two tests are 
sometimes required to confirm diagnosis- urea breath testing and histological 
examination of tissue are most commonly used (Calvet et al., 2009; Graham et al., 
2008). 
Culture of H. pylori is not only useful as a confirmatory test, but also allows 
determination of antibiotic susceptibilities of the strain(s) isolated to aid in treatment 
strategy selection. Urease-based biopsy tests available range from the CLOtest, 
which takes up to 24 hr, to the PyloriTek strip which takes 1 hr to give a result 
(Cutler et al., 1995; Laine et al., 1996). However, non-invasive alternative urease 
breath tests are now commonly used in which labelled urea is ingested and the 
resulting bicarbonate, exhaled as CO2, is detected (Koletzko et al., 1995; Minoli et 
al., 1998). The rapid urease test has > 98% sensitivity, while 
13
C/C
14
 urea breath test 
identifies the presence of H. pylori with sensitivity > 95% (WGO, 2010). PCR offers 
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specificity, high sensitivity and may be used to detect H. pylori non-invasively from 
bodily fluids e.g. saliva; however, PCR has yet to be optimised and standardised for 
this purpose. PCR-based detection of vacA intermediate region has been developed 
which could be used to rapidly screen patients at elevated risk for gastric cancer 
development (Ferreira et al., 2012). Quantitative real-time (qRT) PCR and 
fluorescence qPCR are recently emerging detection methods which may provide an 
alternative to the traditional detection methods (Ou et al., 2013; Saez et al., 2012). 
Recent comparative studies suggest histology may be the most robust detection 
method (Choi et al., 2012; Tian et al., 2012). A recent study involving enzyme-
linked immunosorbent assay (ELISA) of stool samples of children highlights another 
method warranting development as a non-invasive diagnostic of H. pylori infection 
(Leal et al., 2011). 
 2.7 Treatment 
Consensus guidelines recommend treatment to eradicate H. pylori in patients 
presenting symptoms of infection (Malfertheiner et al., 2012). Growing H. pylori 
antibiotic resistance presents a challenge for treatment of infection due to capacity 
for mutation and gene acquisition facilitated by the extreme genome plasticity of 
H. pylori (outlined above) and the common use of antibiotic therapies to treat 
bacterial infections (Mégraud, 2004). Failed dual therapy results in the development 
of H. pylori dual resistance, indicating that emerging resistance is associated with 
previous antibiotic treatments (Heep et al., 2000). Clarythromycin-based triple 
therapy using two antibiotics and a proton pump inhibitor is the standard first line 
treatment for infection (Bazzoli et al., 1993). However, growing resistance to 
clarithromycin, and levofloxacin, means this first line of treatment must be reviewed 
(Mégraud, 2012). 
Quadruple bismuth-based therapies is one approach to overcome the issue of 
resistance (Malfertheiner et al., 2012). Tailored treatment is an attractive solution, 
made more feasible with the development of molecular-based susceptibility 
screening such as GenoType HelicoDR (Cambau et al., 2009). An effective vaccine 
in humans has yet to be described that affords sustainable protection from H. pylori 
infection (Koch et al., 2013). Furthermore, due to the difficulties in identifying the 
point of infection, when to vaccinate could be vital to the success of vaccination 
schemes. OipA, LPS and urease A immunogens have had some success in protection 
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from H. pylori using murine models (Altman et al., 2012; Chen et al., 2012; Guo et 
al., 2012). 
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3 Bacterial Secretion Systems 
The secretion of bacterial proteins is of particular importance for understanding 
pathogenic bacteria. A complete secretion system enables the delivery of toxins, 
enzymes and other virulence factors during infection, while adhesins can be 
presented on cell surfaces to mediate interactions. Non-pathogenic bacteria also 
utilise protein secretion to enhance survival e.g. the secretion of sortase by 
Lactobacillus salivarius subspecies salivarius strain UCC118 (van Pijkeren et al., 
2006). The mechanisms for secretion differ between Gram positive and Gram 
negative organisms. Each of the currently known secretion systems (I - VII) are 
described below. 
  
 
 
Figure 6 Generalised diagram of the known bacterial secretion systems. 
Graphical representation of bacterial protein secretion systems spanning the inner membrane (IM), outer membrane (OM), host membrane (HM) and 
mycomembrane (MM). OMP: outer membrane protein; MFP: membrane fusion protein (Tseng et al., 2009) 
 
Chapter 1 
~ 26 ~ 
 3.1 Type I Secretion System 
The Type I secretion system (T1SS) is found in both Gram positive and Gram 
negative bacteria. It facilitates the secretion of a wide variety of proteins including 
toxins, proteases, lipases and bacteriocins. Bacteria use ABC transporters as a 
mechanism for multidrug resistance, which can account for > 10% of the transporters 
encoded for on the genome (Paulsen, 2003). The T1SS is composed of an inner 
membrane ATPase-binding cassette (ABC) transporter protein, a membrane fusion 
protein and an outer membrane pore-forming protein (Omori and Idei, 2003). The 
mechanism of secretion by this pathway is Sec-independent (Figure 6). Proteins 
exported in this way have a characteristic carboxy-terminal signal sequence, which is 
not cleaved during secretion (Duong et al., 1996). Secretion of the E. coli 
haemolysin, Hly, is the model system for the T1SS (Mackman et al., 1986). 
Lactococcus lactis is a Gram positive organism with 40 putative multidrug resistance 
proteins secreted by the T1SS including LmrCD (Lubelski et al., 2007). H. pylori 
strains possess a number of ABC transporters e.g. NixA (Hendricks and Mobley, 
1997). 
 3.2 Type II Secretion System 
The Type II secretion system (T2SS) is a more complex two-step process used by 
Gram negative bacteria to secrete a variety of proteins, mainly enzymes. This system 
is encoded by 12 - 16 genes, generally found together in one operon, and has been 
studied in detail in E. coli, Pseudomonas aeruginosa and Legionella pneumophila 
(Douzi et al., 2012; Jyot et al., 2011; Rossier et al., 2004). The first step in this 
process is transport across the inner membrane into the periplasm either by the Sec or 
twin-arginine translocation (Tat) pathways (Pugsley, 1993; Voulhoux et al., 2001). 
The Sec secretion system is a general export system used by Gram positive 
bacteria to transport proteins across its single membrane to the extracellular milieu. 
In Gram negative bacteria, Sec secretion translocates proteins to the periplasm in 
three stages: protein sorting, translocation and release/maturation (Papanikou et al., 
2007). Sec secretion requires the recognition of an amino-terminal leader sequence 
on proteins targeted for secretion. These pre-proteins are brought to a channel-
forming translocase complex at the inner membrane composed of SecY, SecE and 
SecG which drives protein export through activity of the SecA ATPase (van den 
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Berg et al., 2004). Once in the periplasm, the signal sequence is cleaved by a signal 
peptidase and protein folding is initiated to produce the mature form of the protein 
(Mogensen and Otzen, 2005; Paetzel et al., 2002). 
The Tat pathway facilitates the transfer of folded proteins across the inner 
membrane and has a role in diverse cellular functions including cell division, quorum 
sensing and cell motility (Ding and Christie, 2003; Palmer and Berks, 2012; Stanley 
et al., 2001; Stevenson et al., 2007). Proteins are targeted to the Tat system for 
export through recognition of an amino-terminal signal sequence containing a twin-
arginine motif (Chaddock et al., 1995). The export apparatus located in the bacterial 
inner membrane consists of TatA and TatC protein families (Palmer and Berks, 
2012). The TatABC complex binds target proteins and export is driven by proton 
motive force (Bageshwar and Musser, 2007; Mould and Robinson, 1991). The 
crystal structure of TatC, the core component of the pathway, from Aquifex aeolicus 
has recently been published (Rollauer et al., 2012). TatC recognises the signal 
sequence of target proteins and recruits other Tat export proteins to initiate export. 
The TatBC complex of E. coli has been modelled from transmission electron 
microscopy (TEM) data (Tarry et al., 2009). TatA forms a homopolymeric pore in 
the inner membrane which has a variable diameter thereby allowing export of 
proteins of varying sizes (Gohlke et al., 2005). 
The T2SS subsequently translocates target exoproteins across the outer membrane 
in a process involving an outer-membrane complex and a pesudopilus structure 
(Korotkov et al., 2012). The pseudopilus is composed of a multimer of the major 
pseudopilin, secretin and four other pseudopilins. The assembled structure resembles 
the Type IV secretion system (Figure 6) (Durand et al., 2003; Sauvonnet et al., 
2000). There is also some similarity with components of the archaeal flagellum, e.g. 
the pre-flagellin peptidase, FlaK in Methanococcus shares homology with prepilin 
peptidases (Peabody, 2003). The current hypothesis for the mechanism of secretion is 
that binding of the target protein to the periplasmic domain of secretins triggers the 
ATPase-driven extension of the pesudopilus which pushes the exoprotein through the 
channel (Korotkov et al., 2012). 
 3.3 Type III Secretion System 
The Type III secretion system (T3SS) is one of the most complex secretion 
systems known, composed of > 20 proteins (Cornelis, 2006). In Gram negative 
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bacteria, the T3SS translocates target proteins in a one-step process which is 
independent of the Sec pathway. The T3SS mediates bacterial/host interactions 
through injection of effector molecules into host cells and plays a role in colonisation 
and pathogenesis (Galán and Collmer, 1999; Rosqvist et al., 1994). It produces an 
injectisome, so-called due to its needle-like structure (Figure 6). There are seven 
families of injectisomes, which have evolved independently of the bacteria in which 
they are found i.e. there is evidence of horizontal gene transfer events in their 
evolution (Troisfontaines and Cornelis, 2005). Injectisomes are produced by 
Yersinia, Pseudomonas, Shigella, and E. coli (Cornelis, 2006). The T3SS allows the 
translocation of a wide variety of effector molecules and is largely considered to be a 
virulence factor, though it has been found in some non-pathogenic bacteria. There is 
evidence that the injectisome itself can cause host cell damage and death, without the 
translocation of effector proteins (Hauser, 2009). 
The T3SS generally requires host-cell contact to activate protein export which is 
guided by chaperones (Pettersson et al., 1996). It is composed of a multi-ring basal 
structure which spans the bacterial membranes, and a protruding needle-like filament 
which delivers effector proteins. A membrane-associated ATPase in the cytoplasm is 
essential for protein export and it has homology to F1-ATPase subunits (Woestyn et 
al., 1994; Zarivach et al., 2007). At the distal end of the needle, there is a tip 
complex which acts as a platform for translocators which induce pore formation in 
the host cell (Moraes et al., 2008; Mueller et al., 2008). Effector proteins are then 
translocated in an unfolded state to the host through the hollow lumen of the 
injectisome (Akeda and Galán, 2005). 
 
 
Figure 7 The bacterial flagellum and the Gram negative injectisome. 
Schematic comparison of the components of these Type III secretion apparatus. Adapted 
from (Saier, 2004). 
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The T3SS shares close similarity at the level of individual components, and how 
they are assembled, to the bacterial flagellar export apparatus (Figure 7). 
Phylogenetic analyses had indicated that these systems evolved independently of 
each other from a common ancestor (Gophna et al., 2003). However, a recent re-
evaluation of the evolutionary relationship between these two systems incorporating 
the large body of genome sequencing information now available, seemed to indicate 
that the T3SS evolved from the bacterial flagellum (Abby and Rocha, 2012). While 
the primary function of the flagellar export apparatus is the sequential export of 
components of the flagellar apparatus (Section 4), there are documented cases where 
it is also used for the export of non-flagellar proteins e.g. YplA of Yersinia 
enterocolitica and CiaC of Campylobacter jejuni (Christensen et al., 2009; Young et 
al., 1999). Similar to flagellar biogenesis, construction of the T3SS is a hierarchical 
process which is tightly regulated. A number of components display sequence 
similarity with their flagellar counterparts. For instance, Spa32, which controls 
needle length of injectisomes produced in Shigella flexneri is homologous with FliK, 
the flagellar hook-length control protein (Magdalena et al., 2002). 
 3.4 Type IV Secretion System 
The Type IV secretion system (T4SS) is found in both Gram positive and Gram 
negative bacteria. It can be sub-divided into three categories based on function: 
bacterial conjugation, DNA transfer and effector protein translocation. The T4SS is 
unique in its ability to transfer both DNA and proteins to bacterial, plant and animal 
cells i.e. interkingdom transfer (Fronzes et al., 2009). Agrobacterium tumefaciens C8 
is the model system of T4S. The VirB/D system is composed of 12 proteins which 
assemble to produce a cytoplasmic/inner membrane complex, a channel which spans 
bacterial and host cell membranes and an external pilus structure (Figure 6). Using 
this system, A. tumefaciens delivers oncogenic DNA-protein complexes to host cells 
which can lead to the development disease in plants (Fronzes et al., 2009). 
Conjugation is a DNA transfer mechanism which requires cell-cell contact. 
Conjugative plasmids generally contain genes with functions in areas such as 
antibiotic resistance and stress-response, which promote environmental adaptation 
and genetic diversity (Wallden et al., 2010). T4SS produce pili which enable a 
“slingshot”-type crawling motility as seen in Pseudomonas aeruginosa (Jin et al., 
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2011). Bordetella pertussis and Legionella pneumophila are examples of human 
pathogens which effectively use the T4SS to illicit disease (Wallden et al., 2010). 
In H. pylori, the CagA virulence protein is exported by the T4SS, the machinery 
for which is encoded on a pathogenicity island (Section 2.4). In addition to 
conjugative transfer of genetic material, H. pylori encodes genes for the ComB 
system which facilitates the transfer of DNA independently of conjugation (Fischer 
et al., 2010; Hofreuter et al., 2001). Each of these mechanisms contributes to the 
characteristic extreme genetic plasticity of H. pylori. 
 3.5 Type V Secretion System 
The Type V secretion system (T5SS) is a two-step process describing three 
distinct mechanisms of protein export: the autotransporter (Va) system, the two-
partner secretion (Vb) pathway and the oligomeric coiled-coil adhesin (Vc) system 
(Henderson et al., 2004). The T5SS is the simplest of the secretion systems and is the 
most commonly employed system for protein secretion by Gram negative bacteria 
(Figure 6). Effector proteins secreted by the Va system are composed of three 
structural domains, the first of which is an N-terminal signal sequence recognised by 
the Sec system for transport across the inner membrane. The exoprotein also contains 
a central passenger domain and a C-terminal translocation β-barrel domain which 
forms a pore that enables the protein to cross the outer membrane and be secreted 
into the extracellular milieu (Pohlner et al., 1987). After secretion, the protein 
undergoes auto-proteolysis to cleave the helper domain e.g. VacA in H. pylori. 
However, there are some exceptions as not all effector proteins have autocatalytic 
protease activity e.g. the Hsr surface protein ring of H. mustelae remains tethered to 
the outer membrane (O’Toole et al., 1994). Autotransporters are widely found in ε-
proteobacteria and are associated with virulence as effector proteins often include 
adhesins, enzymes and toxins (Henderson et al., 2004). 
The two-partner secretion pathway is similar to the Va system. An N-terminal 
signal sequence on the passenger protein facilitates transport to the periplasm. The 
key difference is that the translocation unit is translated as a separate protein in this 
system (Jacob-Dubuisson et al., 2001). The Vc system describes adhesins which are 
composed of 6 distinct domains, the archetype of which is YadA in Yersinia 
(Hoiczyk et al., 2000). An N-terminal signal sequence is followed by domains 
designated as: head-D, neck-D, stalk-D, linking-R and C-terminal β-barrel domains. 
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The lollipop-shaped effector proteins are exposed on the surface of the outer 
membrane where they are anchored by the C-terminal domain. 
Relatively recently, Salacha et al. described a novel T5SS in P. aeruginosa which 
they named the Vd system. This is a hybrid of the autotransporter and two-partner 
systems in which the C-terminus translocation domain of the protein for export, 
PlpD, more closely resembles a translocation unit of the Vb system (Salacha et al., 
2010). An inverse mechanism describes the most recently identified type Ve system. 
This family shares closest similarity to the Va autotransporters, however, the β-barrel 
translocation domain is at the N-terminus, while the C-terminus is exposed on the 
outer membrane surface (Oberhettinger et al., 2012). Intimin of enteropathogenic 
E. coli and invasin of Yersinia, both virulence factors, were the first described 
members of this group. 
 3.6 Type VI Secretion System 
The Type VI secretion system (T6SS) was first described in Vibrio cholera 
(Pukatzki et al., 2006). It has since been identified in the genomes of more than 80 of 
Gram negative bacteria, including both pathogenic and non-pathogenic species such 
as Yersinia pestis and Burkholderia pseudomallei (Boyer et al., 2009). Vibrio 
cholera uses the T6SS to export toxins not only to eukaryotic host cells, but also to 
other bacteria, providing a competitive advantage in its environment (MacIntyre et 
al., 2010). 
The 15 - 25 genes in the T6SS locus encode effector proteins, structural 
components, chaperones and ATPases to power secretion by this Sec-independent 
system (Pukatzki et al., 2009). While many structural proteins have been studied, 
little is known about the other components. Haemolysin A coregulated protein (Hcp) 
is secreted by all functional T6SS to form homohexamer rings. As these rings can be 
stacked to produce a nanotube structure, it is possible that Hcp is the building block 
of a core channel through which effector proteins can be transported (Ballister et al., 
2008). Interestingly, Hcp requires the secretion of VgrG proteins in Vibrio cholera 
which interact to form a complex; these have sequence similarity with bacteriophage 
T4 tailspike proteins which puncture host cells and hence may have a key role T6SS 
function (Pukatzki et al., 2007). Threonine phosphorylation at a post-translational 
level has been identified as playing a role in T6SS regulation (Mougous et al., 2007). 
More work in this area is needed to elucidate the regulation of this secretion system. 
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 3.7 Type VII Secretion System 
The Type VII secretion system (T7SS) is a specialised system used by 
Mycobacterium tuberculosis, the causative agent of tuberculosis in humans (Figure 
6). This system is adapted to the unusual cell envelope of this Gram positive 
pathogen (Brennan and Nikaido, 1995). The T7SS includes five types, ESX 1 - 5, the 
first of which is the archetype for the system (Stanley et al., 2003). Although the 
exact nature of the role the T7SS plays in M. tuberculosis virulence is unknown, 
disruption of this pathway has been shown to attenuate virulence (Abdallah et al., 
2007; Stanley et al., 2003). Effector proteins secreted by this system possess a 
recently identified C-terminal signal sequence and include T cell antigens (Daleke et 
al., 2012). Components of this system include chaperones, membrane-spanning 
proteins and ATPases, though structural information is lacking (Abdallah et al., 
2007). Proteins for secretion by the ESX 1 system form a heterodimeric complex 
which is targeted for secretion (Renshaw et al., 2005). T7SS homologues have been 
identified in other Gram positive bacteria including S. aureus and Bacillus spp.. 
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4 Composition and Organization of the Bacterial Flagellum 
The bacterial flagellum is an ancient and complex nanomachine which facilitates 
motility. It is an important feature of H. pylori because motility is an essential 
colonization factor (Eaton et al., 1992). Phylogenetic analysis suggests that the 
flagellum evolved from a single gene that was duplicated and underwent mutations, 
leading to new functions (Liu and Ochman, 2007). The best studied models for 
bacterial flagellum biogenesis are those in E. coli and Salmonella enterica. The 
H. pylori flagellum largely resembles these models, with some differences, the 
details of which will be discussed in this section. 
 4.1 Morphology of the flagellum in Enterobacteriaceae 
The flagellar superstructure is composed of four sub-sections: basal body, export 
apparatus, hook and filament. The basal body is composed of three rings: an inner 
membrane (MS) ring, a periplasmic (P) ring and an outer membrane (L) ring (Figure 
8). These are connected by the cylindrical rod and the structure serves to anchor the 
flagellum in the bacterial cell membrane (Macnab, 2004). FliF, FlgI and FlgH 
compose the MS, P and L rings, respectively. These proteins, involved in early stages 
of flagellum biogenesis, are assembled using the Sec secretion system (Jones et al., 
1989). The rod is composed of a number of proteins: an MS-ring rod junction protein 
(FliE), transmission shaft proteins (FlgB/C/F/G) and a rod capping protein (FlgJ) 
(Homma et al., 1990). The rod proteins are exported by the flagellar T3SS. 
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Figure 8 Generalised diagram of the bacterial flagellum. 
The basal body and export apparatus are contained in the bacterial membrane and cytoplasm, 
while the rod, hook and filament form a hollow tube through which flagellar components are 
exported (Pallen et al., 2006). 
 
The flagellar motor, composed of stator and rotor elements, interacts with the 
basal body to generate torque which results in propulsion (Lloyd et al., 1996). MotA 
and B proteins of the stator assemble as integral membrane studs in the 
peptidoglycan layer, while the rotor (FliG multimer) is non-covalently attached to the 
cytoplasmic side of the MS ring through interactions with FliF (Braun et al., 1999; 
Francis et al., 1992). Directional movement is achieved by flagellar rotation that is 
either clockwise (tumbling) or anticlockwise (swimming). The switch complex 
which controls rotation is composed of FliM, FliN and FliG proteins which assemble 
a C ring complex around the MS ring (Francis et al., 1994; Yamaguchi et al., 1986). 
MotA and MotB studs in the periplasm interact with the rotor and C ring (Braun et 
al., 1999; Thomas et al., 1999). Thus, the bacterial flagellum contains a motor with 
the capacity for controlled rotation towards stimuli/away from repellents, mediated 
by chemotactic response regulators e.g. CheY (Foynes et al., 2000). 
The hook is known as a universal joint as it links the rod to the filament (propeller 
component of the flagellum). It is a flexible helical assembly of ~120 FlgE 
monomers which allows multiple polar flagella rotate as a coordinated bundle 
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(Macnab, 1977; Makishima et al., 2001). Assembly of the short, curved hook 
requires a capping protein (FlgD) to guide assembly (Ohnishi et al., 1994). Hook 
associated proteins, FlgK (HAP1) and FlgL (HAP3), assemble at the junction 
between the hook and filament where they act as structural adapters (Hirano et al., 
1994). FliK tightly controls the invariant length of the hook, which is 55 nm in 
Salmonella (Hirano et al., 1994). 
The filament is a long, thin helical structure. In Salmonella, the filament is 
composed entirely of FliC which assembles as 11 protofilaments which can be 
modified through supercoiling when alternating between swimming and tumbling 
modes of motility (Samatey et al., 2001). The filament of H. pylori is composed of 
two subunits: a major flagellin, FlaA, and minor flagellin, FlaB (Leying et al., 1992; 
Suerbaum et al., 1993). Assembly of the filament is guided by the filament capping 
protein, FliD (HAP2) which is essential for motility (Ikeda et al., 1987; Kim et al., 
1999). These flagellins have only 58% sequence identity and their expression is 
alternately regulated (see below). FlaB incorporates into the filament in a hook-
proximal position (Kostrzynska et al., 1991). While flaA-null mutants are completely 
non-motile, flaB mutants retain the motility phenotype (Suerbaum et al., 1993). 
Structural proteins of the flagellum are translocated by the export apparatus 
through a narrow central channel using the flagellar Type III secretion system 
(T3SS) and assemble to extend the growing flagellum. The export apparatus is 
composed of soluble proteins (FliH, FliI, FliJ), located in the cytoplasm, and integral 
membrane proteins (FlhA, FlhB, FliO, FliP, FliQ and FliR) likely located in the MS 
ring (Figure 9) (Minamino and Macnab, 1999). Localisation of the export apparatus 
at the MS ring is mediated, in part, by the interaction of FlhA with FliF (Kihara et 
al., 2001). The localisation of FliP and FliR to the basal body supports the hypothesis 
that the export apparatus is found in the central pore of the MS ring (Fan et al., 
1997). Interactions between export apparatus chaperones and the proteins of the C 
ring indicate a role for the C ring in docking (González-Pedrajo et al., 2006). The 
membrane-bound components of the export apparatus form a proton-driven export 
gate where proteins are unfolded and translocated across the membrane (Minamino 
and Namba, 2008; Minamino et al., 2009). The soluble components of the export 
apparatus function to bind and deliver proteins to the export gate for efficient 
flagellum assembly (Minamino and Namba, 2008). 
Chapter 1 
~ 36 ~ 
 
 
Figure 9 Schematic overview of the bacterial flagellar export apparatus. 
FliH, FliI and FliJ are soluble components of the export apparatus (coloured green). FlhA, 
FlhB, FliO, FliP, FliQ and FliR are integral membrane components (coloured blue). Proteins 
coloured red represent substrates for export coupled to a chaperone. Adapted from 
(Minamino et al., 2008). 
 
In H. pylori, FliI is an essential protein in flagellum construction while a fliI-null 
mutant in Salmonella exhibits only reduced motility (Jenks et al., 1997; Minamino 
and Namba, 2008). FliH regulates FliI activity to prevent hydrolysis of ATP when 
FliI is not involved in protein export (González-Pedrajo et al., 2002; Minamino and 
MacNab, 2000; Minamino et al., 2001). When in complex, FliH binds the N-
terminus of FliI and inhibits the ATPase activity but also promotes docking (Lane et 
al., 2006; Minamino and MacNab, 2000). The stable FliH-FliI heterodimer docks at 
the export apparatus through interactions with the FlhA-FlhB complex (Minamino et 
al., 2003). The FliH-FliI complex also binds the C ring through FliH N-terminal 
interactions with FliN (McMurry et al., 2006). 
FliI is homologous to the α and β subunits of F0F1-ATPase and functions in 
protein docking at the export gate (Fan and Macnab, 1996). FliI assembles as a 
hexameric pore at the export apparatus where protein unfolding and export follow 
(Claret et al., 2008; Kazetani et al., 2009). FliJ is an essential component of the 
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export apparatus which is involved in chaperone recycling (Evans et al., 2006). In 
Salmonella, it promotes the ATPase activity of FliI and interacts with FlhA to 
facilitate docking of the FliH-FliI complex (Ibuki et al., 2013; Minamino et al., 
2010). 
As flagellum biosynthesis is a hierarchical process, control of the substrate-
specificity switch is critical to prevent premature export of filament components 
before completion of the hook. FlhB is an integral membrane protein which interacts 
with FliK to control the switch from export of early (rod/hook) to late (major 
flagellin) flagellar proteins (Williams et al., 1996). FlhB is located at the cytoplasmic 
face of the export apparatus and contains a number of transmembrane helices (Zhu et 
al., 2002). The substrate-specificity of FlhB depends on the conformational state of 
the protein, which is mediated by autolytic cleavage of its carboxy terminus (Ferris et 
al., 2005). FliK is the hook length control protein, which triggers the cleavage of 
FlhB once the hook has reached its full length (Erhardt et al., 2010; Moriya et al., 
2006). The mechanism by which FliK determines the hook length is termed the 
molecular ruler theory (Erhardt et al., 2010). FliK is secreted intermittently through 
the growing flagellum during assembly of the hook-basal body complex. Interaction 
of the FliK N-terminus with hook subunits and the hook cap causes a pause in 
secretion when the FliK C-terminus can interact with FlhBc once the hook is long 
enough. 
 4.2 Flagellum Assembly in Enterobacteriaceae 
Flagellum assembly occurs as a sequential, tightly regulated process whereby the 
cell proximal components i.e. basal body, are assembled first and followed by the 
more distal components in a sequential manner (Figure 10). The first component of 
the flagellum to assemble is the MS ring subunit, FliF, mediated by the Sec secretion 
system (Ueno et al., 1994). The export apparatus and substrate switch complex 
assemble around the MS ring in an independent process which does not require other 
flagellar proteins (Kubori et al., 1997). The C-terminal peptidoglycan-binding motif 
of MotB dimers may be responsible for targeting of the flagellar rotor to the stator 
(Kojima et al., 2008). 
 
  
 
  
Figure 10 Ordered flagellum synthesis in Salmonella. 
Sequential assembly of the bacterial flagellum where bracketed steps denote proteins expressed before a functional export apparatus is assembled i.e. proteins 
exported by the Sec secretion system. Assembly of the periplasmic and outer membrane rings requires Sec-mediated protein export. Hook and filament 
proteins are secreted by the flagellar Type III export apparatus. Adapted from (Macnab, 2004). 
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Assembly of the proximal rod components i.e. MS ring rod/junction protein, 
FlgB/C/F is guided by the rod capping protein, FlgJ (Hirano et al., 2001). Distal rod 
formation is followed by Sec-mediated assembly of the P- and L-rings (Figure 10). It 
has been proposed that the hook capping protein (FlgD) attaches to the distal 
growing end of the hook by its N-terminus where it promotes FlgE polymerisation, 
while the C-terminus functions to block and prevent secretion of unincorporated 
monomers into the extracellular milieu (Moriya et al., 2011). As mentioned above, 
FliK acts as a molecular ruler to control flagellar hook length. 
In Salmonella, FlgM is secreted into the extracellular milieu upon completion of 
the hook, releasing FliA suppression (Gillen and Hughes, 1991; Hughes et al., 1993). 
In H. pylori, FlgM is not secreted after the substrate-specificity switch. It is 
hypothesised that FlgM may instead shuttle between FliA and FlhAc in the cytoplasm 
(Rust et al., 2009). This initiates expression of the late flagellar genes which then 
assemble to form the junction, filament and capping proteins. FliD promotes growth 
of the filament at the distal end and is retained in the final structure (Yonekura, 
2000). The filament can contain up to 20,000 subunits (Macnab, 2003). The entropy 
of polymerisation of flagellin subunits at the tip of the growing filament is sufficient 
to recruit another subunit from the export apparatus in a chain mechanism of filament 
extension (Evans et al., 2013). 
 4.3 Regulation of Flagellar Assembly 
Since over 40 proteins are involved in flagellum assembly, the process must be 
tightly regulated to avoid improper assembly and/or energy wastage (Chevance and 
Hughes, 2008). Hierarchical flagellar assembly of Enterobacteriaceae coupled with 
sequential transcriptional activation of flagellar genes maintains tight control of this 
complex process (Chilcott and Hughes, 2000). Flagellar genes can be divided into 
three classes which represent the early, middle and late genes. Three RNA 
polymerase sigma factors control the gene expression of these classes (McCarter, 
2006). 
In Salmonella, Class I genes are located in the flhDC operon. The gene products 
of this operon form a complex, FlhD4C2. Activation/inactivation of FlhD4C2 is 
dependent upon an array of environmental stimuli including osmolarity and catabolic 
repression, as well as bacterial growth phase (Prüss and Matsumura, 1997; Shin and 
Park, 1995; Soutourina et al., 1999). In E. coli, FlhD4C2 is post-transcriptionally 
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regulated by the global regulator, CsrA (Wei et al., 2001). FlhD4C2 also plays a role 
in other cell processes which are not related to bacterial motility (Stafford et al., 
2005). 
The primary function of FlhD4C2 lies in its role as the “master regulator” of 
flagellar gene expression. FlhD4C2 mediates σ
70
 RNA polymerase transcriptional 
activation of the Class II (middle) flagellar genes which include components of the 
basal body and hook (Liu et al., 1995). Included in the genes transcribed by σ70 is 
another RNA polymerase sigma factor, σ28 (Kutsukake et al., 1990). The alternative 
sigma factor (σ28) in turn controls the expression of late flagellar genes i.e. the 
flagellar motor and filament subunits. FlgM is a negative regulator of σ28 and is 
secreted upon completion of the hook (Gillen and Hughes, 1991; Ohnishi et al., 
1992). Secretion of FlgM, and hence release of σ28, triggers transcription of the late 
flagellar genes (Kutsukake, 1994). 
 4.4 Flagellar chaperones in Enterobacteriaceae 
There are a number of cytoplasmic chaperones which play an important role in 
flagellum biosynthesis. Chaperones protect their substrate from degradation in the 
cell before its function is required and target proteins to the export apparatus during 
flagellum synthesis. The chaperone-substrate complexes dock at the export apparatus 
ATPase where they are secreted through the central lumen of the growing flagellum 
by proton motive force (Thomas et al., 2004). Chaperone-substrate complexes bind 
FlhAc at the export gate with different affinities, potentially favouring the export of 
the hook-filament junction substrates prior to filament formation (Kinoshita et al., 
2013). 
As described in Section 4.2, the FliH-FliI heterodimer is a chaperone-substrate 
complex involved in regulating the docking and export of substrates via the flagellar 
T3SS. This complex binds FliJ, a chaperone which is instrumental in efficient 
substrate export through the T3SS. FliJ is responsible for recycling of chaperones for 
the minor filament subunits, FlgK, FlgL and FliD, but not the major subunit, FliC 
(Evans et al., 2006). FliS is a cytoplasmic chaperone which stabilises FliC before 
assembly and assists flagellin export during filament extension (Auvray et al., 2001). 
FliS prevents aggregation and premature polymerisation of FliC subunits in the 
cytoplasm before export. In H. pylori, HP1076 has been identified as a co-chaperone 
which promotes the correct folding and activity of FliS (Lam et al., 2010). 
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In Salmonella, FlgM secretion is suppressed by all members of the fliD operon 
(FliD/S/T) (Yokoseki et al., 1996). FlgN regulates the translation of FlgM as well as 
the export of the hook-filament junction proteins, FlgK and FlgL (Fraser et al., 
1999). In Salmonella, Flk prevents the premature secretion of FlgM; however, no 
such homologue has been identified in H. pylori (Aldridge et al., 2006a). FliA has an 
additional role as a chaperone which promotes FlgM secretion (Aldridge et al., 
2006b). FliT is a chaperone which guides the filament capping protein FliD to the 
export gate for export (Fraser et al., 1999). It also functions as a regulator of flagellar 
gene expression through interactions with FlhD4C2 (Yamamoto and Kutsukake, 
2006). This interaction disrupts the ability of the FlhDC complex to bind the Class II 
promoter and therefore prevents expression of the middle flagellar genes. 
 4.5 Regulation of flagellum biogenesis in H. pylori 
The composition of the flagellum of H. pylori closely resembles that of the 
extensively studied model organisms, Salmonella and E. coli (Lertsethtakarn et al., 
2011). However, there are notable deviations in both structure and regulation of 
assembly (Figure 11). At genome level, there is a clear difference in the organisation 
of flagellar genes in H. pylori and that of E. coli and S. typhimurium. The latter 
contain a number of distinct operons, while in H. pylori flagellar genes are scattered 
throughout the genome in multicistronic operons (Danielli et al., 2010; Tomb et al., 
1997). 
One major deviation from the model of flagellum biogenesis is the lack of an 
FlhD4C2 homologue in H. pylori. This is a clear indication that H. pylori flagellar 
gene expression is alternatively regulated. Hierarchical assembly is coupled to 
ordered flagellar gene expression, which is controlled by three RNA polymerase 
sigma factors (σ80, σ54, σ28) (Alm et al., 1999; Beier and Frank, 2000; Josenhans et 
al., 2007; Niehus et al., 2004). RpoD, or σ80, controls the expression of Class I genes 
which include regulators and components of the basal body. In H. pylori, there is an 
additional component of the MS ring, FliY, with sequence similarity to FliN 
(Lowenthal et al., 2009). Notably, the Class I genes include a two-component 
system: histidine kinase, HP0244, and its response regulator, FlgR (Spohn and 
Scarlato, 1999). Together, these function as enhancers of RpoN activity, the sigma 
factor controlling expression of the Class II genes. 
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Figure 11 Overview of the known flagellar components of the H. pylori flagellum. 
Major structural elements of the flagellum are colour-coded based and largely match the 
transcriptional regulatory class: components of the export apparatus (Class I) are coloured 
red; rod and hook proteins (Class II) are coloured blue; and filament proteins are coloured 
green. FlaB is an exception as it is a Class II gene. Proteins in grey either have unknown 
transcriptional regulation, or are not regulated within the flagellar transcriptional hierarchy. 
Adapted from (Lertsethtakarn et al., 2011). 
 
A transcriptional checkpoint has been identified at an early stage of flagellum 
assembly; mutational inactivation of early flagellar genes results in reduced 
transcription of Class II and Class III genes (Allan et al., 2000). RpoN is a sigma 
factor which triggers the expression of middle flagellar genes including the rod 
capping protein, hook, and minor flagellin, flaB (Niehus et al., 2004). In addition to 
RpoN activation, FlgR also represses premature production of the major filament 
protein, FlaA (Jagannathan et al., 2001). An intermediate class of flagellar genes is 
regulated by both RpoN and FliA (σ28) (Niehus et al., 2004). Included in this class 
are components of the export apparatus, chaperones and early filament structural 
proteins. FliA controls the expression of late (Class III) flagellar genes which include 
that for the major flagellin, FlaA. 
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As in Salmonella, FlgM binds and inhibits FliA to prevent early Class III gene 
expression (Josenhans et al., 2002). In H. pylori, however, FlgM is not secreted upon 
completion of the hook; instead it is now known to be predominantly cytoplasmic. 
This may indicate that the switch in expression in the case of H. pylori may require a 
different stimulus (Rust et al., 2009). FlhA and FlhF have been suggested as the 
H. pylori alternative to flagellar master regulators (Niehus et al., 2004). FlhA-FlgM 
interaction illicits a negative feedback control mechanism on the expression of 
Class II genes. FlhF is a GTPase which is involved in control of RpoN expression, 
the details of which remain unclear (Balaban et al., 2009; Lertsethtakarn et al., 2011; 
Niehus et al., 2004). These proteins are central to the regulation of flagellar assembly 
in H. pylori, as illustrated by a double knock-out mutant which was aflagellate and 
non-motile (Niehus et al., 2004). 
A yeast two-hybrid study investigating the protein-protein interaction map of 
H. pylori strain 26695 identified a number of potential interaction partners of RpoN 
(Rain et al., 2001). A protein from this subset, HP0958, was later identified as a 
chaperone of RpoN (Pereira and Hoover, 2005; Ryan et al., 2005a). The role of 
HP0958 in flagellum biogenesis is discussed in more detail in Section 4.6. FlhB and 
FliK are involved in the substrate-specificity switch between export of rod/hook to 
filament proteins, but the mechanism is complex and currently unknown (Ryan et al., 
2005b; Smith et al., 2009). 
FlaA levels are controlled by a number of diverse mechanisms, from DNA 
supercoiling to posttranslational regulation. In addition to the mechanisms described 
above, flaA expression is also regulated by growth phase. LuxS-based quorum 
sensing has been shown to affect flaA expression whereby low cell density is 
associated with low flaA transcription while at higher cell densities, flaA 
transcription rate increases (Loh et al., 2004). The spacer length between a promoter 
and transcriptional start site can affect the strength of expression. In H. pylori, the 
normal spacer region for σ28 promoters is 14 - 15 bp (Josenhans et al., 2002). The 
flaA promoter spacer has a length of 13 bp which is important for growth phase 
dependent alterations in DNA supercoiling (Ye et al., 2007). Relaxation of 
supercoiling resulted in reduced flaA transcription, whereas increased supercoiling 
increased flaA transcription levels. Interestingly, the RpoN chaperone, HP0958, also 
contributes to FlaA regulation, but at a posttranscriptional level (Douillard et al., 
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2008). Therefore, the regulation of flagellum biogenesis in H. pylori differs from the 
model systems, with many details remaining unknown at present. 
 4.6 HP0958 
HP0958 was characterised as a hypothetical protein of unknown function in the 
genome of H. pylori strain 26695 (Tomb et al., 1997). HP0958 is well conserved 
within the Helicobacter genus and orthologues can also be found in some ε-
proteobacteria, but are absent in E. coli and Salmonella (Figure 12). 
 
 
Figure 12 Conservation of HP0958 in ε-proteobacteria. 
Genome region of selected strains containing HP0958 orthologues (coloured black). Image 
generated and adapted from TIGR CMR Genome Region Comparison online tool (Peterson 
et al., 2001). 
 
In 2001, the interaction network of the H. pylori strain 26695 proteome was 
published; the data can be viewed on the Hybrigenics PIMRider
®
 platform where 
PIM Biological Scores indicate the confidence for predicted interaction sets 
(PIMRider®, Rain et al., 2001). This study revealed HP0958 as a potential novel 
flagellar-associated protein due to predicted interactions with the flagellum 
biosynthesis proteins FliH and RpoN. Subsequent studies were undertaken by our 
group and others to characterise the predicted role of HP0958 in flagellum assembly. 
Knock-out studies generated hp0958-null mutants which were completely 
aflagellate and non-motile (Pereira and Hoover, 2005; Ryan et al., 2005a). Mutant 
H. pylori strains lacking HP0958 had altered transcription levels of both Class II and 
Class III flagellar genes (Ryan et al., 2005). Further investigation has shown that 
HP0958 plays multiple roles in the flagellar regulatory process. HP0958 is not only a 
chaperone that stabilises the Class II sigma factor, RpoN, but it also interacts with 
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the major flagellin mRNA transcript (Douillard et al., 2008). In the absence of 
HP0958, H. pylori mutants had increased flaA transcription but decreased levels of 
FlaA protein (Douillard et al., 2008). Therefore, HP0958 is an essential component 
of flagellum biogenesis in H. pylori and studying it may yield insights into the 
different mechanism by which assembly is regulated in H. pylori compared to the 
model systems. 
A hypothesis for the mechanism by which HP0958 influences flagellum assembly 
was proposed by Douillard et al. (Figure 13) whereby HP0958 interacts with FliH, 
potentially to guide the flaA mRNA transcript to the export apparatus in advance of 
flaA translation and assembly of the filament. In this model, RpoN is less stable in 
the absence of HP0958, resulting in no Class II expression. When HP0958 binds 
RpoN, the sigma factor is stabilised and can initiate transcription of the middle 
flagellar genes. During the switch in substrate specificity from rod/hook to filament 
subunits, HP0958 interacts with the flaA mRNA transcript to destabilize it, in order 
to prevent premature secretion of the major flagellin. Interaction with FliH guides the 
HP0958-flaA mRNA complex to the export apparatus where translation and export of 
FlaA subunits can begin (Douillard et al., 2008). 
 
 
Figure 13 Proposed model for the role of HP0958 in flagellum biogenesis. 
Adapted from (Douillard et al., 2008). 
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The crystal structure of HP0958 was solved in 2010, providing insights into the 
mechanism by which it can interact with flagellar proteins and RNA (Caly et al., 
2010). It revealed that HP0958 consists of two domains: an N-terminal, anti-parallel 
coiled-coil and a C-terminal zinc-finger domain (Figure 14). 
 
 
Figure 14 Structural domains of HP0958. 
Image generated in Pymol highlighting the secondary structural elements of HP0958: helix 1 
(red); helix 2 (cyan); helix 3 (blue); helix 4 (pink); and two beta strands in the Zn-ribbon 
domain (mauve).The four cystine residues of the Zn-finger are yellow. 
 
The coiled-coil domain reveals a highly elongated, kinked, anti-parallel structure. 
The motif consists of two α-helices supercoiled around one another. The residues are 
arranged in a heptad repeat (a-g) where residues at a and d are generally apolar, e.g. 
leucine, valine and isoleucine, and hydrophobic. The 4-3 hydrophobic repeat along 
with charged residues at e and g contribute to the stability of the structure (Oakley 
and Hollenbeck, 2001; Parry et al., 2008). Helix 3 (residues 173-185) separates the 
coiled-coil and Zn-finger and interacts with both domains. Discontinuities in the 
heptad sequence are called stutters, stammers and skips (Brown et al., 1996; Lupas 
and Gruber, 2005). The coiled-coil kinks strongly in helix 1 at residue Arg29 and 
helix 2 kinks at Glu143 as a result of a stammer in the HP0958 structure (Caly et al., 
2010). Hydrophobic and positively charged residues have a preference to form 
coiled-coils: alanine, glutamic acid, lysine, leucine and arginine (Gromiha and Parry, 
2004). Hydrophobicity, salt bridges (between residues Ile121 and Glu52; Lys85 and 
Glu89; and Lys73 and Glu96) and hydrogen bonding contribute to the stability of 
this motif (Caly et al., 2010). 
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The Zn-ribbon domain (residues 174-238) contains a large number of solvent-
exposed aromatic (Phe178, Tyr179, Trp185 and Tyr211) and positively charged 
(Arg181, Arg184, Arg205, Lys209) amino acids (Caly et al., 2010). An abundance 
of these types of residues is associated with involvement in protein-RNA interactions 
(Ellis et al., 2007; Jones et al., 2001). In HP0958, the Zn-finger domain contains the 
consensus sequence CXGCX20CPHCGR (where X is any amino acid) involving 
four cystines co-ordinating one zinc ion (Caly et al., 2010). Aromatic residues in zinc 
ribbon domains tend to form aromatic stacking interactions with nucleic acid bases. 
Positively charged residues can interact with the phosphate group of nucleic acids, as 
well as with other proteins (Gamsjaeger et al., 2007; Laity et al., 2001). 
The elucidation of protein structures has contributed to our understanding of their 
function. Flagellum biogenesis models have been aided by emerging structural 
analyses of proteins from various organisms that compose the hook/basal body 
complex, the export apparatus and the filament. The crystal structure of the FliC 
chaperone in complex with its co-chaperone, HP1076, revealed a hydrophobic 
binding interface distinct from the FliS-FliC binding site (Lam et al., 2010). The 
structure of FliT revealed that this chaperone interacts with the FlhDC complex, FliI 
and FliJ through its C-terminal helices indicating a conformational change in FliT is 
responsible for the switch in binding preference (Imada et al., 2010). Therefore, 
structure-function analysis of HP0958 could provide key insights into interactions 
during flagellum biogenesis. 
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5 Aims of this Study 
Bacterial motility through the use of flagella has been extensively studied in the 
enteric model systems E. coli and Salmonella. Motility in H. pylori is a key feature 
of pathogenesis and is essential for colonisation of its human host. While the 
composition of the flagellum in H. pylori closely mirrors that of the model systems, 
there are a number of differences in the regulation of assembly. Therefore, there is a 
need to further investigate the mechanism by which H. pylori controls the complex, 
hierarchical process of flagellar assembly. 
A key feature of H. pylori is its extreme genetic plasticity. With the relatively 
recent upsurgence in genome sequencing, subtle differences between bacterial strains 
at the gene level can be identified. For instance, an additional level of regulation of 
H. pylori motility is phase-variation (Josenhans et al., 2000). Today, there is a large 
volume of genome sequence information from H. pylori strains. However, H. pylori 
CCUG 17874 (the highly motile type-strain for the species) is frequently used in 
motility studies, and its genome has not been sequenced. This strain is not readily 
transformable, which is a barrier to the use of this strain for motility studies 
involving genetic manipulations. On the other hand, another motile strain, P79, is 
readily transformable. 
HP0958 is an essential component of flagellar biogenesis (Ryan et al., 2005a). 
The crystal structure revealed two domains, an N-terminal coiled-coil, and a C-
terminal Zn-finger (Caly et al., 2010). Initial knock-out studies as well as structure-
function analysis of HP0958 provided clues as to how it regulates flagellum 
construction (Caly et al., 2010; Pereira and Hoover, 2005; Ryan et al., 2005a). 
HP0958 is a chaperone of RpoN and is predicted to interact with the ATPase 
inhibitor, FliH; however, how HP0958 forms these interactions at a structural level is 
unknown. Point-mutation of HP0958 indicated that the Zn-finger may be prominent 
in the HP0958-flaA mRNA interaction. A hypothesis for the function of HP0958 
during flagellum biogenesis (outlined in Section 4.6) included HP0958 targeting the 
flaA transcript to the export apparatus through an interaction with FliH. 
Therefore, the global objective of this study was to expand the current 
understanding of flagellum biogenesis and regulation in H. pylori. Additionally, 
genome comparative analyses was performed in the hope that it would provide 
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insights into the determinants for natural competence, as well as a broader definition 
of the core genome of H. pylori. 
The aims of this study were: 
 to sequence the genomes of H. pylori strains CCUG 17874 and P79 
 to perform comparative genomics on these strains and the currently 
sequenced, publically available genomes of other H. pylori strains 
 to define the interacting regions within the HP0958, RpoN and FliH 
 to investigate the potential role of HP0958 in switching between 
expression of the σ54 and the σ28 regulons during flagellum biogenesis 
 to determine the effect of expressing site-directed mutant derivatives of 
HP0958 upon flagellum biosynthesis. 
The results of this study were collated into a short publication (a genome 
announcement) and an expanded comparative analysis (both described in Chapter 2), 
and a detailed analysis of the role of HP0958 in flagellum biogenesis (Chapter 3). 
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1 Abstract 
Helicobacter pylori is a human pathogen which colonises the human gastric 
mucosa, causing gastritis, duodenal and gastric ulcers, and gastric carcinoma. Here 
we announce the draft genomes of H. pylori strain 17874, commonly used for 
studying motility, and P79, a strain for which plasmid vectors have been developed. 
2 Genome Announcement 
H. pylori genomes sequenced to date exhibit significant variation. H. pylori 
CCUG 17874 was originally isolated from the gastric antrum of a patient in Perth, 
Australia and is the type strain for the species (4) that is often used for flagellum 
biogenesis studies. P79 is a derivative of strain P1, transformed with 17874 
chromosomal DNA to generate a streptomycin resistant mutant (3). This readily-
transformable strain facilitates in vivo studies on H. pylori. The genomes of these 
strains were sequenced to provide a clearer genomic platform for H. pylori motility 
investigation. 
The H. pylori 17874 and P79 genomes were sequenced at the Beijing Genomics 
Institute (BGI) on the Illumina HiSeq platform, generating a paired-end library 
containing 20,154,284 and 13,298,804 reads of 90 bp, respectively. In a reference-
guided assembly strategy using MIRA (version 3.2.1), reads for both genomes were 
mapped to the genomes of H. pylori 26695 (GenBank acc. NC_000915) (5) and J99 
(NC_000921.1) (1). A de novo assembly using Velvet was also performed and 
aligned to the MIRA assembly to close gaps. 17874 and P79 contigs were assembled 
into 80 and 48 scaffolds, respectively. Protein coding regions were identified using 
the NCBI Prokaryotic Genome Automated Annotation Pipeline (PGAAP) and 
manually curated, with particular interest in flagellum-related genes. Predicted 
coding regions were identified with a minimum cut-off size of 30 amino acids. 
H. pylori 17874 and P79 have genome sizes of 1,615,763 bp and of 1,641,495 bp, 
respectively and GC content of 38.97% and 38.86%, respectively. Both strains are 
cagA+ and vacA+, well described virulence factors (2). Strain-unique genes were 
identified using a pairwise bi-directional BLASTP comparison, where the query 
sequence has no detectable homologues. The 17874 genome contains 1,639 open 
reading frames, with 35, 45 and 24 unique genes that are absent in 26695, J99 and 
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P79, respectively. Sixteen genes from 26695 and 6 genes from J99 are absent in 
17874. H. pylori P79 contains 1,699 open reading frames, with 40, 52 and 36 unique 
genes that are absent in 26695, J99 and 17874, respectively. Twelve genes from 
26695 and 6 genes from J99 are absent in P79. Twenty one genes are unique to the 
17874 and P79 genomes compared across these four strains. 
The majority of strain-unique genes identified encode hypothetical protein 
products. Of note, 17874 possesses a unique type II restriction enzyme, and P79 
possesses a unique hypothetical membrane protein that is absent in 26695/J99. 17874 
and P79 lack metal-binding proteins present in both 26695 and J99, but possess Cag 
island protein B. All major flagellar and outer membrane proteins are present and 
intact in both 17874 and P79 compared to 26695 and J99. A hypothetical protein 
with predicted involvement in ATPase activity during flagellum biogenesis is absent 
in P79. 
3 Nucleotide Sequence Accession Numbers 
The draft genome sequence of H. pylori 17874 has been deposited in GenBank, 
available through the BioProject accession number PRJNA76569 and project ID 
76569. Similarly, the draft sequence of P79 is available in GenBank through the 
BioProject accession number PRJNA76567 and project ID 76567. 
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1 Abstract 
H. pylori was the first species for which two genomes were sequenced (Alm et al., 
1999; Tomb et al., 1997). This revealed a large degree of synteny in overall genome 
organisation between the strains 26695 and J99. However, H. pylori genomes 
possess regions of hypervariability e.g. cytotoxin-associated gene pathogenicity 
island (cagPAI) and plasticity zones (Alm and Trust, 1999). 
The draft genome sequence of Helicobacter pylori CCUG 17874, the type-strain 
for the species, comprises 80 scaffolds containing 1.61 Mbp of sequence with a 
GC content of 38.97%. In silico analysis identified 1,639 coding genes, including 
vacA, cagA, 3 IS elements and 28 pseudogenes. This motile strain is widely used in 
flagellum biogenesis studies. P79 is a readily-transformable derivative of strain P1, 
which facilitates genetic manipulation of H. pylori cells. A draft assembly of P79, 
comprising 48 scaffolds, contains 1.64 Mbp of sequence with a GC content of 
38.86%. Similarly, in silico analysis identified 1,699 coding genes including vacA, 
cagA, 5 IS elements and 33 pseudogenes. 
Comparative analysis of these two strains revealed that both possess the full 
complement of flagellar genes. H. pylori CCUG 17874 possesses 35, 45 and 24 
unique genes that are absent in 26695, J99 and P79, respectively. H. pylori P79 
possesses 40, 52 and 36 unique genes that are absent in 26695, J99 and 17874, 
respectively. The core genome of H. pylori comprises 898 genes, based on analysis 
of 43 sequenced strains, including 17874 and P79. Core genomes were also 
identified for the following disease subtypes: gastritis, duodenal ulcer, gastric cancer 
and MALT lymphoma. 
This analysis provides sequence information for these useful lab strains, and 
insights into the genetic organisation of H. pylori. As a result, a more conservative 
core genome for the species has now been determined. The genomes of these strains 
provide a clearer genomic platform for H. pylori motility investigation. 
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2 Introduction 
Helicobacter pylori is a pathogen which colonises the human gastric mucosa, 
causing gastritis, duodenal and gastric ulcers, and gastric carcinoma (Blaser, 1997; 
Goodwin et al., 1986; Uemura et al., 2001). Motility is an essential feature for 
colonisation as it enables H. pylori to move from the lumen of the stomach, through 
the mucosal lining where it can interact with host epithelial cells (Algood and Cover, 
2006; Eaton et al., 1992). H. pylori motility requires the presence of 2 - 6 polar, 
sheathed flagella (Eaton et al., 1992; Yoshiyama and Nakazawa, 2000). Flagellum 
biogenesis in H. pylori is a complex, hierarchical process which differs from other 
model organisms such as Salmonella and E. coli (Lertsethtakarn et al., 2011; 
Macnab, 2003). The genome of H. pylori strain 26695 was the first to be sequenced 
for the species. The genome features of this strain have been well described and used 
in subsequent comparative studies (Alm et al., 1999; Tomb et al., 1997). However, 
this non-motile strain is not appropriate for motility studies because of a frameshift in 
the flip gene (Josenhans et al., 2000). The type-strain, CCUG 17874, has been 
extensively used to investigate motility, but the genome had not been sequenced. 
H. pylori was the first species for which the genome of more than one strain was 
sequenced (Alm et al., 1999; Tomb et al., 1997). Comparative analysis revealed that 
H. pylori genomes exhibit significant variation in defined regions of hypervariability, 
while retaining synteny in the overall genome organisation. The striking genome 
plasticity of this gastric pathogen coupled with the variety of clinical outcomes 
which can arise from infection have served as the impetus for genome mining studies 
to identify strain-specific virulence factors and genetic markers for disease. At the 
time of writing, the genomes of 52 H. pylori strains had been fully sequenced, 
annotated and are publically available through the NCBI web resource (NCBI, 2013). 
Additionally, the draft genome sequences of a further 228 strains are available, 
though some lack annotation. 
The first live organisms to have their genomes sequenced were 
Haemophilus influenzae (Fleischmann et al., 1995) and Mycobacterium genitalium 
(Fraser et al., 1995) at the J. Craig Venter Institute (formerly the Institute of 
Genomic Research (TIGR)). These were shortly followed by the genome sequence of 
other organisms including that of E. coli (Blattner, 1997), and later 
Salmonella enterica serovar Typhimurium (McClelland et al., 2001), the model 
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organisms for bacterial motility studies. Sequencing methods have developed 
considerably from the initial chain termination sequencing to next generation, and 
now third generation sequencing technologies. Next generation sequencing (NGS) 
can be subdivided into single nucleotide addition (pyrosequencing), cyclic reversible 
termination (Illumina) and sequencing by ligation (Applied Biosystems SOLiD). 
Each of these methods involves random fragmentation of genomic DNA and 
hybridisation to adapters followed by sequencing by either non-
fluorescent/fluorescent means (Metzker, 2010). These methodologies have 
limitations including slow processing time due to the large number of sequencing 
cycles per run, amplification of errors in the PCR-based sequencing and short read 
lengths. Nevertheless, NGS allows the generation of a large volume of sequence data 
cheaply. Third generation sequencing methods including single real time (Pacific 
Bioscience) (Eid et al., 2009) and nanopore (Oxford) sequencing have recently been 
developed. These eliminate amplification bias problems, and generate longer read 
lengths, thus improving the quality of genome sequencing for the future (Koren et 
al., 2013). 
As genome sequencing has become increasingly affordable and rapid in recent 
years, this has lead to an increase in the volume of genome information available for 
mining (Horner et al., 2010; Loman et al., 2012). A whole-genome shotgun 
sequencing approach is a powerful strategy to sequence and assemble whole genome 
data both rapidly and cheaply. Illumina sequencing followed by mapping to a 
reference genome is a reliable means for genome analysis and comparative studies. 
Furthermore, comparison with a de novo assembly of the same reads improves 
resolution of genome assembly. 
H. pylori CCUG 17874 was originally isolated from the gastric antrum of a 
patient in Perth, Australia and is the type-strain for the species (Marshall et al., 
1984). P79 is a derivative of strain P1 (isolated from a patient with non-ulcer 
dyspepsia), transformed with 17874 derivative chromosomal DNA to generate a 
streptomycin-resistant mutant (Heuermann and Haas, 1998). This readily-
transformable strain facilitates genetic studies of H. pylori. The genomes of these 
strains were sequenced to enhance H. pylori motility investigation and contribute to 
our understanding of the genomic organisation of this pathogen. Comparative 
analyses with other sequenced strains of H. pylori provided an updated core genome 
for the species and disease-associated subtypes. 
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3 Methods 
 3.1 Bacterial Strains and Culture Conditions 
H. pylori strains CCUG 17874 and P79 were grown on Columbia Base Agar 
(CBA) solid medium (Oxoid, UK), supplemented with 5% v/v heat-inactivated, 
defibrinated horse blood (Cruinn, Ireland). Plates were incubated at 37°C, 5% CO2 
and sub-cultured every two days. 
 3.2 Genomic DNA Extraction 
Cells were harvested from 2 day old full plates in sterile phosphate buffered saline 
(PBS). Genomic DNA was extracted using DNeasy Blood and Tissue DNA 
Extraction Kit (Qiagen, Germany) according to manufacturer’s instructions. Briefly, 
cells were lysed and treated with proteinase K and RNase A. DNA was then bound to 
a silica column and washed before elution. DNA concentration and quality was 
estimated using Nanodrop 2000 (Thermo Scientific). Genomic DNA was run on a 
1% agarose gel in TAE buffer at 90 V for 30 min to confirm quality. 
 3.3 Genome Sequencing and Annotation 
The genomes of H. pylori CCUG 17874 and H. pylori P79 were sequenced on the 
Illumina HiSeq platform (Beijing Genomics Institute, China). A paired-end library 
was generated and sequenced containing 20,154,284 and 13,298,804 reads of 90 bp 
for the genomes of CCUG 17874 and P79, respectively. In a reference-guided 
assembly strategy using MIRA (version 3.2.1) (Chevreux et al., 1999), reads for both 
genomes were mapped to the genomes of H. pylori 26695 (GenBank acc. 
NC_000915) and J99 (NC_000921.1) (Alm et al., 1999; Tomb et al., 1997). A de 
novo assembly using Velvet was also performed for each genome and aligned to the 
MIRA assembly to close gaps. H. pylori CCUG 17874 and P79 contigs were 
assembled into 80 and 48 scaffolds, respectively. 
Automated gene calling and annotation were performed by the NCBI Prokaryotic 
Genome Automated Annotation Pipeline (PGAAP). Open reading frames (ORFs) 
were predicted by Genemark searches within the manually curated Protein Clusters 
database. Reverse PSI-BLAST (RPS-BLAST) was performed against the Clusters of 
Orthologous Groups (COGs) database to assign COG fuctional categories to the 
predicted ORFs. Additionally, InterProScan was used to identify protein domains 
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and signatures (Quevillon et al., 2005). Frameshifts and partial gene fragments 
indicating potential pseudogenes were identified by alignment of proteins from the 
target set to the genome with ProSplign (a global alignment algorithm) and then 
checked with GeneMarkS. Clustered Regularly Interspaced Short Palindromic 
Repeats (CRISPRS) were identified by searching the CRISPR database (Grissa et al., 
2007). tRNAs were identified using tRNA-scan (Lowe and Eddy, 1997) and 
ribosomal binding sites using RBSfinder (Suzek et al., 2001).  
Identified protein coding regions were manually curated in Artemis (Rutherford et 
al., 2000), with particular interest in flagellum-related genes. Predicted ORFs had a 
minimum cut-off size of 30 amino acids. Each of the draft genomes were submitted 
to the KAAS (KEGG Automatic Annotation Server) online server which 
automatically assigns K numbers to genes, enabling reconstruction of KEGG 
pathways and BRITE hierarchies using a bi-directional best hit BLAST approach 
(Moriya et al., 2007). 
Accession numbers: The draft genome of H. pylori CCUG 17874 is available 
under the BioProject accession number PRJNA76569. Similarly, the draft genome 
sequence of P79 is available under accession number PRJNA76567. 
 3.4 Genome Comparisons 
Whole genome alignments were generated using Big Blast software (available 
from the Welcome Trust Institute (http://www.sanger.ac.uk)) to compare the 
genomes. Artemis Comparison Tool (ACT) was used to visualise the alignments 
(Carver et al., 2005). Nucmer, part of the MUMmer software package, was used to 
generate further alignments (Kurtz et al., 2004). METAPHORE is a custom in-house 
software which was used to identify orthologues, unique genes and core genes by 
performing bi-directional BLASTP comparisons on two or more genomes (Van der 
Veen et al., 2014). Proteins with minimum 30% identity over 80% of their sequence 
length were classed as orthologues. Core genes were defined as those present in all 
possible pairwise genome combinations tested. Unique genes were defined as genes 
with no detectable homologues in bidirectional BLASTP comparisons. Phylogenetic 
trees were built based on concatenated MLST (multi locus sequence typing) analysis 
of 7 housekeeping genes that are distributed throughout the genome (Jolley and 
Maiden, 2010). 
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4 Results and Discussion 
 4.1 General Genome Features 
The draft genome sequences of two H. pylori strains, CCUG 17874 and P79, are 
described in the following sections. Due to the draft nature of these sequences, 
information generated regarding pseudogenes, unique genes and specific gene 
numbers are estimates limited by the coverage of the genome sequences in this 
project. In order to ascertain absolute numbers, gap closure of the draft sequences 
would be required. For the purposes of this thesis, the sections ahead will refer to 
details generated from the draft genome sequences. 
H. pylori CCUG 17874 and P79 have assembled genome sizes of 1,615,763 bp 
and of 1,641,495 bp, respectively and GC content of 38.97% and 38.86%, 
respectively (Table 2). Bioinformatic analysis of the H. pylori CCUG 17874 genome 
identified 1,639 coding regions with a coding density of 86.5% and an average gene 
length of 853 bp (Figure 15). In H. pylori P79, 1,699 coding regions were identified, 
representing a coding density of 85.1% and an average gene length of 812 bp (Figure 
16). Gene synteny was largely conserved between 17874/P79 and reference strain 
26695 (Figure 17). Biological functions could be assigned to 1,114 (67.9%) of the 
predicted proteins of H. pylori CCUG 17874. Of the remaining 525 predicted 
hypothetical proteins, 182 had COG functional categories assigned. Similarly, 
biological functions could be assigned to 1,079 (63.5%) of the predicted proteins of 
H. pylori P79. Of the remaining 620 predicted hypothetical proteins, 218 had COG 
functional categories assigned. The rest were either homologous to hypothetical 
proteins in other species or had no match to any known proteins, and hence were 
classified as unique proteins. Phylogenetic analysis based on MLST core genes 
predicted that 17874 clusters with the European strains, where it’s predicted most 
closely related, sequenced strain is G27 (Figure 18). P79 also clusters with the 
European strains, closest to 26695 and P12. 
Thirty six tRNA genes were identified in the genome of H. pylori CCUG 17874, 
while 35 were identified in the genome of P79. In both cases, the genes represent all 
20 amino acids (redundant genes were present for 8 tRNAs in 17874, and 9 tRNAs in 
P79). In both genomes, 22 of these tRNAs were located on the lagging strand, most 
of which cluster near the 23S rRNA gene. 
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The genome of H. pylori CCUG 17874 contains 25 predicted pseudogenes (1.5% 
of coding sequences) (Table 2), generally as a result of homopolynucleotide 
mutations which cause in-sequence frame shifts. The H pylori P79 genome contains 
29 predicted pseudogenes (1.7% of coding sequences). These predicted pseudogenes 
include recombinase A, genes in the plasticity regions of the strains and components 
of the restriction modification systems. Three transposases were indentified in the 
genome of H. pylori CCUG 17874, all part of the IS605 family. Four transposases 
were identified in the genome of P79, from IS605, IS606 and PS3IS, as well as an 
IS200 from H. pylori SARA17 (Table 3). The genomes of both strains were also 
found to harbour phage-associated genes (Table 4). 
 4.2 Plasticity Zones 
There are 5 and 3 regions with deviating GC content in H. pylori CCUG 17874 
and P79, respectively. The genes encoding cagA and vacA are both located in these 
low GC regions (“plasticity zones”), as well as many of the strain-specific genes of 
H. pylori (Alm and Trust, 1999; Boneca et al., 2003). The plasticity zones of the 
26695 and J99 genomes are flanked by the ftsZ gene and the rRNA 5S/23S subunit 
genes (Alm et al., 1999; Tomb et al., 1997). Other strains have been identified with 
three plasticity regions e.g. P12 which have since been identified as transposable 
elements (Kersulyte et al., 2009). Plasticity regions include large genomic islands 
containing genes acquired by horizontal gene transfer, whereas PAIs are plasticity 
regions which encode virulence factors which contribute to the pathogenicity of the 
strain. Recent analysis of previously sequenced strains including 26695 have 
identified novel PAIs such as the tfs3PAI (Wang et al., 2013). The availability of 
sequence data for a large number of H. pylori strains will enable a better 
understanding of these hypervariable regions and their potential for uncovering novel 
disease markers. 
The fifth concentric circle in the genome atlas of 17874 shows 3 regions where 
the GC content is below the whole-genome average (Figure 15). The first region, 
which occurs near the origin, contains genes encoding transposases A and B, 
hypothetical proteins, RM system components and replicase A. The second region 
contains the cagPAI which includes genes encoding a T4SS apparatus which 
assemble to facilitate secretion of the CagA effector protein. The third region of low 
% GC includes genes encoding hypothetical proteins flanking a competence-like 
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protein, RM genes and an integrase. Other genes with low GC content which occur 
outside of these regions include ABC-type multidrug resistance genes, hypothetical 
genes and an inactivated helicase. 
In the P79 genome, there are two plasticity zones: left and right. Plasticity zone 
left has a GC content of 33.3%, while plasticity zone right has a GC content of 
32.66%, both lower than the rest of the genome (Figure 16). Genes present in 
plasticity zone left include those encoding hypothetical proteins, 
phage/colicin/tellurite resistance cluster terY, transposases A and B, topoisomerase 
and helicase. The ftsZ gene flanks plasticity zone right of P79, containing genesof the 
cagPAI. Similar to 17874, low GC content genes which occur outside of these two 
plasticity zones encode hypothetical proteins, multi-drug resistance proteins and RM 
system components. 
 4.3 Motility Genes, Virulence Factors and OMPs 
All of the major regulatory and structural components required for flagellum 
biogenesis are present in the genomes of H. pylori CCGUG 17874 and P79 with 
reference to 26695 and J99 (Table 5). While the flagellar genes are not organised into 
discrete operons as is the case for Salmonella, the gene order is largely preserved 
across strains (Figure 19). The gene for a hypothetical protein with predicted 
involvement in ATPase activity during archaeal flagellum biogenesis is absent in 
P79. Both 17874 and P79 are motile strains of H. pylori with fully functional 
flagella, which is supported by the presence of the flagellar gene complement 
essential for motility (Figure 20). 
Cytotoxin-associated gene A (CagA) and vacuolating cytotoxin (VacA) are two 
key virulence factors involved in H. pylori pathogenesis (Basso et al., 2010). 
CCUG 17874 and P79 are both cagA and vacA positive and encode homologues of 
the virulence factor mviN protein (HP17_03394 and HP79_02579) (Table 6). In 
addition to these, P79 contains two virulence genes not present in 17874, both of 
which are annotated as encoding virulence associated protein D (VapD): 
HP79_08912 and HP79_08333. Both strains are urease and catalase positive, key 
virulence factors that enhance colonisation and infection of the host. HP17_07827 
encodes a labile enterotoxin product which is absent in the genome of P79. Both 
strains also express a number of multidrug-resistance proteins enabling bacterial 
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survival in the presence of compounds such as methicillin and tetracycline in the case 
of P79. 
CagA is a potent oncoprotein which induces inflammation and is associated with 
the more severe clinical outcomes of H. pylori infection including gastric cancer and 
mucosa-associated lymphoid tissue (MALT) lymphoma (Murata-Kamiya, 2011; 
Ohnishi et al., 2008; Wroblewski and Peek, 2011). The cagPAI of 17874 contains 
30 genes with an average GC content which is lower than is typical for the H. pylori 
genome (Figure 15). The gene encoding Cag15 is absent from the genome of 17874, 
while it contains two genes encoding hypothetical proteins which are absent in P79 
(Table 6). The function of Cag15 is unknown. However, Cag15 contains putative 
transmembrane domains (Joyce et al., 2001). The cag7 gene is identified as a 
pseudogene in the genome of P79 and cag3 is potentially inactive due to a frameshift 
mutation. Cag3 is hypothesised to be a novel secreted effector protein or an 
interaction partner of CagA (Olbermann et al., 2010). Both strains have prematurely 
truncated cag epsilon genes which are thus, also likely to be pseudogenes. 
VacA is a virulence factor which is associated with pathological outcomes of 
infection, depending on the allele present in a given strain of H. pylori (Atherton et 
al., 1995; Leunk et al., 1988; Rhead et al., 2007). In addition to the vacA gene, 
17874 contains 3 vacuolating cytotoxin paralogues. P79 contains 4 genes annotated 
as toxin-like outer membrane proteins (vacA paralogues) and 1 copy of vacA. One of 
these vacA paralogues may be inactive due to frameshift mutation. Both strains 
possess the i1 allele which is strongly associated with vacA and cagA positive 
H. pylori strains and has been associated with an increased risk of gastric atrophy and 
gastric carcinoma (Ferreira et al., 2012). 
Duodenal ulcer-promoting protein (DupA) has been identified as a marker of 
virulence when accompanied by an intact T4SS cluster (Jung et al., 2012; Lu et al., 
2005). 17874 does not contain the dupA gene cluster which is present as a complete 
unit in G27, and incomplete in reference strains J99 and 26695 (Jung et al., 2012). 
P79 is similar to 26695 as it contains a tfs3b partial cluster which contains a virB4 
gene with ~60% homology to dupA, and the secretion system genes virB8, virD4 and 
virD2. Outer membrane proteins and adhesins can contribute to virulence by 
mediating bacterial-host interactions. The annotated genes encoding OMPs of 17874 
(53 genes) and P79 (43 genes) are listed in Table 7 and Table 8. HopL is potentially 
non-functional in 17874 due to a frameshift mutation while an iron-regulated OMP 
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and a VacA paralogue are potentially frameshifted in the genome of P79. 17874 
contains the gene encoding sialic acid-binding adhesin, SabA, which is absent from 
the genome of P79. The blood group antigen binding protein (BabA) is also absent 
from these strains. Outer inflammatory protein (OipA/HopH) and HopQ homologues 
as well as Hom and Hof families are present in both 17874 and P79. Therefore, the 
diverse selection of OMPs available for presentation on the cell surface of H. pylori 
contributes to the inter-strain variation of this pathogen. Table 9 and Table 10 list the 
ABC transporter proteins annotated in the genomes of 17874 and P79, respectively. 
 4.4 Homopolymeric Repeats 
The genomes of H. pylori strains contain a characteristic high number of repeat 
sequences of varying lengths composed of cytosine or guanine nucleotides (Saunders 
et al., 1998; Tomb et al., 1997). Variation in the number of repeats incorporated 
during DNA replication by slipped-strand mispairing can alter the strength of 
expression of genes where the homopolymeric tract determines the promoter distance 
from its transcriptional start site (Moxon et al., 2006). Alternatively, changes in GC 
tract length located within a gene can alter the reading frame and introduce 
premature stop codons. In this way, H. pylori can switch its expression profile in a 
process termed phase variation (Lertsethtakarn et al., 2011). FliP is an example of 
this within the motility genes of H. pylori; a homopolymeric repeat of nine cytosines 
is responsible for the altered reading frame during expression of fliP in the non-
motile 26695 strain (Figure 21). A motile pseudorevertant was isolated in which the 
C9 tract had reverted to a C8 repeat, enabling expression of the functional form of 
FliP. Analysis of this tract in the genome sequence of P79 confirmed the presence of 
a C8 repeat. In 17874, the repeat is disrupted by the presence of an adenine at 
position 5, a silent mutation, as is the case in J99 (Figure 21). 
All genes containing homopolymeric GC repeats (≥ 8) either within the gene itself 
or upstream in the promoter region in the genomes of 17874 and P79 are listed in 
Table 11 and Table 12. In 17874, 39 genes have GC tracts of ≥ 8 bp, while there are 
21 such genes in P79. There are hundreds of instances of 6 - 8 bp homopolymeric 
repeats. Broadly, the genes potentially subject to antigenic variation are involved in 
LPS and outer membrane synthesis, replication and cell division, motility, virulence 
and restriction modification systems. Additionally, some ABC transporter genes and 
genes encoding tRNA synthetases for amino acid synthesis and multidrug efflux 
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pumps were identified containing poly GC tracts. A number of predicted 
pseudogenes are potentially silenced by phase variation, including an endonuclease 
and a type III restriction enzyme (Table 13 and Table 14). 
Therefore, H. pylori is complex in its regulation of gene expression. Phase 
variation enables this pathogen to conserve energy by restricting the genes of central 
cellular processes which can be expressed while retaining them for future use when 
they are required e.g. motility and virulence genes which are expressed during 
infection. 
 4.5 Natural Competence 
H. pylori strains are generally naturally competent for the uptake of exogenous 
DNA (Yeh et al., 2002). Natural competence of H. pylori involves core components 
of the T4SS, also known as the Com apparatus (Hofreuter et al., 2001; Karnholz et 
al., 2006). While competence is not essential during colonisation, it does promote 
colonisation during chronic infection as shown in a murine model (Dorer et al., 2010, 
2013). In H. pylori, most of the competence-related genes are found in two operons 
(comB2 - 4 and comB6 - 10) (Hofreuter et al., 2001). 
All of the known components involved in natural competence are present in 
17874 and P79 (Table 15). Comparing the Com apparatus components at a protein 
level highlighted some differences between strains 17874 and P79. ComB2 and 
ComB3 homologues have identical amino acid sequences while those of ComB4 
vary in 22 positions and ComB6 varies in 14 positions. ComB4 is an ATPase which 
is thought to power DNA translocation; ComB6 is an inner membrane component 
(Hofreuter et al., 2001; Karnholz et al., 2006). In P79, ComB7 is prematurely 
truncated due to the presence of an additional thymidine which changes the reading 
frame, resulting in a protein which is 7 aa shorter than its homologue in 17874. 
However, ComB7 is not an essential competence gene and as P79 is more readily 
transformable compared to 17874, this truncation does not have a negative impact on 
the natural competence of the strain (Hofreuter et al., 2001). Similarly, ComB8 is 
disrupted by a frame shift which changes the reading frame, resulting in a 
prematurely-truncated gene which encodes a 101 aa protein. This is due to the 
absence of one thymidine nucleotide in P79: 5’-TTGATG-3’ in P79 where the 
sequence is 5’-TTTGATG-3’ in 17874. This is likely a sequencing error as this 
truncated form of comB8 lacks the transmembrane domain which is critical for its 
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function, yet P79 is more efficient at DNA uptake through the Com apparatus than 
17874, which has the full length form of comB. The ComB9 homologue in 17874 
(HP17_04796) encodes 6 additional amino acids which are absent in that of P79. 
HP17_04796 also differs in protein sequence from HP79_04966 at 6 amino acid 
positions, though these are likely not to impact on the function of this protein e.g. L/I 
substitution. 
ComEC is an essential gene for H. pylori competence which is homologous to 
ComE3 in Bacillus subtilis, a channel-forming protein (Yeh et al., 2003). A proposed 
model for the mechanism of DNA uptake by natural competence is a two-step 
process, whereby double-stranded DNA is transported across the outer-membrane to 
the periplasm. ComEC then produces a pore through which the DNA can traverse the 
inner-membrane and enter the cytoplasm (Stingl et al., 2010). ComEC protein 
sequence is highly conserved among sequenced strains of H. pylori which harbour 
plasmids. While the sequences of 17874 and P79 ComEC homologues are not 
identical, these differences are confined to the variable regions, and hence are likely 
not to be responsible for the difference in competence between these strains. 
HP17_03604 is a putative periplasmic competence protein which is absent in P79. 
ComH is an essential component of natural transformation and is conserved across 
strains with varying transformation efficiencies (Smeets et al., 2000). It contains an 
N-terminal leader sequence, though the role of this protein in natural transformation 
is currently unknown. At a protein level, ComH of 17874 and P79 share 96% 
sequence similarity. DNA processing A (DprA) protein contributes to natural 
competence in H. pylori, where disruption of the gene causes reduced transformation 
efficiency of both plasmid and chromosomal DNA (Ando et al., 1999). DprB is co-
transcribed with DprA; it promotes DprA activity and may also function as a 
resolvase (Humbert et al., 2011; Sharma et al., 2010). The homologues of DprA and 
DprB in 17874 and P79 share 96% and 93% amino acid sequence similarity. The 
variation in DprB sequence is higher than is typical for H. pylori homologous 
proteins (4 - 5%), which possibly impacts on the function of this competence protein. 
Restriction modification (RM) poses a barrier to transformation and 
recombination of exogenous DNA into H. pylori (Ando et al., 2000). There are four 
types of RM sytems; the type II ststem is the most common and well-described of 
these. Type II RM requires the action of two enzyme types: methylases and 
endonucleases (Xu et al., 2000). Methylases methylate DNA at specific recognition 
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sites to label DNA as “self”. Endonucleases cleave DNA at specific recognition sites 
if these are not methylated. In this way, H. pylori can restrict the level of genetic 
exchange between strains. In 2012, a derivative strain of 26695 lacking type II 
restriction enzymes was found to have enhanced natural competence (Zhang and 
Blaser, 2012). 
H. pylori strains possess a large number of RM systems and many of these are 
strain-specific (Huimin et al., 2000). Comparative genomics of the RM systems of 
strains 26695 and J99 revealed that although H. pylori strains possess genes for 
multiple type II RM systems, many of these may not be biologically active (< 30% in 
J99/26695) (Lin et al., 2001). Table 16 and Table 17 list the type II restriction 
modification genes present in the genomes of 17874 and P79, respectively. There are 
21 such genes in the genome of 17874 while 9 were identified in that of P79. This is 
likely to be a key factor in the differing capacity of these strains for natural 
transformation due to altered restriction profiles. However, it must be considered that 
many of these systems may not be functionally active. 
Interestingly, several restriction enzymes contain homopolymeric tracts (Table 
12) and others are annotated as potential pseudogenes (Table 13) indicating that their 
expression can be modulated through phase variation. In P79, the gene encoding a 
type II methyltransferase (HP79_01260) is prematurely truncated due to a 
homopolymeric G tract containing 12 bp where the full length gene has 14 bp, as in 
reference strain 26695. RM and hypothetical genes are often strain-specific, as is the 
case for a number of gastric cancer-associated strains of H. pylori (McClain et al., 
2009). HP17_01508 and HP79_04682 encode homologues of the type II RM enzyme 
HsdR which is absent from the genome of J99. There is also a striking difference 
between the total number of methylases and endonucleases in 17874 and P79. 17874 
possesses genes encoding 32 methylases and 21 endonucleases, while P79 possesses 
37 methylases and just 13 endonucleases (Appendix 1 - Appendix 4), highlighting 
the inter-strain variation of RM components in H. pylori. 
 4.6 The Core Genome of H. pylori 
The most recently determined core genome identified 1,063 genes common to 
39 strains of H. pylori (Lu et al., 2013). The revised core genome of H. pylori was 
determined by bi-directional BLASTP analysis of 43 sequenced strains including 
17874 and P79 (Appendix 5). Here we present a more refined core genome 
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containing 898 genes (Appendix 6). Twenty six percent of the core genes are 
involved in metabolic pathways, while 10% are involved in the biosynthesis of 
secondary metabolites. Twenty two flagellum-related genes, 9 chemotaxis and 
15 LPS biosynthesis genes are conserved across all 43 strains of H. pylori. Thirteen 
ABC transport genes are conserved along with components of the ComB natural 
transformation system. There are 172 genes encoding hypothetical proteins in the 
core genome of H. pylori, emphasising its capacity for encoding novel biological 
functions. 
Of the 43 strains used to determine the core genome, 26 strains were isolated from 
individuals suffering from 1 of 4 H. pylori-related diseases: gastritis (10), duodenal 
ulcer (7), gastric cancer (7) and MALT lymphoma (2) (Appendix 5). The “disease 
core” genome was determined for these 26 strains, resulting in 977 genes which are 
common to all sequenced strains isolated from individuals suffering from H. pylori-
related disease. Approximately 40% of the proteome of H. pylori consists of 
hypothetical proteins with no known function (Alm and Trust, 1999; Boneca et al., 
2003). Hypothetical proteins account for 330 products of the “disease core” genes 
according to the annotation of strain 26695. Seventy nine genes are unique to the 
disease-type strains which may include disease markers and virulence genes 
(Appendix 7). Functional analysis of the 28 hypothetical proteins may contribute to 
our understanding of the mechanisms behind the induction of disease by H. pylori. 
Of note, vacA is a core gene of the disease-inducing strains which is not conserved 
by all 43 sequenced strains. Gene content comparisons of H. pylori isolates from 
patients suffering from gastroduodenal diseases have also been employed to probe 
for biomarkers of disease (Romo-González et al., 2009). Recently, Blanchard et al. 
reported the sequences of 65 H. pylori strains isolated from patients suffering from 4 
disease states as well as asymptomatic adults (Blanchard et al., 2013). In addition to 
the currently sequenced “disease” strains, this provides a valuable resource for 
further research into the pathogenesis of this gastric pathogen. 
Core genome analysis for strains isolated from patients suffering from gastritis, 
duodenal ulcer, gastric cancer and MALT lymphoma was performed to serve as a 
platform for the identification of potential disease-specific genetic markers in 
H. pylori. The “gastritis core” genome consists of 1,186 core genes, 288 of which are 
conserved by this group in addition to the “total core” H. pylori genome (Appendix 
8). These include the cagPAI, and genes encoding DNA translocase FtsK and 
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methicillin resistance protein. Additionally, 86 genes encoding hypothetical proteins 
form part of the “gastritis core” (26695 annotation). The “duodenal ulcer core” 
genome of H. pylori contains 1,236 conserved genes, 338 of which are duodenal 
ulcer-specific when compared to the “total core” genes (Appendix 9). In addition to 
127 genes encoding hypothetical proteins, genes encoding urease accessory proteins, 
spore coat polysaccharide biosynthesis protein C and RM system components are 
also conserved (J99 annotation). The “gastric cancer core” genome consists of 
1,114 genes, 216 of which are “gastric cancer core”-specific (Appendix 10). The 
additional genes encode products including 56 hypothetical proteins, OMPs, the 
cagPAI, virulence factor MviN, recombinase A and topoisomerase (F32 annotation). 
The “MALT core” genome contains 1,311 conserved genes and 413 “MALT core”-
specific genes with reference to the “total core” genome (Appendix 11). Among 
these 413 genes are those encoding OMPs, chemotaxis proteins, cobalt-zinc-
cadmium resistance protein, superozide dismutase and 128 hypothetical proteins 
(HELPY annotation). 
 4.7 Unique Genes 
Strain-unique genes were identified using a pairwise bi-directional BLASTP 
comparison of 17874, P79, 26695 and J99, where the query sequence has no 
detectable homologues. The 17874 genome contains 41, 45 and 25 unique genes that 
are absent in 26695, J99 and P79, respectively, including 20 which are absent in all 
three other strains (Appendix 12). All of these genes encode hypothetical proteins 
except for the type II restriction enzyme R which is present in 26695 and P79 but 
absent in the genome of J99. Twenty four genes from 26695 are absent from the 
genome of 17874, including genes encoding a metal-binding polypeptide and 
hypothetical proteins (Appendix 13). Seven genes all encoding hypothetical proteins 
from the genome of J99 are absent in 17874 (Appendix 14). P79 contains 41, 54 and 
38 unique genes that are absent in 26695, J99 and 17874, respectively (Appendix 
15). Twenty two genes from 26695 are absent from P79, many of which are also 
absent in 17874. Six genes from J99 encoding hypothetical proteins are absent in P79 
(Appendix 14). Thirty six genes are shared by 17874 and P79 but absent in 26695 
and J99. 
H. pylori has been associated with its anatomically modern human host for 
~60,000 years (Linz et al., 2007). Many of the strain-specific genes of H. pylori 
Chapter 2: Comparative Genomics 
 
~ 104 ~ 
encoding hypothetical proteins have a % GC content which is lower than the whole-
genome average, indicating that they have been acquired by horizontal gene transfer. 
This is refective of the evolutionary proccess by which H. pylori continuously adapts 
to its environment. Therefore, it is likely that many of these uncharacterised 
hypothetical proteins have biological functions which give competitive advantage to 
the strain from which they were isolated for survival in their specific host e.g. 
colonisation factors and stress response genes. H. pylori is one of the most 
genetically variable pathogens described and genetic recombination has a significant 
impact on population genetics in which allelic diversity can be associated with 
pathogenicity e.g. vacA s1/m1 allele is linked to higher risk of gastric cancer 
development (Miehlke et al., 2000; Suerbaum and Josenhans, 2007). 
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5 Conclusions 
The increased ease and reduced expense in bacterial genome sequencing has lead 
to the availability of large volumes of data for gene mining. The genome of H. pylori 
undergoes extensive genetic flux, as revealed by comparative genomics of many 
strains. The draft genome sequence of 17874, the type strain for the species, has been 
deposited in GenBank. In addition, the draft genome of P79, a motile and readily 
transformable strain has also been deposited. Availability of these sequences will 
contribute to future motility studies as well as studies requiring genetic modification. 
Comparative genomic analysis of strains 17874 and P79 revealed 1,639 and 
1,699 coding genes in genomes of 1.61 and 1.64 Mbp, respectively. H. pylori 
genome size is much smaller than that of enteric pathogens Staphylococcus aureus 
(~2.8 Mbp), Salmonella enterica (4.5 - 4.8 Mb) and Yersinia sp. (4.3 - 4.8 Mb) 
(Chen et al., 2010; Deng et al., 2003; Gill et al., 2005; Holt et al., 2009). Variations 
in the ComB complement and differences between the RM systems encoded for in 
the genomes of 17874 and P79 are likely to be responsible for the difference in 
natural transformation efficiency between these strains. Phase variation facilitated by 
the presence of homopolymeric nucleotide repeats may also contribute to this 
difference. Many of the strain-unique genes in 17874 and P79 (compared to 
reference strains 26695 and J99) are in regions of low % GC content and encode 
hypothetical proteins. Core genome analysis of 43 sequenced strains of H. pylori 
identified a more conservative 898 core genes for the species. The core genome of 
H. pylori is much smaller than those of other pathogens including S. aureus 
(2,245 genes based on the genomes of 13 strains) and Salmonella enterica 
(2,882 genes based on the genomes of 73 strains) (Boissy et al., 2011). Analysis of 
core genes conserved by strains isolated from patients suffering from H. pylori-
related diseases identified potential biomarkers of disease including the cagPAI and 
vacA.  
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6 Tables and Figures 
Table 2 General genome features of two H. pylori strains compared with reference 
strain H. pylori 26695 
Feature 
H. pylori 
CCUG 17874* 
H. pylori P79* H. pylori 26695 
Genome size (bp) 1,615,763 1,641,495 1,667,867 
G+C content (%) 38.97 38.86 39.00 
Coding genes 1,639 1,699 1,590 
Coding density (%) 86.5 85.1 90.4 
rRNA operons 2 2 7 
tRNAs 36 35 36 
Pseudogenes 25 29 3 
IS elements 3 5 14 
*Figures for CCUG 17874 and P79 are estimates based on the draft assembly automated 
annotation. 
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Table 3 IS elements identified in the genomes of H. pylori CCUG 17874 and P79 
Locus tag Contig Product 
HP17_01198 22 IS605 transposase (tnpB) 
HP17_01203 22 IS605 transposase (tnpA) 
HP17_08409 160 IS605 transposase (tnpB) 
   
HP79_04127 112 IS200 insertion sequence from SARA17 
HP79_04132 112 Transposase-like protein, PS3IS 
HP79_04137 112 IS606 transposase 
HP79_06476 159 IS605 transposase (tnpA) 
HP79_06481 159 IS605 transposase (tnpB) 
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Table 4 Phage-associated genes identified in the genomes of H. pylori CCUG 17874 and 
P79 
Locus tag Contig Product 
HP17_04069 73 Uncharacterised phage-associated protein 
HP17_06262 106 Phage integrase family site-specific recombinase 
HP17_08434 162 Phage/colicin/tellurite resistance cluster Y protein 
   
HP79_00375 14 Phage integrase family site-specific recombinase 
HP79_02479 69 Phage/colicin/tellurite resistance cluster Y protein 
  
Table 5 Flagellar genes identified in the genomes of H. pylori CCUG 17874 and P79 and their orthologues in H. pylori strains 26695 and J99 
Strain: 17874 P79 26695 J99 
 
Gene name Locus tag Contig Locus tag Contig Locus tag Locus tag Product function 
putative secreted 
heat shock protein 
HP17_03754 71 HP79_01330 35 HP_1462 jhp_1355 Secreted protein involved in motility 
fliR HP17_00295 6 HP79_07780 188 HP_0173 jhp_0159 Flagellar biosynthetic protein 
flgE1 HP17_03309, 
HP17_0329, 
HP17_03314 
60, 62, 
63 
HP79_02664, 
HP79_02669 
74, 75 HP_0870 jhp_0804 Fagellar hook protein 
flgK HP17_03469 68 HP79_08992 214 HP_1119 jhp_1047 Hook-associated protein 1 (HAP 1) 
flgA HP17_03844 72 HP79_01230 31 HP_1477 jhp_1370 Flagellar basal body P-ring biosynthesis protein 
flaB HP17_00935 17 HP79_04542 123 HP_0115 jhp_0107 Flagellin B 
pflA HP17_01373 24 HP79_06751 164 HP_1274 jhp_1195 Paralysed flagella protein PflA 
flgH HP17_01838 31 HP79_00560 19 HP_0325 jhp_0308 Flagellar basal body L ring protein 
flaG 1 HP17_01853 31 HP79_00575 19 HP_0327 jhp_0310 Flagellar associated protein-glycosylation 
fliF HP17_01975 33 HP79_00717 21 HP_0351 jhp_0325 Flagellar basal body M ring protein 
fliG HP17_01980 33 HP79_00722 21 HP_0352 jhp_0326 Flagellar motor switch protein 
fliH HP17_01985 33 HP79_00727 21 HP_0353 jhp_0327 Flagellar export protein 
hypothetical 
protein 
HP17_02010 33 Absent  HP_0206 jhp_0192 Predicted ATPase involved in biogenesis of 
archaeal flagella 
hypothetical 
protein 
HP17_04675  HP79_08575  HP_0256 jhp_0240 Involved in motility and cell envelope 
architecture 
flgG HP17_02025 33 HP79_06991 170 HP_1092 jhp_0333 Basal body rod protein 
flhA HP17_02297 36 HP79_07273 175 HP_1041 jhp_0383 Flagellar basal body protein involved in export 
flhF HP17_02327 36 HP79_07303 175 HP_1035 jhp_0389 Flagellar biosynthesis regulator/GTP-binding 
  
protein 
flhG HP17_02332 36 HP79_07308 175 HP_1034 jhp_0390 ATP-binding protein 
fliA HP17_02342 36 HP79_07318 175 HP_1032 jhp_0392 Sigma 28 subunit of DNA-dependent RNA 
polymerase 
fliM HP17_02347 36 HP79_07323 175 HP_1031 jhp_0393 Flagellar motor switch protein 
fliY HP17_02352 36 HP79_07328 175 HP_1030 jhp_0394 Flagellar motor switch protein 
flgE2 HP17_02559 41 HP79_01645 43 HP_0908 jhp_0844 Flagellar hook protein homolog 
flgD HP17_02564 41 HP79_01650 43 HP_0907 jhp_0843 Flagellar hook capping protein 
fliE HP17_04401 81 HP79_05396 135 HP_1557 jhp_1465 Flagellar hook-basal body protein 
flgC HP17_04406 81 HP79_05391 135 HP_1558 jhp_1466 Flagellar basal body rod protein 
flgB HP17_04411 81 HP79_05386 135 HP_1559 jhp_1467 Flagellar basal body rod protein 
flgG HP17_04556 82 HP79_05246 133 HP_1585 jhp_1492 Distal rod protein 
flgI HP17_04911 86 HP79_08525 202 HP_0246 jhp_0231 Flagellar basal body P-ring protein 
flgL HP17_05185 90 HP79_08807 209 HP_0295 jhp_0280 Flagellar hook-associated protein 
flaA HP17_05595 99 HP79_02059 61 HP_0601 jhp_0548 Flagellin A 
fliN HP17_05695 99 HP79_02184 66 HP_0584 jhp_0531 Flagellar motor switch protein 
fliP HP17_06317 108 HP79_00335 14 HP_0684, 
HP_0685 
jhp_0625 Flagellar biosynthesis protein 
fliW 2 HP17_06902 130 HP79_05914  149 HP_1377 jhp_1291 Flagellar assembly protein 
hpaA3 HP17_07457 145 HP79_04057 109 HP_0492 jhp_0444 Flagellar sheath adhesin 
fliI HP17_07767 148 HP79_00065 4 HP_1420 jhp_1315 Flagellum-specific ATP synthase 
fliQ HP17_07772 148 HP79_00060 4 HP_1419 jhp_1314 Flagellar biosynthesis protein 
flaG 2 HP17_07932 149 HP79_03366 95 HP_0751 jhp_0688 Uncharacterised flagellar protein 
fliD HP17_07937 149 HP79_03361 95 HP_0752 jhp_0689 Flagellar hook associated protein 2 (capping 
protein) 
  
fliS HP17_07942 149 HP79_03356 95 HP_0753 jhp_0690 Flagellin specific chaperone 
flhB1 HP17_08034 150 HP79_03271 93 HP_0770 jhp_0707 Flagellar basal body protein 
motB HP17_08666 165 HP79_03001 83 HP_0816 jhp_0752 Flagellar motor protein 
motA HP17_08671 165 HP79_03011, 
HP79_03006 
84, 83 HP_0815 jhp_0751 Flagellar motor protein 
fliL HP17_08701 165 HP79_03046 86 HP_0809 jhp_0745 Flagellar basal body-associated protein 
rpoN HP17_06522 116 HP79_00175 8 HP_0714 jhp_0652 RNA polymerase factor sigma-54 
flgM HP17_03484 68 HP79_09007 214 HP_1122 jhp_1051 Anti-fliA 
envA/lpxC HP17_02230 35 HP79_07213 174 HP_1052 jhp_0373 UDP-3-O-[3-hydroxymyristoyl] N-
acetylglucosamine deacetylase 
fliT HP17_07947 149 HP79_03351 95 HP_0754 jhp_0691 Flagellar chaperone, hypothetical protein 
fliK HP17_02569 41 HP79_01655 43 HP_0906 jhp_0842 Hypothetical protein 
flgJ HP17_02688 44 HP79_03583 101 HP_1233 jhp_1154 Hypothetical protein 
atoS HP17_04901 86 HP79_08515 202 HP_0244 jhp_0229 Histidine kinase specific for flgR 
neuA/flmD HP17_01843 31 HP79_00565 19 HP_0326 absent CMP-N-acetylneuraminic acid synthetase 
flaA1 HP17_06000 101 HP79_02849 79 HP_0840 jhp_0778 UDP-GlcNAc C6 dehydratase 
putative fliZ HP17_01473 24 HP79_06681 163 HP_1286 jhp_1206 Uncharacterised conserved protein 
*potential frameshift in P79 
flhB2 HP17_04491 81 HP79_05311 135 HP_1575 jhp_1483 Homologue of flhB protein cytoplasmic domain 
hpaA2 HP17_07264 143 HP79_05691 139 HP_0410 jhp_0971 Flagellar sheath associated protein paralog 
hpaA HP17_08561 165 HP79_03111 87 HP_0797 jhp_0733 Flagellar sheath associated protein paralog 
flgZ HP17_08776 166 HP79_08283 199 HP_0958 jhp_0892 Hypothetical protein 
fliB HP17_05065 88 HP79_08677 204 HP_0274 jhp_0259 Flagellin N-methylase family protein 
  
Table 6 List of genes in the cagPAIs of H pylori CCUG 17874 and P79 
17874 
Locus tag 
 
Contig 
P79 
Locus tag 
 
Contig 
 
Product 
HP17_07617 147 HP79_03897 108 Cag pathogenicity island protein (Cag1) 
HP17_07622* 147 HP79_03892* 108 Cag pathogenicity island protein epsilon 
HP17_07627 147 HP79_03887/82* 108 Cag pathogenicity island protein (Cag3) 
HP17_07632 147 HP97_03877 108 Cag pathogenicity island protein gamma 
HP17_07637 147 HP79_03872/67 108/7 Cag pathogenicity island protein 5 
HP17_07642 147 HP79_03862 107 Cag pathogenicity island protein alpha 
HP17_07647 147 HP79_03857 107 Cag pathogenicity island protein (Cag6) 
HP17_07652 147 HP79_03852 107 Hypothetical protein 
HP17_07657/03179/84 147/58/57 Pseudogene 107 Cag pathogenicity island protein Y VirB10-like protein (Cag7) 
HP17_03174 57 HP79_02474 68 Cag pathogenicity island protein X (Cag8) 
HP17_03169 57 HP79_02469 68 Cag pathogenicity island protein W (Cag9) 
HP17_03164 57 HP79_02464 68 Cag pathogenicity island protein V (Cag10) 
HP17_03159 57 HP79_02459 68 Cag pathogenicity island protein U (Cag11) 
HP17_03154 57 HP79_02454 68 Cag pathogenicity island protein T (Cag12) 
HP17_03149 57 HP79_02449 68 Cag pathogenicity island protein S (Cag13) 
HP17_03144 57 Absent  Hypothetical protein 
HP17_05960 100 HP79_02444 68 Cag pathogenicity island protein Q (Cag14) 
HP17_05955 100 Absent  Hypothetical protein 
Absent  HP79_02443 68 Cag island protein (Cag15) 
HP17_05950 100 HP79_02439 68 Cag pathogenicity island protein M (Cag16) 
HP17_05945 100 HP79_02434 68 Cag pathogenicity island protein N (Cag17) 
  
HP17_05940 100 HP79_02429 68 Cag pathogenicity island protein L (Cag18) 
HP17_05935 100 HP79_02424 68 Cag pathogenicity island protein (Cag19) 
HP17_05930 100 HP79_02419 68 Cag pathogenicity island protein H (Cag20) 
HP17_05925 100 HP79_02414 68 Cag pathogenicity island protein G (Cag21) 
HP17_05920 100 HP79_02409 68 Cag pathogenicity island protein F (Cag22) 
HP17_05915 100 HP79_02404 68 Cag pathogenicity island protein E (Cag23) 
HP17_05910 100 HP79_02399 68 Cag pathogenicity island protein D (Cag24) 
HP17_05905 100 HP79_02394 68 Cag pathogenicity island protein C (Cag25) 
HP17_05900 100 HP79_02389 68 Cag pathogenicity island protein B 
HP17_05895 100 HP79_02384 68 Cytotoxin-associated protein A (Cag26) 
*Potentially frameshifted. 
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Table 7 List of OMPs annotated in the genome of H. pylori CCUG 17874 
Locus tag Contig Product 
HP17_05565 97 Outer-membrane protein of the hefABC efflux system 
HP17_06167 104 Protective surface antigen D15 
HP17_03504 68 Peptidoglycan-associated lipoprotein precursor 
HP17_03904 72 Lipase-like protein 
HP17_00746 15 Outer membrane protein 
HP17_00045 2 Outer membrane protein 
HP17_06737 125 Outer membrane protein 
HP17_02957 48 Outer membrane protein 
HP17_04826 86 Outer membrane protein HopA; signal peptide 
HP17_04953 87 Outer membrane protein HopF; putative signal peptide 
HP17_04958 87 Outer membrane protein HopG 
HP17_00320 7 Outer membrane protein 
HP17_00355 8 Outer membrane protein; signal peptide 
HP17_00415 10 Putative outer membrane protein 
HP17_00501 12 Putative outer membrane protein 
HP17_07134 140 Outer membrane protein HofC 
HP17_07129 140 Outer membrane protein HofD; signal peptide 
HP17_05785 99 Outer membrane protein, predicted permease 
HP17_05385 93 Outer membrane protein, OipA 
HP17_06247 106 Outer membrane protein 
HP17_06387 112 Outer membrane protein 
HP17_06472 115 Outer membrane protein HopE 
HP17_06497 116 Putative outer membrane protein HomB 
HP17_06502 116 Outer membrane protein 
HP17_06567 121 Outer membrane protein SabA 
HP17_08129 153 Outer membrane protein HofF 
HP17_08556 165 Outer membrane protein HorG 
HP17_06005 101 Outer membrane protein P1 
HP17_03344 64 Iron-regulated outer membrane protein 
HP17_02524 41 Outer membrane protein HopB 
HP17_02519 41 Outer membrane protein 
HP17_02509 41 Iron-regulated outer membrane protein 
HP17_01010 19 Putative outer membrane protein 
HP17_02160 35 Outer membrane protein HorD 
HP17_02080 34 Outer membrane protein HofB; signal peptide 
HP17_01833 31 Outer membrane protein HorC; signal peptide 
HP17_01788 29 Outer membrane protein 
HP17_08264 158 Outer membrane protein HopI 
HP17_08259/54 158 Outer membrane protein HopL * 
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HP17_08199 157 Outer membrane protein HofH 
HP17_03139 56 Outer membrane protein HopQ; signal peptide 
HP17_03102 54 Outer membrane protein (omp27) (HopQ) 
HP17_08154/49 156/5 Outer membrane protein BabA 
HP17_03689 71 Outer membrane protein HomD; signal peptide 
HP17_03784 71 Outer membrane protein; signal peptide 
HP17_03799 72 Outer membrane protein HorJ; signal peptide 
HP17_03979 73 Outer membrane protein (omp32) 
HP17_04039 73 Iron-regulated outer membrane protein 
HP17_04226 78 Outer membrane protein 
HP17_04436 81 Outer membrane protein 
HP17_04631 82 Outer membrane protein 
HP17_04716 83 Outer membrane protein (omp2) 
HP17_08806 168 Outer membrane protein HopK; signal peptide 
*Potentially frameshifted. 
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Table 8 List of OMPs annotated in the genome of H. pylori P79 
Locus tag Contig Product 
HP79_02039 61 Hypothetical protein 
HP79_00490/85 16/15 Protective surface antigen D15 
HP79_09027 214 Peptidoglycan-associated lipoprotein precursor 
HP79_01170 31 Lipase-like protein 
HP79_05146/41 131/30 Outer membrane protein 
HP79_05056 129 Outer membrane protein (omp2) 
HP79_04747 126 Outer membrane protein (omp3) 
HP79_08030 191 Outer membrane protein (omp4) 
HP79_08433 201 Outer membrane protein (omp6) 
HP79_08560 202 Outer membrane protein (omp7) 
HP79_08565 202 Outer membrane protein 
HP79_08762/67/72 206/7 Toxin-like outer membrane protein* 
HP79_00515 18 Outer membrane protein (omp9) 
HP79_00555 19 Outer membrane protein (omp10) 
HP79_01819 13 Outer membrane protein (omp13) (OipA) 
HP79_00395 14 Outer membrane protein (omp14) 
HP79_00285 12 Outer membrane protein 
HP79_00220/15 9/8 Outer membrane protein HopE; signal peptide 
HP79_03156 88 Outer membrane protein 
HP79_03116 87 Outer membrane protein (omp18) 
HP79_02854 79 Outer membrane protein P1 (ompP1) 
HP79_02634/29 73/72 Iron-regulated outer membrane protein 
HP79_01725 45 Outer membrane protein (omp19) 
HP79_01625 43 Outer membrane protein (omp20) 
HP79_01620 43 Outer membrane protein (omp21) 
HP79_01605/00 43 Iron-regulated outer membrane protein* 
HP79_01570 42 Toxin-like outer membrane protein 
HP79_08137 195 Putative outer membrane protein 
HP79_01495 38 Outer membrane protein (omp23) 
HP79_01460 37 Outer membrane protein (omp24) 
HP79_06306/01 154/3 Outer membrane protein (omp25) 
HP79_06296 153 Outer membrane protein (omp26) 
HP79_06179 152 Outer membrane protein (omp27) (HopQ) 
HP79_06029 149 Outer membrane protein (omp30) 
HP79_01045 29 Iron-regulated outer membrane protein 
HP79_01105 30 Outer membrane protein (omp32) 
HP79_01275/80 32/33 Outer membrane protein (omp31) 
HP79_01555 39 Outer membrane protein (omp12) 
HP79_01560 40 Outer membrane protein 
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HP79_07460 179 Outer membrane protein (omp9) 
HP79_08077 194 Outer membrane protein (omp29) 
HP79_01754 48 Outer membrane protein 
HP79_05366 135 Outer membrane protein 
*Potentially frameshifted. 
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Table 9 List of ABC transport genes annotated in H. pylori CCUG 17874 
Locus tag Contig Product 
HP17_08389 159 ABC-type antimicrobial peptide transport system, ATPase 
component 
HP17_04938 87 Oligopeptide permease ATPase protein 
HP17_04943 87 Oligopeptide permease integral membrane protein 
HP17_05200 90 Peptide ABC transporter substrate-binding protein 
HP17_05205 90 Peptide ABC transporter permease 
HP17_05210 90 ABC-type transport system, permease; dipeptide 
transporter protein 3; membrane protein 
HP17_05215 90 ABC-type transport system, ATP-binding protein; 
dipeptide transporter protein 4 
HP17_05220 90 Dipeptide ABC transporter 
HP17_05605 99 ABC-type transport system, permease and ATP- binding 
protein; putative membrane protein 
HP17_05600 99 Multidrug resistance protein SpaB 
HP17_05530 95 Multidrug resistance protein SpaB 
HP17_05525 95 ABC transporter, permease 
HP17_05520 95 ABC transporter, ATP-binding protein 
HP17_06527 116 ABC-type transport system, ATP binding protein 
HP17_07837 149 Hypothetical protein, ABC-type multidrug transport 
system 
HP17_07917 149 Cell division protein, ABC-type antimicrobial peptide 
transport system, ATPase component 
HP17_08119 152 Hypothetical protein, ABC-type transport system, 
involved in lipoprotein release 
HP17_08651 165 Osmoprotection protein (proV) 
HP17_08656 165 ABC-type transport system, permease; 
betaine/proline/choline transporter; membrane protein 
HP17_03409 66 Iron (III) dicitrate transport system ATP-binding protein 
HP17_03414 66 Iron(III) dicitrate ABC transporter permease protein 
(fecD) 
HP17_01025 19 Amino acid ABC transporter permease 
HP17_01030 19 Putative polar amino acid transport system substrate-
binding protein 
HP17_02972 50 Molybdenum ABC transporter ATP-binding protein 
(modD) 
HP17_02982 51 Molybdenum ABC transporter (modB) 
HP17_02987 51 Molybdenum ABC transporter 
HP17_02210 35 Hypothetical protein, ABC-type multidrug transport 
system 
HP17_02085 34 ABC-type transport system, ATP binding protein; lipid A 
and glycerophospholipid transporter; membrane protein; 
signal peptide 
HP17_02020 33 Hypothetical protein, ABC-type multidrug transport 
system, ATPase component 
HP17_08189 157 Glutamine ABC transporter permease 
HP17_08184 157 Glutamine ABC transporter permease 
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HP17_08179 157 Phosphate ABC transporter ATP-binding protein 
HP17_08174 157 Glutamine ABC transporter periplasmic glutamine-
binding protein 
HP17_02818 44 ABC transporter ATP-binding protein 
HP17_02763 44 ABC-2 type transport system ATP-binding protein 
HP17_01258 24 Oligopeptide ABC transporter, permease protein 
HP17_01263 24 ABC transporter substrate-binding protein 
HP17_03764 71 ABC transport system substrate binding protein t 
HP17_03769 71 ABC transporter ATP-binding protein 
HP17_03774 71 ABC transporter permease protein 
HP17_03889 72 Antibiotic transport system permease protein 
HP17_03894 72 Hypothetical protein, ABC-type multidrug transport 
system 
HP17_04421 81 Iron(III) ABC transporter periplasmic iron-binding protein 
(ceuE) 
HP17_04426 81 Iron(III) ABC transporter periplasmic iron-binding protein 
HP17_04436 81 Outer membrane protein, ABC-type metal ion transport 
system 
HP17_04496 81 DL-methionine transporter ATP-binding subunit 
HP17_04501 81 ABC-type transport system, permease; putative D- and L-
methionine transport protein; putative membrane protein 
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Table 10 List of ABC transport genes annotated in H. pylori P79 
Locus tag Contig Product 
HP79_04682 126 Type II restriction enzyme R protein (hsdR), ABC-type 
sugar transport systems 
HP79_07745 188 ABC transporter ATP-binding protein 
HP79_08545 202 Oligopeptide ABC transporter ATP-binding protein 
(oppD) 
HP79_08550 202 Oligopeptide permease integral membrane protein 
HP79_08822 209 Dipeptide ABC transporter periplasmic dipeptide- binding 
protein (dppA) 
HP79_08827 209 Dipeptide ABC transporter periplasmic dipeptide- binding 
protein (dppB) 
HP79_08832 209 Dipeptide ABC transporter periplasmic dipeptide- binding 
protein (dppC) 
HP79_08837 209 Dipeptide ABC transporter periplasmic dipeptide- binding 
protein (dppD) 
HP79_08842 209 Dipeptide ABC transporter ATP- binding protein (dppF) 
HP79_04212 114 Molybdenum ABC transporter periplasmic molybdate-
binding protein (modA) 
HP79_04217 114 Molybdenum ABC transporter ModB 
HP79_04222 114 Molybdenum ABC transporter ATP-binding protein 
(modD) 
HP79_02069 61 Multidrug resistance protein (spaB) 
HP79_01984 57 Hypothetical protein, ABC-type multidrug transport 
system 
HP79_01979 57 ABC transporter, permease 
HP79_01974 57 ABC transporter ATP-binding protein 
HP79_00170 8 ABC-type transport system, ATP binding protein 
HP79_03381 95 Cell division protein (ftsE) 
HP79_03171 90 Hypothetical protein, ABC-type transport system involved 
in lipoprotein release 
HP79_02991 83 Osmoprotection protein (proWX) 
HP79_02986 83 Osmoprotection protein (proV) 
HP79_02559 70 Iron compounds ABC transporter ATP-binding protein 
HP79_02554 70 Iron(III) dicitrate ABC transporter permease protein 
(fecD) 
HP79_08157 195 Amino acid ABC transporter permease protein (yckJ) 
HP79_08162/67 195/6 Amino acid ABC transporter periplasmic binding protein 
(yckK) 
HP79_07051/46 172/1 Multidrug resistance protein (msbA) 
HP79_06219 152 Glutamine ABC transporter permease protein (glnP) 
HP79_06214 152 Glutamine ABC transporter, permease protein 
HP79_06209 152 Phosphate ABC transporter ATP-binding protein 
HP79_06204 152 Glutamine ABC transporter periplasmic glutamine- 
binding protein (glnH) 
HP79_03708 102 Multidrug resistance protein (hetA) 
HP79_03653 102 ABC transporter ATP-binding protein 
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HP79_06881 166 Oligopeptide ABC transporter permease protein (oppB) 
HP79_06496 161 Hypothetical protein, ABC-type multidrug transport 
system 
HP79_01180 31 Hypothetical protein, ABC-type multidrug transport 
system 
HP79_01185 31 Antibiotic transport system permease protein 
HP79_01305 35 Hypothetical protein, ABC-type transport system involved 
in resistance to organic solvents 
HP79_01320 35 ABC transport system substrate binding protein 
HP79_06491 160 Iron(III) ABC transporter periplasmic iron- binding 
protein (ceuE) 
HP79_06486 160 Iron(III) ABC transporter periplasmic iron- binding 
protein (ceuE) 
HP79_05376 135 Iron(III) ABC transporter periplasmic iron- binding 
protein 
HP79_05366 135 Outer membrane protein, ABC-type metal ion transport 
system 
HP79_05306 135 DL-methionine transporter ATP-binding subunit 
HP79_05301 134 D-methionine transport system permease protein 
 
  
Table 11 List of the homopolymer G/C tracts in the genomes of H. pylori CCUG 17874 
Track length Homopolymer Coordinates Within or upstream Locus tag Gene  
14 C 1066317 Within HP17_05490 Glycosyltransferase involved in LPS biosynthesis 
 C 317042c Within HP17_07012 Type I restriction-modification system methyltransferase 
subunit 
      
11 C 122576c Within HP17_00245 Histidine kinase sensor protein 
 C 571724 Within HP17_01893 Unique hypothetical protein 
 G 358564c Within HP17_01553 Methionine aminopeptidase 
 C 317904c Within HP17_07017 Hypothetical protein; possible helicase 
 G 1332106 Upstream HP17_06847 Biotin synthase 
 G 160957c Within HP17_04104 Adenine specific DNA methylase Mod 
      
10 G 286752c Within Pseudogene Putative type III restriction enzyme M protein 
      
9 C 17213 Upstream HP17_00596 Hypothetical protein 
 G 589898 Within HP17_06182 Processing zinc-metalloprotease 
 G 609849c Upstream HP17_06272 Hypothetical protein, predicted permease 
 C 935726 Within HP17_03032 Type I restriction enzyme R protein (HsdR) 
 C 1061205 Within HP17_03459 Unique hypothetical protein 
 G 495211c Upstream HP17_08159 Hypothetical protein, predicted permease 
 G 127478c Within HP17_04266 DNA polymerase III subunit epsilon 
 G 1555297 Within HP17_04656 DNA primase 
      
  
8 G 1570131c Within HP17_00781 Hypothetical protein, predicted cell wall-associated hydrolase 
 G 79680 Upstream HP17_00950 Fe-S oxidoreductases 
 G 261927 Within HP17_05160 Diaminopimelate decarboxylase 
 C 371781 Within HP17_07239 Hypothetical protein 
 C 1119744c Within HP17_05720 Hypothetical protein, predicted neuraminidase (sialidase) 
 G 539301 Within HP17_05535 Vacuolating cytotoxin VacA 
 C 1060411c Within HP17_05460 Hypothetical protein, predicted aspartate/tyrosine/aromatic 
aminotransferase 
 G 586755 Within HP17_06167 Outer membrane protein, protective surface antigen D15 
 G 994105c Within HP17_06332 Ferrous iron transport protein B 
 G 915690c Within HP17_08017 Hypothetical protein 
 G 769945 Within HP17_06005 Outer membrane protein P1 
 C 832222 Within HP17_02559 FlgE 
 G 745461c Within HP17_08791 GpsA, NAD(P)H-dependent glycerol-3-phosphate 
dehydrogenase 
 G 607041c Within HP17_02085 ABC-type transport system, ATP binding protein; lipid A and 
glycerophospholipid transporter; membrane protein; signal 
peptide 
 G 498344c Upstream HP17_08194 Carbon starvation protein 
 G 1132966 Within HP17_03072 Multidrug-efflux transporter 
 G 448806c Within HP17_02808 Adenine-specific DNA methylase 
 G 326181c Within HP17_07072 Pgk, phosphoglycerate kinase 
 G 218249c Within HP17_03809 Type IIS R-M system restriction enzyme 
 G 108811c Within Pseudogene Preprotein translocase subunit SecD 
 C 11186 Within HP17_07112 RepA 
  
Table 12 List of the homopolymer G/C tracts in the genomes of H. pylori P79 
Track length Homopolymer Coordinate Within or upstream Locus tag Gene  
23 C 736422c Within HP79_04869 Hypothetical protein, predicted chromosome segregation ATPase 
      
14 C 755064c Upstream HP79_04157 Type I restriction enzyme R protein 
 C 846702 Within HP79_04667 Hypothetical protein 
      
13 C 1389708 Within HP79_07820 Histidine kinase sensor protein 
      
12 G 236345 Within HP79_01260 Type IIS restriction enzyme R protein (BCGIB) 
      
11 C 785102c Within HP79_04617 Hypothetical protein 
 G 284324c Within HP79_07520 Hypothetical protein 
      
10 G 775826c Within HP79_04657 2-hydroxyacid dehydrogenase 
 G 1062663 Within HP79_05864 Adenine-specific DNA methylase 
      
9 G 116689 Within HP79_00622 Hypothetical protein 
 C 575481c Within HP79_05774 Hypothetical protein, predicted helicase 
      
8 C 1556675c Within HP79_00335 FliP 
 G 1524647c Within HP79_00490 Protective surface antigen D15 
 G 1427680c Within HP79_01035 Selenocysteine synthase 
 C 1305344c Within HP79_01645 FlgE 
  
 C 1205534 Within HP79_02214 Hypothetical protein, predicted neuraminidase (sialidase) 
 G 893230c Within HP79_04022 Outer membrane phospholipase A1 
 G 981644 Within HP79_05436 Preprotein translocase subunit SecD 
 G 531200c Within HP79_06044 Alanine dehydrogenase 
 G 509784c Within HP79_06149 Multidrug-efflux transporter 
 G 1311993 Within HP79_07363 Hypothetical protein 
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Table 13 Predicted pseudogenes in the genome of H. pylori CCUG 17874 
Locus tag Contig Product 
HP17_00100 3 Iron-sulphur cluster binding protein 
HP17_00656 13 ATP-binding protein 
HP17_00691 13 Urease accessory protein UreE 
HP17_00940 17 DNA topoisomerase I 
HP17_01378 24 Phosphomannomutase 
HP17_02000 33 Hypothetical protein 
HP17_02907 46 Aldo-keto reductase 
HP17_03969 73 Putative endonuclease 
HP17_04089 74 Type III restriction enzyme 
HP17_04134 75 Chromosomal replication initiation protein 
HP17_04526 80 Undecaprenyl phosphate N-acetylglucosaminyltransferase 
HP17_04576 82 Hypothetical protein 
HP17_04721 84 Type II citrate synthase 
HP17_05270 91 Type II restriction enzyme 
HP17_05850 99 Sialidase A 
HP17_05975 101 Thiamine biosynthesis protein 
HP17_06322 108 Iron (III) dicitrate transport protein FecA; signal peptide 
HP17_06397 112 N-methyl hydantoinase 
HP17_06452 115 Hypothetical protein 
HP17_06852 130 Type III restriction enzyme R protein (res 1) 
HP17_06862 130 Putative type III restriction enzyme M protein 
HP17_07144 140 Non-functional type II restriction endonuclease 
HP17_07487 145 Sodium- and chloride-dependent transporter; membrane 
protein 
HP17_08209 157 Tetracycline resistance protein tetA (P) 
HP17_08349 159 MobC-like protein 
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Table 14 Predicted pseudogenes in the genome of H. pylori P79 
Locus tag Contig Product 
HP79_00005 1 Outer membrane protein (omp 29) 
HP79_00320 14 Iron (II) transport protein (feoB) 
HP79_00410 14 Type II R-M system protein 
HP79_00807 21 Type II DNA modification enzyme (methyltransferase) 
HP79_01005 29 Cytoplasmic protein 
HP79_01310 35 ABC transporter ATP-binding protein 
HP79_01670 43 Phosphate acetyltransferase 
HP79_01994 57 Vacuolating cytotoxin VacA 
HP79_02024 61 Acriflavine resistance protein (acrB) 
HP79_03401 95 Rod shape determining protein RodA 
HP79_03446 96 D-alanyl-alanine synthetase A3 
HP79_03837 107 Cag pathogenicity island protein (cag7) 
HP79_03842 107 Cag pathogenicity island protein Y VirB10-like protein 
HP79_03967 109 Glycolate oxidase subunit (glcD) 
HP79_04252 115 Nicotinate-nucleotide adenyltransferase 
HP79_04789 127 Urease subunit beta 
HP79_04901 128 Restriction endonuclease 
HP79_04926 128 Transcriptional regulator (hypF) 
HP79_05256 133 DNA-binding/iron metalloprotein/AP endonuclease 
HP79_06004 149 DNA repair protein (recN) 
HP79_06246 153 Glucose-6-phosphate isomerise 
HP79_06446 158 Type II DNA modification methyltransferase 
HP79_06681 163 Hypothetical protein 
HP79_06831 166 NAD+-dependent deacetylase, Sir2 family 
HP79_06871 166 Oligopeptide ABC transporter periplasmic oligopeptide-
binding 
HP79_07870 189 Recombinase A 
HP79_07935 189 Sodium/sulphate symporter 
HP79_07950 189 L-lactate permease (lctP) 
HP79_08777 207 Diaminopimelate decarboxylase (dap decarboxylase) 
(lysA) 
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Table 15 List of competence-related genes in the genomes of H. pylori CCUG 17874 and 
P79 
Locus tag Contig Product 
HP17_03604 70 Periplasmic competence protein-like protein 
HP17_04671 83 ComB2 
HP17_04676 83 ComB3 
HP17_04681 83 ComB4 
HP17_04781 84 ComB6 
HP17_04786 84 ComB7 
HP17_04791 84 ComB8 
HP17_04796 84 ComB9 
HP17_04801 84 ComB10 
HP17_06972 131 ComEC 
HP17_01883 31 DNA processing chain A (DprA) 
HP17_01888 31 DprB 
HP17_04129 75 ComH 
   
HP79_05106 129 ComB2 
HP79_05101 129 ComB3 
HP79_05096 129 ComB4 
HP79_04981 128 ComB6 
HP79_04976 128 ComB7 
HP79_04971 128 ComB8 
HP79_04966 128 ComB9 
HP79_04961 128 ComB10 
HP79_05824 147 ComEC 
HP79_00612 20 DNA processing chain A (DprA) 
HP79_00617 20 DprB 
HP79_00963 28 ComH 
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Table 16 List of the type II restriction modification system components identified in the 
genome of H. pylori CCUG 17874 
Locus tag Contig Product 
HP17_00556 13 Type II adenine methyltransferase 
HP17_00811 15 Type II adenine methyltransferase 
HP17_04995 88 Type II DNA modification methyltransferase 
HP17_05005 88 Type II R-M system restriction endonuclease 
HP17_05010 88 Type II DNA modification enzyme (methyltransferase) 
HP17_08484 162 Type II restriction endonuclease 
HP17_07184 141 Type II adenine methyltransferase 
HP17_07164 140 Type II DNA modification enzyme (methyltransferase) 
HP17_07159 140 Type II restriction endonuclease 
HP17_07154 140 Type II DNA modification enzyme 
HP17_06342 110 Putative type II cytosine specific methyltransferase 
HP17_06347 110 Putative type II restriction enzyme 
HP17_03479 68 M. HpyAVIII, type II cytosine specific DNA 
methyltransferase 
HP17_01443 24 Type II restriction endonuclease 
HP17_07037 133 Type II R-M system restriction endonuclease 
HP17_03809 72 Type IIS R-M system restriction enzyme 
HP17_03814 72 Type IIS restriction enzyme M protein (Mod) 
HP17_03959 73 Type II methylase 
HP17_03964 73 Type II adenine methyltransferase 
HP17_04079/84 73/74 Type IIS restriction-modification protein 
HP17_04286 80 Putative type II methylase protein 
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Table 17 List of the type II restriction modification system components identified in the 
genome of H. pylori P79 
Locus tag Contig Product 
HP79_01020 29 Type IIS restriction enzyme R and M protein (ECO57IR) 
HP79_04677 126 Type II restriction enzyme M protein (hsdM) 
HP79_05511 137 Type II N-6 Adenine-specific DNA methylase 
HP79_05849 147 Type IIS restriction enzyme R protein (MBOIIR) 
HP79_05854 147 Type IIS restriction enzyme M1 protein (mod) 
HP79_05859 147 Type IIS restriction enzyme M2 protein (mod) 
HP79_01255 31 Type IIS restriction enzyme M protein (mod) 
HP79_01260/65 31 Type IIS restriction enzyme R protein (BCGIB) 
HP79_04682 126 Type II restriction enzyme R protein (hsdR) 
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Figure 15 Genome atlas of H. pylori CCUG 17874. 
Graphical representation of the genome was generated using Artemis. Numbers are 
nucleotide co-ordinates. From the outermost circle to the innermost: H. pylori genes on the 
forward strand (purple); H. pylori genes on the reverse strand (gold); pseudogenes (green); 
flagellar genes (red); cag PAI genes (blue); % GC (black= below the mean, grey= above the 
mean); and GC skew. 
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Figure 16 Genome atlas of H. pylori P79. 
Graphical representation of the genome was generated using Artemis. Numbers are 
nucleotide co-ordinates. From the outermost circle to the innermost: H. pylori genes 
on the forward strand (purple); H. pylori genes on the reverse strand (gold); 
pseudogenes (green); flagellar genes (red); cag PAI genes (blue); %GC (black= 
below the mean, grey= above the mean); and GC skew. 
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A H. pylori CCUG 17874 
 
 
    
 
B H. pylori P79 
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Figure 17 Genome synteny of H. pylori strains CCUG 17874/P79 and 26695. 
Left panel: Mummerplot alignment of H. pylori CCUG 17874 (A) and P79 (B) (Y-
axis) and reference strain H. pylori 26695. Red dots represent regions of homology 
between the genomes which are in the same orientation. Blue dots represent 
homology between the genomes which are in the opposite orientation. Right panel: 
ACT comparison (DNA vs DNA) of H. pylori CCUG 17874 (A) and P79 (B) (top) 
and reference strain H. pylori 26695 (bottom). 
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Figure 18 Phylogenetic structure based on MLST analysis of 43 H. pylori strains. 
Neighbour-joining tree illustrating clustering of strains by geographical location where: 
red = Europe; blue = North America; green = South America; brown = Asia; yellow = East 
Asia and purple = Africa. Bootstrap values (100 replicates) are listed on each branch. 
  
 
 
Figure 19 Flagellar gene organisation of H. pylori CCUG 17874 and P79 based on reference strain 26695. 
Distribution of flagellar genes in both strains is across the genome, represented here as a single locus for illustrative purposes where: purple = flagellar genes; 
blue = non-flagellar genes; and red = genes whose size is estimated due to lack of sequencing coverage. 
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Figure 20 Flagellar genes present in the genomes of H. pylori CCUG 17874 and P79. 
Image generated by KEGG Automatic Annotation Server bi-directional best hit BLAST 
against a database of publicly available H. pylori genomes. Map of H. pylori CCUG 17874 
and P79 are identical. Image based on flagellum of Salmonella enterica where 
green = present and white = absent. 
  
 
 
 
Figure 21 ClustalW multiple sequence alignment of flip nucleotide and translated amino acid sequences. 
Sequences of the fliP gene of reference strains H. pylori 26695 and J99 compared to those of 17874 and P79. “26695 fliP C” is the altered sequence of flip 
from 26695 where one C has been deleted in the homopolymeric tract to illustrate the frameshift caused by this phase variable tract. 
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1 Abstract 
Background: Motility is an essential feature of Helicobacter pylori infection. A 
yeast two-hybrid study investigating the proteome of H. pylori 26695 previously 
identified that the flagellum biogenesis protein HP0958 interacts with flagellar 
proteins FliH and RpoN (σ54). HP0958 also interacts with the flaA mRNA transcript 
and may have a regulatory role in flagellum construction. 
Materials and Methods: A panel of site-directed mutants of HP0958 was 
generated in order to elucidate the mechanisms of HP0958 function. A hp0958-null 
derivative strain of P79 was complemented with hp0958 mutant alleles. GST pull-
down, yeast two-hybrid and PXG assays were performed to investigate HP0958-FliH 
and HP0958-RpoN interactions. HP0958-flaA mRNA interaction was analysed by 
electrophoretic mobility shift assay. 
Results: The previously reported HP0958-FliH (89-258) interaction could not be 
substantiated. Further, RpoN (74-210) also failed to interact with HP0958 at a 
detectable level when investigated using pull-down assay. The HP0958-RpoN (74-
284) interaction was confirmed but was relatively weak by quantitative analysis yeast 
two-hybrid assay. Complementation of the hp0958-null P79 derivative with mutant 
alleles revealed that mutations in the coiled-coil have a more pronounced effect on 
motility than those in the zinc-finger. Many mutant derivative strains produced 
atypical flagellar extrusions from the cells at non-polar sites. 
Conclusions: HP0958 does not interact with FliH. Residues 74-284 of RpoN are 
required for interaction with HP0958, predominantly along the coiled-coil domain. 
The zinc-finger domain of HP0958 is critical for interaction with the flaA mRNA 
transcript. We propose a novel function of HP0958 in localisation of flagellum 
biogenesis to the cell pole. 
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2 Introduction 
Helicobacter pylori has been closely associated with humans throughout their 
evolution (Linz et al., 2007). It currently infects approximately half of the global 
population, with higher prevalence in Asian and African countries (Linz et al., 2007). 
Colonisation with this opportunistic pathogen is associated with many effects on the 
host, some positive and but mostly negative. Typically in later life, H. pylori 
infection can lead to development of duodenal and gastric ulcers, gastric cancer and 
MALT lymphoma in humans and H. pylori was identified as a Class I pathogen in 
1994 (International Agency for Research on Cancer, 1994; Jemal et al., 2011; 
Marshall and Warren, 1984; Pounder and Ng, 1995; The Eurogast Study Group, 
1993; Warren and Marshall, 1983). 
Motility is a key feature of H. pylori infection and is essential for colonisation 
(Eaton et al., 1992). Flagellum biogenesis is a hierarchical and highly regulated 
process. In H. pylori, regulation of this process differs from that of the well described 
model systems of flagellum construction e.g. Salmonella enterica and E. coli 
(Anderson et al., 2010; Chevance and Hughes, 2008; McCarter, 2006; Niehus et al., 
2004). Flagellar genes can be subdivided into three classes, the expression of which 
is under the control of specific sigma factors. Sigma 80 regulates the expression of 
Class I (early) genes which encode regulators and components of the basal body. 
RpoN (σ54) control expression of Class II (middle) genes which encode components 
of the rod and hook, while σ28 controls expression of Class III (late) genes which 
encode the major filament protein FlaA (Niehus et al., 2002). 
HP0958 was identified as a hypothetical protein of unknown function in the 
genome of H. pylori 26695 (Tomb et al., 1997). It was since identified as an essential 
component of flagellar construction, because inactivation of this gene generated 
aflagellate, non-motile cells (Pereira and Hoover, 2005; Ryan et al., 2005a). 
Insertional mutation of the hp0958 gene of H. pylori strain CCUG 17874 resulted in 
reduced levels of RpoN and lowered expression of Class II flagellar genes including 
flgE and flaB, deeming HP0958 a chaperone of RpoN. HP0958 also interacts with 
the mRNA transcript of the major flagellin-encoding gene, flaA, at a post-
transcriptional level (Douillard et al., 2008). The crystal structure of HP0958 
revealed an N-terminal anti-parallel α-helical coiled-coil and a C-terminal zinc-finger 
domain (Caly et al., 2010). Initial structure-function analysis of the HP0958-flaA 
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mRNA interaction indicated that the zinc-finger of HP0958 is involved in RNA 
binding (Caly et al., 2010). However, little is known about what region of the mRNA 
transcript is required for this interaction.  
In 2001, the protein-protein interaction map of H. pylori strain 26695 was 
predicted using yeast two-hybrid screens, identifying 1,200 potential interactions 
(Rain et al., 2001). PIMRider was developed by Hybrigenics to view and analyse the 
output of the Rain study, and is accessible online (http://pim.hybrigenics.com). This 
study covered 46% of the proteome, including the predicted interaction network of 
HP0958. Statistically significant interactions were identified between HP0958 and 
the flagellar proteins RpoN and FliH, the negative regulator of FliI ATPase, as well 
as a number of other proteins of lower probability scores (Rain et al., 2001). 
Douillard et al. proposed a model of the role of HP0958 in flagellum biogenesis. 
This model suggests that HP0958 acts as a chaperone to RpoN during the expression 
of Class II flagellar genes; upon the switch in specificity to Class III genes, HP0958 
acts to guide the flaA transcript to the export apparatus through its interaction with 
FliH (Douillard et al., 2008). However, the mechanism of binding in HP0958-FliH 
and HP0958-RpoN interactions has not been investigated at a structural level. 
Protein-protein interactions (PPIs) are essential for cellular function. Transient 
PPIs, although short-lived, are extremely important for a variety of biological 
processes e.g. signalling cascades and transcription factors (Hahn and Kim, 2012; 
Ozbabacan et al., 2011). PPIs can be detected using a number of biochemical and 
computational means including pull-down assay (Fields and Song, 1989; Geva and 
Sharan, 2011; Lane et al., 2006; Stynen et al., 2012; Tang and Bruce, 2009; Xia et 
al., 2010; Zhang et al., 2012). While the yeast two-hybrid system allows proteome 
analysis of a subject, it has a number of shortcomings. High rates of false-positives, 
incomplete coverage of the entire interactome, and the use of a eukaryotic system to 
investigate bacterial protein-protein interactions are limiting factors of this method 
(Stynen et al., 2012); nevertheless, it is a valuable high throughput tool in identifying 
PPIs. The yeast two-hybrid performed on the proteome of H. pylori 26695 (Rain et 
al., 2001) provided a valuable data set which can be used to create a more complete 
understanding of flagellum biogenesis in H. pylori. This study focused on the 
interactions of motility protein HP0958 with other flagellum biogenesis components 
including RpoN and FliH, identified from the previous yeast two-hybrid study. 
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3 Methods 
 3.1 Bacterial Strains and Culture Conditions 
The bacterial and yeast strains used in this study are listed in Table 18. H. pylori 
strains were grown on Columbia Base Agar (CBA) solid medium, supplemented 
with 5% v/v heat-inactivated, defibrinated horse blood (Cruinn, Ireland) at 37°C, 
5% CO2 and sub-cultured every two days. For broth culture, cells were grown in 
brain heart infusion (BHI) broth (Sigma) supplemented with heat-inactivated foetal 
bovine serum (Sigma) and gently agitated in a microaerobic environment for 20 hrs. 
Mutant derivatives of H. pylori strain P79 were supplemented with chloramphenicol 
(10 µg/ml) and kanamycin (25 µg/ml) where required. 
E. coli XLI-Blue Supercompetent cells (Stratagene, Agilent Technologies) were 
used as the host for molecular cloning of HP0958 site-directed mutants; E. coli 
Top 10 (Invitrogen, Carlsbad, CA) was used as the cloning system in all other cases. 
Proteins were over-expressed in E. coli Rosetta (Novagen, Darmstadt, Germany). 
E. coli XL1-Blue Supercompetent cells were grown in NZY
+
 broth at 37°C with 
agitation. All other E. coli strains were cultured in Luria-Bertani (LB) media at 37°C 
or 18°C with agitation. Media was supplemented with ampicillin (100 µg/ml), 
erythromycin (50 µg/ml) and chloramphenicol (34 µg/ml) where required. 
 3.2 Molecular Cloning 
All flagellar genes were amplified from H. pylori CCUG 17874 (Culture 
Collection University of Gothenburg, Gothenburg, Sweden). Genomic DNA was 
extracted from two-day old plates using DNeasy Blood and Tissue DNA Extraction 
Kit (Qiagen, Hilden, Germany) as previously described (Douillard et al., 2008). PCR 
was performed on genomic template DNA using the primers listed in Appendix 16 at 
standard conditions for Velocity (Bioline, UK) and Taq DNA Polymerase (New 
England Biolabs, UK). PCR amplicons were cloned into restriction digested vectors 
and transformed into chemically competent E. coli host cells. In all cases, positive 
clones were selected through propagation on relevant agar supplemented with 
appropriate antibiotics (Table 18) and screened by colony PCR. Plasmid DNA was 
extracted from E. coli cells using Qiaprep Spin Miniprep kit (Qiagen, Hilden, 
Germany). DNA concentration and quality was estimated using Nanodrop 2000 
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(Thermo Scientific). Correct constructs were confirmed by sequencing performed by 
Eurofins MWG Operon (Ebersberg, Germany). 
Yeast strains were made competent using a standard lithium acetate procedure and 
transformed with the relevant plasmids (Table 19) in the presence of salmon sperm 
carrier DNA according to the Clontech Yeast Protocols Handbook (Clontech 
Laboratories, USA). Briefly, 100 µg competent cells were incubated with 100 ng of 
the relevant plasmids and 0.1 mg salmon sperm DNA in the presence of 0.6 ml 
sterile polyethyleneglycol (PEG) 3350 and 1 X Tris-EDTA (TE) lithium acetate. 
Cells were incubated at 30ºC for 30 min, shaking. To each tube, 70 µl dimethyl 
sulfoxide (DMSO) was added, cells were heat shocked at 42ºC for 15 min and 
chilled on ice briefly before pelleting cells and resuspending in 500 ml 1 X TE. Cells 
were plated on appropriate media and incubated at 30ºC for 2 - 5 days. Positive 
clones were selected for through propagation on relevant drop out base YPD agar 
lacking different combinations of the amino acids tryptophan, leucine, adenine and 
histidine. 
 3.3 Site-Directed Mutagenesis 
Point mutations of selected amino acids were generated using Quikchange II Site-
Directed Mutagenesis kit (Stratagene, Agilent Technologies). Primers were designed 
according to the manufacturer’s recommendations (Appendix 17) and synthesized by 
MWG Biotech (Ebersberg, Germany). Rationale for selection of targets within 
HP0968 to be mutated is described in Appendix 18. Plasmid DNA was isolated from 
an E. coli Top10 strain carrying the pDC006 plasmid using the Qiaprep® Spin 
Miniprep kit (Qiagen, Hilden, Germany). The hp0958 gene present on pDC006 was 
used as the template DNA for mutagenesis. Pfu DNA polymerase amplified site-
directed mutants from 10 ng plasmid DNA by thermal cycling as previously 
described (Caly et al., 2010). Dpn I restriction digestion at 37°C for 1 hr was 
performed to remove template DNA. The resulting single-stranded plasmids were 
transformed into XL1-Blue Supercompetent cells and plasmids containing the correct 
mutation were screened by insert sequencing. 
 3.4 Allelic Exchange Mutagenesis 
All genes were amplified from Helicobacter pylori CCUG 17874 using primers 
listed in Appendix 17 (manufactured by Eurofins MWG Operon (Germany)) and 
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standard Velocity polymerase cycling parameters. The promoter region of the alkyl 
hydroperoxide reductase (ahpC) gene, php1563 was amplified to produce DNA with 
a 3’ overhang complementary to the 5’ of hp0958. Similarly, genes encoding wild-
type or site-directed mutants of HP0958 were amplified to incorporate a 5’ overhang 
complementary to the 3’ of php1563. Splicing by overlapping extension (SOE) PCR 
was used to generate a single fused product php1563_hp0958 as previously described 
(Douillard et al., 2008; Heckman and Pease, 2007). SOE PCR products were ligated 
to shuttle vector pIR203K04 (a kind gift from D. J. McGee) following BamHI and 
ClaI restriction digestion. This plasmid harbours a kanamycin resistance cassette and 
was designed to introduce DNA fragments into the intergenic region of H. pylori 
between genes hp0203 and hp0204 (Langford et al., 2006). 
 3.5 Natural Transformation of H. pylori 
Generation of the hp0958 deletion mutant, H. pylori P79-0958KO, was previously 
described (Ryan et al., 2005). E. coli Top10 was used as a cloning host before 
transformation into H. pylori. All constructs were confirmed by sequencing 
performed by Eurofins MWG Operon (Germany) and GATC (Germany). H. pylori 
P79-0958KO cells were transformed with shuttle vector pIR203K04 harbouring 
either wild type or site-directed mutants of hp0958, see Table 20 for details. Briefly, 
H. pylori P79-0958KO cells from one full 48 hr-old CBA plate were harvested in 
BHI broth supplemented with 0.5% FBS. The OD600 was corrected to 0.4 - 0.6 and 
recipient cells were incubated with 2 - 5 µg plasmid DNA at 37°C, 5% CO2 for 2 hrs. 
The mixture was then plated on non-selective CBA. After 24 hours, cells were 
harvested in BHI broth and transferred to CBA agar supplemented with 
chloramphenicol (10 µg/ml) and kanamycin (25 µg/ml) and incubated for 3 - 4 days. 
Transformants were screened by motility assay and colony purified. Colony PCR and 
sequencing of the hp0203-0204 intergenic region confirmed integration. 
 3.6 Motility Assay 
Freshly prepared BHI soft agar plates containing 0.3% (w/v) agar supplemented 
with 10% heat-inactivated FBS (Sigma) and antibiotics, where appropriate, were 
inoculated with H. pylori strains and mutants. Cells from 48 hr-old CBA plates were 
harvested in BHI broth and OD600 was corrected to 0.4 - 0.6. Cells (5 µl) were 
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stabbed into the centre of each motility plate and incubated at 37°C, 5% CO2. Plates 
were imaged after 4 days using the Gene Genius Bio-Imaging System (Syngene). 
 3.7 Electron Microscopy 
Flagellum morphology was determined using transmission electron microscopy 
(TEM) to observe negatively stained H. pylori cell preparations. Liquid cultures were 
grown for 20 hrs and fixed with 2.5% glutaraldehyde solution (Sigma). Cells were 
allowed to sediment overnight, and gently resuspended in fresh 2.5% glutaraldehyde 
solution. One drop containing ~5 x 10
6
 cells was applied to the surface of Formvar 
carbon-coated 200 mesh copper grids (Electron Microscopy Sciences, UK). Grids 
were quickly rinsed with H2O and stained with 2% uranyl acetate (Sigma). Imaging 
was performed using a FEI Tecnai 120 transmission electron microscope operating at 
120 kV (Biological Imaging Facility, Conway Institute of Biomolecular and 
Biomedical Research, University College Dublin). 
 3.8 Preparation of Whole Cell Fractions 
H. pylori cells were harvested from 20 hr liquid cultures and pelleted at 
13,000 rpm for 15 s. Pellets were washed with 1 ml sterile phosphate-buffered saline 
(PBS) and pelleted again. Supernatant was removed and pellets were resuspended 
gently in 500 µl fresh PBS. All cultures were corrected to an OD600 of 1.0 and 
centrifuged at 13,000 rpm for 15 s. Pellets were resuspended in Laemmli sample 
buffer, boiled at 100°C for 5 min and stored at -80°C. 
 3.9 Protein Electrophoresis and Western Blot 
Standard protocols were used to separate and visualise proteins by sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) (Sambrook et al., 
1989). Proteins were separated on 12.5% SDS acrylamide gels and transferred onto 
polyvinylidine fluoride (PVDF) membrane by electroblotting for 1 hr (Towbin et al., 
1979). Anti-hook and anti-flagellin polyclonal antibodies were used as primary 
antibodies during western blotting of H. pylori whole cell fractions (Kostrzynska et 
al., 1991; O′Toole et al., 1994). Anti-rabbit antibody raised in goat was coupled to 
horseradish-peroxidase (Sigma) and was used as the secondary antibody (Douillard 
et al., 2008). Detection was performed with 4-chloro-1-nathphol and hydrogen 
peroxide. 
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 3.10 Quantitative Analysis of Transcription by Real-Time PCR 
Quantitative real-time PCR (qRT)-PCR was performed as described previously 
using primers designed with Primer 3 software (Appendix 19) (Douillard et al., 
2008; Untergasser et al., 2012). Cells were grown in BHI broth supplemented with 
10% FBS for 20 hrs and harvested in Bacteria RNA Protect (Qiagen). Cells were 
washed with PBS and lysed by bead-beating in Trizol
®
 reagent (Ambion). RNA was 
purified using RNeasy Protect Bacteria Mini Kit (Qiagen) according to 
manufacturer’s instructions and DNase-treated to remove residual DNA using 
TURBO DNA-Free (Ambion) as instructed. RNA was quantified by Nanodrop 2000 
(Thermo Scientific) and RNA quality was assessed using Bioanalyser 2100 (Agilent 
Technologies) as directed by manufacturer. 200 ng of RNA was reverse transcribed 
to cDNA using High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems). All cDNA was diluted 50-fold before use in qRT-PCR. Briefly, 5 µl 
cDNA, 2 µl of 5 µM primer mix, 10 µl 2x mastermix (including Syber Green I 
polymerase) and 3 µl H2O were mixed and qRT-PCR was performed in Roche 
LightCycler
®
 480 II. Reactions were performed in triplicate on at least three 
biological replicates and data was normalised to the era housekeeping gene. Relative 
fold-changes in gene expression were calculated as previously described (Pfaffl, 
2001). Heat plots of normalised flagellar gene expression were generated, ranking 
strains according to flaB and flgE expression levels. 
 3.11 Protein Over-Expression and Purification 
Proteins used in pull-down assay were expressed with an N-terminal glutathione 
sepharose (GST) tag and purified affinity purified as previously described (Caly et 
al., 2010). An 8 residue N-terminal FLAG-tag (DYKDDDDK) was fused to bait 
proteins to facilitate immunoblotting. E. coli strains possessing the relevant plasmids 
(Table 19) were grown to OD600 0.4 - 0.6 and protein expression was induced with 
0.1 mM isopropylthiogalactoside (IPTG) for 16-20 hours at 18°C. Cells were 
harvested and lysed by passage through a French Press twice at 1,000 psi. 
The soluble cytoplasmic fraction was incubated with Glutathione Sepharose 4B 
(GE Healthcare, UK) for 16 hours at 4°C. Purified proteins were released using 
PreScission protease (GE Healthcare, UK) in cleavage buffer (50 mM Tris-HCl, 
150 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol (DTT), pH 7.5) at 4°C for 16 hrs 
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with gentle agitation. For elution of intact fusion proteins, resin was incubated with 
elution buffer containing 10 mM reduced glutathione according to the 
manufacturer’s instructions. Eluted proteins were concentrated (≤ 2 mg/ml) and 
buffers dialysed using Amicon Centrifugal Filter Units (Millipore, Billerica, MA). 
Proteins were further purified by anion exchange in a starting buffer of 20 mM 
ethanolamine, pH 9.0 on HiTrap FF 1 ml columns (GE Healthcare, UK) attached to 
an Äkta Purifier. Eluted purified proteins were concentrated and quantified using the 
Pierce Bicinchoninic Acid (BCA) assay (Thermo Scientific, USA) (Smith et al., 
1985). 
 3.12 GST Pull-Down Assay 
The GST pull-down assay was adapted from Lane et al., 2006 (Lane et al., 2006). 
Briefly, 30 µl glutathione sepharose 4B was washed 4 times with 100 µl PBS at 4°C. 
GST-tagged bait protein (60 µg) was bound to resin in a total volume of 200 µl at 
room temperature for 30 min with gentle agitation (Table 19). Resin-bound protein 
was washed 4 times and incubated with FLAG-tagged prey protein at various 
prey : bait molar ratios. Samples were incubated at room temperature for 30 min with 
gentle agitation. Samples were washed twice with 100 µl PBS 0.5% Tween 20, 
250 mM NaCl. Laemmli buffer was added to resin and samples were boiled for 5 
min at 100°C, run on 12.5% SDS-PAGE gels and transferred onto PVDF membrane. 
A horseradish peroxidase coupled anti-FLAG monoclonal antibody was used to 
detect prey proteins. The membrane was incubated with Enhanced 
Chemiluminescence (ECL) Western Blot Detection Reagents and developed on 
Hyperfilm in darkness according to manufacturer’s instructions (GE Healthcare, 
UK). 
 3.13 Yeast Two-Hybrid Assay 
Saccharomyces cerevisiae strains AH109 and Y187 were used as hosts for yeast 
two hybrid assay (Y2H) (Table 19). S. cerevisiae wild type strains were grown on 
yeast extract peptone dextrose (YPD) agar or broth and supplemented with 0.003% 
(v/v) adenine-2-hemisulphate. S. cerevisiae strains possessing bait vector pGBKT7 
were selected for on synthetically defined (SD) media lacking tryptophan; strains 
possessing prey vector pGADT7 were selected for on SD lacking leucine. SD media 
was supplemented with the following amino acids: 0.3 µM adenine-2-hemisulphate, 
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0.3 µM L-histidine-HCl, 1.67 µM L-leucine and 0.4 µM L-tryptophan. Cells were 
grown at 30ºC with agitation. 
The Y2H strategy was based on the Clontech Matchmaker
TM
 Gold Yeast Two 
Hybrid system (Clontech Laboratories, USA). See Table 19 and Appendix 16 for list 
of plasmids and primers used. Cells were made competent by standard lithium 
acetate procedure and transformed with relevant plasmids to investigate a given PPI. 
Transformed cells were plated on SD drop-out base with relevant amino acid 
supplements. Transformants were counted after 2 - 5 days and colony purified. 
 3.14 Plate X-Gal Assay 
Y187-derivative strains possessing both bait and prey vectors were selected on SD 
media lacking tryptophan and leucine. Plate X-gal (PXG) assay was adapted from 
Möckli et Auerbach to assess protein-protein interactions (PPI) through activation of 
histidine-encoding reporter gene expression (Möckli and Auerbach, 2004). Five 
biological replicates per strain were assayed in triplicate. SD-T-L broth was 
inoculated at a starting OD546 < 0.1. Cells were grown at 30°C with agitation to an 
OD546 of 0.8 - 1. One absorbance unit of cells was transferred to a 96-well round-
bottomed plate and pelleted. Cell lysis was achieved by 2 freeze thaw cycles: 3 
minutes submerged in liquid nitrogen, 3 minutes at 37°C. Lysed pellets were 
resuspended in 20 µl sterile H2O and transferred to a 96-well flat bottomed plate. 
Cells were incubated with 100 µl PBS, pH 7.4 containing 500 µg/ml X-gal, 0.3% 
(w/v) agarose and 0.05% (v/v) β-mercaptoethanol. Plates were incubated at room 
temperature in darkness. Time points were taken using a flatbed scanner and 
analysed by densitometry with ImageJ online software (Abramoff et al., 2004). 
 3.15 RNA Secondary Structure Prediction and in vitro Transcription 
Secondary structure prediction analysis of the full length flaA mRNA transcript 
was performed using RNAdraw which predicts structure based on McCaskill 
minimum free energy (Matzura and Wennborg, 1996) and RDM Circles which is 
based on maximum weight matching (Page, 2000). Truncated transcripts (regions 1, 
2 and 3) were designed using RNAdraw and generated using the primers listed in 
Appendix 20. SOE-PCR was performed to generate the region 1 truncation of flaA 
mRNA which required deletion of the central portion of the transcript. PCR 
templates for in vitro transcription were concentrated using the Minielute PCR 
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Purification Kit (Qiagen). Biotin-labelled RNA was synthesised from an artificially 
fused 5’ T7 polymerase binding site using the Riboprobe System T7 kit (Promega) 
and Biotin RNA Labelling Mix (Roche) as previously described (Caly et al., 2010). 
Transcripts were DNase treated for 15 min at 37°C and concentrated by 
phenol/chloroform extraction followed by ethanol precipitation. Quality of RNA was 
assessed by agarose gel electrophoresis in a 3-(N-morpholino) propanesulfonic acid 
(MOPS) buffer followed by post-staining with ethidium bromide and imaging using 
the Gene Genius Bio-Imaging System (Syngene). 
 3.16 Electrophoretic Gel Migration Shift Assay 
Electrophoretic gel migration shift assay (EMSA) was performed to investigate 
the nature of the interaction between HP0958 and flaA mRNA transcripts as 
previously described (Caly et al., 2010). Briefly, 6 µg of purified HP0958 was 
incubated with 15 ng of full length flaA riboprobe (8 ng region 1/5 ng region 2/3.2 ng 
region 3) in a final volume of 15 µl binding buffer containing 20 mM Tris-acetate 
(pH 7.9), 50 mM potassium acetate, 10 mM magnesium acetate, 1 mM dithiothreitol 
(DTT), 200 μM S-(5-adenosyl)-L-methionine chloride (Sigma), and 40 U RNasin 
(Promega, USA). Samples were incubated at room temperature for 10 min followed 
by 5 minutes at 37°C. The RNA was then resolved by native agarose gel 
electrophoresis. 
 3.17 Northern Blotting 
Resolved RNA was transferred from agarose gel to a Biodyne B nylon membrane 
(GE Healthcare, UK) overnight by capillary transfer. The membrane was rinsed with 
5 X sodium chloride-sodium citrate (SSC) buffer and RNA was cross-linked to the 
membrane by UV-cross-linking at 120 mJ using the Stratalinker UV-linker 
(Stratagene, USA). The membrane was washed with Odyssey blocking buffer (Li-
COR Biosciences) 1% SDS for 30 minutes at room temperature with gentle agitation. 
The blot was then incubated with Odyssey blocking buffer 1% SDS supplemented 
with streptavidin IRDye 680 (diluted 1:10,000) (Li-COR Biosciences) for 30 min at 
room temperature. The membrane was washed 3 times with PBS 0.1% Tween 20 and 
once with PBS before imaging using the Odyssey Infrared Imaging System (Li-COR 
Biosciences). 
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4 Results 
 4.1 The previously reported HP0958-FliH interaction could not be 
substantiated. 
In 2001, a study was published in Nature which predicted by yeast two-hybrid 
that HP0958 interacts with the flagellar protein FliH, in addition to the sigma factor 
RpoN (Rain et al., 2001). GST pull-down assay was performed with soluble proteins 
which were expressed in E. coli and purified by affinity and anion exchange 
chromatography. Concentrated, purified proteins were assessed by SDS-PAGE (data 
not shown). GST-tagged bait proteins were bound to glutathione sepharose resin and 
FLAG-tagged prey proteins were co-incubated to investigate predicted interactions. 
GST-HP0958 pull-down assay was performed against FliH (2-258) (full length) and 
FliH (89-258), the previously identified domain involved in this predicted interaction 
(Rain et al., 2001). All assays failed to show any detectable interaction above 
background non-specific retention of the prey protein (lanes 5 and 6 vs lanes 2 and 3, 
Figure 22). 
The HP0958-RpoN interaction also predicted in the Y2H study has since been 
confirmed and HP0958 was identified as a chaperone of σ54 (Pereira and Hoover, 
2005; Rain et al., 2001; Ryan et al., 2005a). RpoN (74-284) was previously 
identified as the domain involved in the HP0958-RpoN interaction. However, we 
were unable to purify this protein in soluble form, and so GST pull-down analyses 
were performed with the soluble truncated protein RpoN (74-210) (Rain et al., 2001). 
No interaction was detected between HP0958 and RpoN (74-210) under the 
conditions tested. HP0958 has been shown to interact with the flaA mRNA transcript 
(Douillard et al., 2008). The soluble cytoplasmic fraction of motile culture of a 
H. pylori P79 lysate was also assayed for ability of any of its constituent proteins to 
bind GST-HP0958 (data not shown); however, no clear targets for interaction with 
HP0958 were identified. 
To further investigate the results of the Rain et al. study regarding HP0958 
protein-protein interactions, proteins were introduced by cloning respective genes 
into S. cerevisiae strains AH109 and Y187 and yeast two-hybrid assays were 
performed. Activation of expression of the reporter gene lacZ due to the interaction 
of bait and prey proteins produced β-galactosidase which was measured by the 
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adapted plate X-gal assay. β-galactosidase activity of Y187 derivative strains 
harbouring genes encoding a given PPI set was determined relative to β-
galactosidase activity of an E. coli strain in which lacZ is constitutively expressed. 
PXG assay failed to detect any interaction between HP0958 and FliH (89-258) in 
both prey-bait combinations (Figure 23). The FliH (89-258)-FliI (2-91) interaction 
served as a positive control since this interaction set was also predicted in the Rain et 
al. study and was subsequently confirmed by biochemical means (Lane et al., 2006; 
Rain et al., 2001). Additionally, the HP0958-RpoN (74-284) interaction was verified 
as a weak interaction by Y2H assay, inducing ~7 fold less lacZ expression than Y187 
derivative strains possessing FliH (89-258) and FliI (2-91) (Figure 23). 
 4.2 Complementation of hp0958-null derivative of P79 with HP0958 mutant 
alleles. 
A panel of 18 target residues for site-directed mutagenesis of HP0958 were 
selected based on their potential contribution to HP0958 function during flagellum 
biogenesis (Appendix 18). A recent study suggested that conserved histidine residues 
may have a propensity to form stacking interactions with aromatic amino acids and 
so may be involved in PPIs (Liao et al., 2013). Surface-exposed hydrophobic 
residues (leucine, isoleucine and phenylalanine) with a propensity to form 
interactions with other hydrophobic amino acids were also selected for mutation 
(Jones and Thornton, 1996). Conserved positively charged residues (arginine, lysine 
and histidine) were selected for mutation as they may be involved in protein-nucleic 
acid interactions with the negatively charged phosphate groups of nucleic acids (Ellis 
et al., 2007; Iwakiri et al., 2011). 
Genes encoding mutant alleles of HP0958 were introduced into the chromosome 
of a hp0958-null derivative of H. pylori P79 at an intergenic site by natural 
transformation with the suicide vector pIR203K04 (Langford et al., 2006) (Table 
20). Mutant allele expression was under the control of the ahpC promoter Php1563 
(Douillard et al., 2008). To establish whether these mutant forms of HP0958 were 
capable of restoring motility to the non-motile derivative P79-0958KO, 
transformants were screened by motility assay on soft agar. Additional phenotypic 
analyses included microscopy, TEM, immunoblotting and qRT-PCR of selected 
flagellar genes. Flagellum biogenesis is a highly energy-consuming process for the 
cell and hence, without the highly selective pressure of its native environment, 
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strains grown in a lab setting had a tendency to revert to a non-motile state, as seen 
previously (Eaton et al., 1992; Josenhans et al., 2000). The re-introduction of the 
wild-type hp0958 gene into a hp0958-null non-motile derivative strain of P79 was 
capable of restoring motility beyond wild-type P79 levels, as previously shown in a 
H. pylori 17874 mutant derivative (Douillard et al., 2008). Therefore, it must be 
considered that the restoration of motility as determined by ex-vivo analyses is 
limited by the tendency for this highly genetically plastic pathogen to return to an 
aflagellate state, likely through reversible phase-variation of flagellar genes e.g. fliP 
(Josenhans et al., 2000). 
Electron microscopy revealed that derivative strains transformed with some 
HP0958 mutant alleles produced normal flagella, while others were unable to do so. 
Wild-type P79 cells generally possessed 1 - 2 polar flagella encased in a 
characteristic sheath (Figure 24; for further details see Appendix 21). P79-0958KO 
cells in which the hp0958 gene has been insertionally inactivated were aflagellate 
and non-motile (Ryan et al., 2005a) (Figure 24). Introduction of the wild-type 
hp0958 gene under the control of the ahpC promoter restored flagellar production, as 
previously seen in a hp0958-null derivative of H. pylori strain CCUG 17874 
(Douillard et al., 2008) (Figure 24). The crystal structure of HP0958 revealed two 
structural domains: an N-terminal coiled-coil and a C-terminal Zn-finger. Mutation 
of residues in the Zn-finger generally produced flagellate mutant cells (Table 21). 
However, only 2 out of 11 mutations in the coiled-coil/hinge region produced 
derivative strains which were flagellate (Table 21). 
Interestingly, several types of extrusions which did not resemble a typical 
H. pylori flagellum were observed by electron microscopy (Figure 24). Six mutations 
in the coiled-coil and 4 in the Zn-finger resulted in P79-0958KO complemented cells 
which produced a multi-bulb phenotype, so-called due to the protrusion of 
appendages which resembled multiple flagellar sheath distal bulbs without the 
presence of a flagellar filament. In some mutants (I99A and I204A), the strains 
produced singular or multiple enlarged bulbs (Figure 24). Surprisingly, 11 mutants 
(L47A, L58A, I99A, F161A, K195A, F203V, I204A, R205A, K209E, T222A and 
Y231F) spanning the two structural domains of HP0958 produced cells with 
appendages at non-polar sites, including 4 in the Zn-finger (F203V, K209E, T222A 
and Y231F) with fully-formed flagella at both poles/non-polar sites (Figure 24). 
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Thus, complementation of P79-0958KO strain with HP0958 mutant alleles produces 
strains which indicate HP0958 is either inactive or fully/partially active. 
 4.3 H. pylori P79-0958KO derivative strains complemented with coiled-coil 
mutant HP0958 alleles are non-motile while complementation with Zn-finger 
mutant alleles restores motility. 
Motility of H. pylori strains was assessed by microscopy and soft agar assay. 
Strains which were flagellate according to TEM imaging also produced motility 
zones on 0.3% BHI agar (Figure 25). P79-0958KO cells were non-motile and only 
grew in the centre of the agar at the site of inoculation. Alanine substitution of 
leucine at position 47 (L47A) in the coiled-coil of the HP0958 protein was the only 
complemented mutant which appeared non-motile by motility assay (Figure 25). 
Eight mutant complemented strains (T3A, H4A, I99A, F161A, R181E, K187A, 
K195A and I204A), 6 of whose sequence changes are in the coiled-coil, did not 
produce a zone of motility within the agar. However, complemented strains 
harbouring these mutations produced a ring phenotype on the surface of the soft agar, 
possibly due to impaired motility (Figure 25). The L58A, F203V, T222A and Y231F 
complemented derivative strains produced halos similar to that of the P79-0958KO 
complemented strain with wild-type HP0958 allele (Figure 25). R205A, R205V and 
K209E complemented derivative strains produced halos of diameter similar to that of 
wild-type P79 and smaller than that of the complemented strain with wild-type 
HP0958 allele (Figure 25). 
Previous studies of hp0958 knock-out derivatives found that in the absence of 
HP0958, the Class II sigma factor, RpoN, is unstable which causes reduced 
expression of RpoN-dependent genes (Pereira and Hoover, 2005; Ryan et al., 2005a). 
Additionally, HP0958 is thought to interact directly with the flaA mRNA transcript; 
in the absence of HP0958, FlaA expression levels are also impaired (Douillard et al., 
2008; Ryan et al., 2005a). Therefore, expression levels of flagellin (FlaA and FlaB) 
and hook (FlgE) proteins were monitored as an indicator of HP0958 activity. Cell 
lysates from H. pylori strains grown in liquid to exponential phase were 
immunoblotted with anti-flagellin and anti-hook antibodies. In agreement with 
previous findings, the hp0958 knock-out derivative of P79 had reduced flagellin 
protein levels and no FlgE was detected (Figure 26). The 9 mutant derivative strains 
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which were motile by motility assay (H13A, L58A, R184E, F203V, R205A, R205V, 
K209E, T222A and Y231F) all had a similar flagellin/hook profile to that of the 
wild-type P79 strain. Six mutant derivative strains (H4A, I99A, F161A, R181E, 
K187A and K195A) had expression profiles matching that of the P79-0958KO 
derivative of P79, indicating that these mutations impair HP0958 activity (Figure 
26). Derivative strains harbouring the T3A and L47A mutations which affected the 
HP0958-RpoN interaction appear to produce more FlaB than the hp0958-null 
derivative of P79. The I204A complemented derivative has flagellin levels similar to 
P79-0958KO but does produce FlgE at a detectable level, albeit less than that of the 
wild-type complemented derivative (Figure 26). 
The mRNA expression levels of 5 flagellar genes were monitored relative to the 
housekeeping era gene. Figure 27 shows a heatplot of the qRT-PCR data, ranking the 
HP0958 mutants by expression of the RpoN regulon genes, flaB and flgE. In 
agreement with Douillard et al., fliA and rpoN experience the least fluctuation in 
expression when hp0958 is deleted or mutated compared to the P79 wild-type. 
Overall, the expression profiles for motile and non-motile strains form two separate 
clusters, with the following exceptions. In the case of non-motile derivative strains 
harbouring the H4A and F161A mutations in HP0958, these restored flaA expression 
levels close to that of the wild-type complement, with higher flgE expression and 
lower flaB expression. Motile derivative strains K209E and R205A are found within 
the non-motile cluster (Figure 27), however, these cells produced reduced zones of 
motility by soft agar assay (Figure 25). Seven of the 10 mutant derivative strains 
which produced multi-bulb extrusions cluster together between the motile and 
aflagellate cells. Therefore, these strains have an intermediate expression profile of 
flagellar genes indicating some level of function of the HP0958 mutant alleles. 
 4.4 Structure/function analysis of the HP0958-RpoN (74-284) interaction 
reveals involvement of the HP0958 coiled-coil domain. 
Though the HP0958-RpoN interaction has been confirmed by biochemical means, 
little is known about the mechanism of this interaction. The Rain et al. study 
predicted that residues 30-218 of HP0958 were required for the interaction with 
RpoN (74-284) (Rain et al., 2001). In order to investigate this, 14 site-directed 
mutants of HP0958 were screened by Y2H and PXG analysis to determine their 
effect upon the HP0958-RpoN (74-284) interaction. β-galactosidase induction due to 
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interactions involving these mutants was expressed as a proportion of the wild-type 
HP0958-RpoN (74-284) β-galactosidase activity (Figure 28). 
Interactions involving R181E and R184E mutants in the coiled-coil, and F203V, 
K209E and T222A in the Zn-finger behaved similarly to wild-type HP0958 (Figure 
28). Alanine substitution of residues T3, H13, L47, F161 and K187 in the coiled-coil 
and hinge region resulted in β-galactosidase levels which differed significantly from 
the wild-type. The I99A mutant failed to support any measurable level of reporter 
gene expression, indicating that alanine substitution of I99 in the coiled-coil 
abolished the interaction between HP0958 and RpoN (74-284). H13A, L47A, K195A 
and 1204A mutations all decreased the strength of interaction between HP0958 and 
RpoN (74-284), while T3A, F161A and K187A all increased the strength of 
interaction.  
 4.5 The full length flaA transcript is required for full-strength HP0958 
interaction. 
Secondary structural analysis of the flaA mRNA transcript revealed a predicted 
structure which forms three distinct regions (Figure 29). Region 1 contains 
nucleotides 1-317 (including the ribosomal binding site) and nucleotides 1202-1633 
(Figure 29). This truncated RNA transcript was predicted to have almost identical 
secondary structure to that of the full length sub-region, except for the presence of an 
additional loop replacing the deleted middle section (regions 2 and 3). Region 2 
contains nucleotides 326-817 of the flaA mRNA transcript and region 3 contains 
nucleotides 869-1198, both of which were truncated at these points to retain the same 
predicted secondary structure as those regions within the full length flaA mRNA. 
EMSA analysis was performed to identify the region(s) of the flaA transcript 
which interact(s) with HP0958 during flagellum biogenesis (Figure 30). Full length 
flaA mRNA in complex with HP0958 migrated more slowly than unbound transcript 
and produced a diffuse gel-shift band, as previously shown (Caly et al., 2010; 
Douillard et al., 2008). None of the truncated flaA transcripts (regions 1-3) produced 
a gel-shift similar to the full length mRNA-HP0958 complex and hence were 
impaired in their ability to interact with HP0958. A very faint band was visible at the 
same position as the full length gel-shift for the flaA region 1 (lane 6). A very weak 
gel-shift with a higher mobility was produced by the HP0958-flaA region 2 complex. 
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Region 3 was unable to produce any detectable gel-shift through interactions with 
HP0958. 
 4.6 Structure/function analysis of the HP0958-flaA mRNA interaction. 
Caly et al. previously tested 14 site-directed mutants of HP0958 to determine the 
impact on the HP0958-flaA mRNA interaction (Caly et al., 2010). While many of 
these impacted upon the interaction, none of the mutations abolished the interaction. 
In order to augment the structure-function analysis of HP0958, 14 additional site-
directed mutants of the flagellum biogenesis protein were generated in this study. 
The targets for mutagenesis spanned the two structural domains of HP0958 with 6 in 
the coiled-coil, 1 in the hinge region and 7 in the Zn-finger domain. These mutants 
were selected based on their conservation in HP0958 homologues across ε-
proteobacteria and their positively charged or aromatic characteristics (Jones et al., 
2001). The previous study found that R181A, R184A and K209A mutations had an 
observable effect on the complex gel-shift relative to wild-type HP0958 (Caly et al., 
2010). Glutamic acid substitution was performed for these 3 residues in order to 
determine if this mutation could exacerbate the effect caused by alanine mutation. 
Alanine substitution of T3A, H4A, H13A and Y231F had little or no effect on the 
migration of the HP0958-flaA transcript complex when compared to the gel-shift 
produced by wild-type HP0958 (Figure 31). L58A and K187A mutations produced a 
HP0958-flaA mRNA complex gel-shift similar to that of the wild-type HP0958. The 
T222A mutant apparently strengthened the protein-RNA interaction. K195A, F203V 
and R205V mutants formed complexes with flaA mRNA that migrated slightly faster 
than the wild-type complex, resulting in a slightly lower gel-shift position. R181E, 
R184E and K209E mutations did not alter the migration of flaA mRNA and hence 
abolished the HP0958-flaA mRNA interaction. L58A and T222A in complex with 
the flaA mRNA transcript produced gel-shifts which were slightly less diffuse than 
that of wild-type HP0958-flaA mRNA complex. 
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5 Discussion 
HP0958 is an essential component of flagellum biogenesis which is involved in 
multiple interactions during the assembly process (Caly et al., 2010; Douillard et al., 
2008; Ryan et al., 2005a). The protein-protein interaction network of H. pylori 
provided a platform for investigation into the role of HP0958, identifying 
interactions with two key flagellar components, FliH and RpoN (Rain et al., 2001). 
In this study, we present a detailed structure-function analysis of HP0958 through 
investigation of previously identified interactions with RpoN, FliH and flaA mRNA. 
Y2H and GST pull-down analyses failed to confirm the previously identified 
HP0958-FliH interaction. This interaction as indicated by Rain (Rain et al., 2001) 
appears to be a false positive within a large scale analysis of protein-protein 
interactions. Although measures have been taken to reduce the level of false positives 
wrongly identified as interaction pairs in yeast two-hybrid assays, our study affirms 
the necessity to confirm Y2H data by biochemical methods. 
Complementation of a non-motile hp0958-null derivative of P79 with site-
directed mutant alleles of hp0958 resulted in derivative strains with wild-type, partial 
or no HP0958 activity. Mutations which abolished or significantly decreased 
HP0958-RpoN interactions resulted in aflagellate cells while all mutant derivative 
strains which produced flagella resembling the wild-type were capable of motility. 
Thus, not unexpectedly, HP0958 contributes solely to flagellum assembly, not 
flagellum function. In general, mutations in the Zn-finger resulted in cells which 
produced flagella, while those in the coiled-coil lacked flagella resembling the wild-
type. This indicates that the RpoN interaction site in HP0958 is predominantly 
localised to the coiled-coil, supporting the Y2H analysis performed in this study. 
Complementation of the non-motile P79-0958KO strain with 2 mutant proteins 
which abolished HP0958-flaA mRNA interaction (R184E and K209E; assessed by 
EMSA) but did not significantly affect the RpoN interaction produced cells with 
diminished motility. Complementation of the hp0958-null derivative of P79 with 
R205A and R205V mutant proteins also resulted in cells with reduced motility when 
compared to cells complemented with wild-type HP0958; these mutations formed 
HP0958-flaA mRNA complexes which migrated differently to that of the wild-type 
in complex (Figure 31). Thus, the data indicates that HP0958 functions can be 
separated based the on activities of two distinct structural domains (coiled-coil and 
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Zn-finger) through the combined structure-function analysis of HP0958-flaA mRNA 
and HP0958-RpoN interactions, supporting the hypothesis proposed by Douillard et 
al. (Caly et al., 2010; Douillard et al., 2008) (Figure 32). 
Recently, Iwakiri et al. performed structural analysis of 91 protein-RNA 
interactions for which 3D information was available and found that aspartic acid is 
often present at protein-RNA interfaces where it is proposed to be involved in RNA 
loop recognition (Iwakiri et al., 2011). The presence of two conserved aspartic acid 
residues (D208 and D219) between the cystine knuckles of the Zn-finger in HP0958 
supports the involvement of this domain in flaA mRNA interactions (Appendix 22). 
Detailed structure-function analysis of the HP0958-flaA mRNA interaction, together 
with the previously published work of Caly et al. has identified key residues in the 
Zn-finger of HP0958 involved in RNA contact (Caly et al., 2010). Coiled-coil 
mutations at the N-terminal (T3A, H4A, H13A) did not affect the interaction. 
Positively charged amino acids (R181, R184, K209 and K195) which are associated 
with protein-RNA interactions were found to be involved in flaA mRNA binding, 
likely through electrostatic interactions with negatively charged phosphate groups of 
RNA (Ellis et al., 2007; Iwakiri et al., 2011). Residue I204 of HP0958 may have a 
dual function as mutation significantly affected both RpoN and flaA mRNA 
interactions. 
Y2H analysis confirmed that HP0958 interacts with the domain spanning residues 
74-284 of RpoN. Analysis of the HP0958-RpoN interaction revealed many contact 
points along the structure of HP0958: 5 in the coiled-coil, 1 in the hinge region and 2 
in the Zn-finger. This indicates that the RpoN protein is likely to be in an extended 
conformation while interacting with HP0958. I99A and K187A mutations abolish the 
HP0958-RpoN (74-284) interaction in a Y2H interaction model. H13A, L47A, 
K195A and I204A mutations all result in a significant decrease in the strength of the 
RpoN interaction. Interestingly, T3A, F161A and K187A all significantly increased 
the interaction strength but none of these mutant alleles were capable of restoring 
motility when transformed into P79-0958KO. We hypothesise that by enhancing the 
binding of HP0958 to RpoN beyond that of the wild-type interaction, this can inhibit 
activity of this sigma factor by reducing its interaction with the core RNA 
polymerase. 
Mutations disturbing the RpoN regulon had a more dramatic effect on flagellum 
biogenesis as seen by TEM analysis when compared to mutations which disturbed 
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the HP0958-flaA mRNA interaction. It may be that the flaA mRNA interacts at more 
residues which are in close proximity which can compensate for single site-
mutations, whereas residues involved in RpoN interactions are dispersed across a 
much larger surface area which more easily destabilise the interaction. It is also 
possible that some mutants which impede flaA incorporation into the filament can 
compensate for this by producing filaments with higher FlaB composition than the 
wild-type and hence produce flagella which are still capable of motility. 
H. pylori are lophotrichous and generally possess 2 - 6 polar sheathed flagella 
with a characteristic bulbed tip (Geis et al., 1993; Goodwin et al., 1985). FlhF and 
FlhG have been implicated in localisation of flagellum biogenesis to the bacterial cell 
pole and in control of flagellum number in H. pylori, Campylobacter jenuni and 
Vibrio cholerae (Balaban and Hendrixson, 2011; Balaban et al., 2009; Lertsethtakarn 
et al., 2011). TEM analysis revealed that many derivative strains of P79-0958KO 
complemented with HP0958 mutant proteins presented flagellar-type extrusions from 
the cell surface at non-polar positions which did not resemble typical flagella. 
Furthermore, F203V and Y231F mutations resulted in complemented cells which 
produced wild-type flagella at both poles; T222A complemented cells produced 
wild-type flagella which protruded from the side of the bacterial cells. Therefore, we 
propose a novel function of HP0958 during flagellum biogenesis: localisation of 
flagellum biogenesis to a single cell pole. The occurrence of non-polar flagellar 
extrusions from cells complemented with mutated alleles spanning all secondary 
structural elements of HP0958 suggests that this role may involves both the coiled-
coil and Zn-finger domains. These extrusions are likely to either be empty flagellar 
sheaths or sheaths encasing abnormal flagellar sub-structures, similar to the empty 
sheaths produced by fliD mutant derivative cells (Kim et al., 1999). Transcriptional 
analysis of strains producing such extrusions indicates partial restoration of HP0958 
function/flagellar gene expression, indicating some flagellum biogenesis activity 
within the cells. 
In Caulobacter crescentus, the flagellin genes fljK and fljL are transcribed but not 
translated until the hook/basal-body complex has been completed. FlbT binds and 
destabilises the transcript to prevent premature translation and secretion, much as we 
hypothesise HP0958 may act on the flaA mRNA transcript in H. pylori (Anderson 
and Gober, 2000). FlbT, the post-transcriptional regulator of flagellin synthesis in 
Caulobacter crescentus, interacts with the 5’ untranslated region of flagellin mRNA. 
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Deletion of the 5’ untranslated regon of the H. pylori flaA mRNA transcript did not 
have any effect upon HP0958 binding (Douillard et al., 2008). Therefore, a 
secondary structure-based approach was adopted in order to investigate the nature of 
this interaction from the RNA perspective. Region 1 and Region 2 truncated mRNA 
transcripts had significantly reduced capacity to bind HP0958. However, the 
observation of very faint gel-shifts does indicate the involvement of these branches 
of the full length predicted secondary structure. While Region 3 of the flaA mRNA 
transcript alone may not be capable of interacting with HP0958, these results indicate 
that the flaA transcript as a whole is required for efficient protein-RNA interaction. 
This may be mediated by sequence-specific interactions or recognition of the 
secondary structure of the complete mRNA transcript. 
In conclusion, this study presents an in depth structure-function analysis of the 
role of HP0958 during flagellum biogenesis in H. pylori. Taken together, these data 
support the previously proposed mechanism of HP0958 function with one exception. 
HP0958 was proposed to target the flaA mRNA transcript to the export apparatus 
through its interaction with FliH (Douillard et al., 2008). With the elimination of the 
FliH interaction from this model, there is a need for further refinement of our 
understanding of the role of HP0958 in flagellum assembly. One possibility is that 
the HP0958 has additional interaction partners which have not yet been identified. It 
cannot be excluded that HP0958 and the identified interaction partners discussed in 
this study may require additional flagellar components to form a fully functional 
complex. Analysis of potential interactions between HP0958 and components of the 
basal body and export apparatus such as FlhA may provide the key for what targets 
the transcript in complex with HP0958 for efficient export. Purification of a soluble 
form of the RpoN (74-284) would facilitate analyses to determine the potential role 
of HP0958 in the switch between expression of Class II and Class III flagellar genes. 
The presence of flagellar extrusions from non-polar sites in derivative strains of P79-
0958KO complemented with mutant alleles suggests a novel role of HP0958 in 
localisation of flagellum biogenesis to a single cell pole. Further investigation into 
this function is warranted to further elucidate flagellum assembly of H. pylori. 
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7 Tables and Figures 
Table 18 List of strains used in this study 
Strain Relevant characteristics Source 
H. pylori   
CCUG 17874 Wild type strain CCUG, Sweeden 
P79 P1 Str
r
 (Heuermann and Haas, 1998) 
P79-0958KO
1 P79 Δhp0958::Cmr (Douillard et al., 2008) 
P79-0958/pIR203K04 P79 Δhp0958::Cmr with pIR203K04 (Kanr) (Douillard et al., 2008) 
E. coli   
XL1-Blue Supercompetent 
cells 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F⁻ proAB lacIqZΔM15 Tn10 
(TetR)] 
Stratagene, USA 
One shot Top 10 F⁻ mcrA _ (mrr-hsdRMS-mcrBC) _80lacZ_M15 _lacX74 nupG recA1 araD139 (ara-
leu)7697 galE15 galK16 rpsL (StrR) endA1 
Invitrogen, CA 
DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, 
mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
Invitrogen, CA 
Rosetta 2(DE3) pLysS  F⁻ ompT hsdSB (rB–mB–) gal dcm (DE3) pLysSRARE2 (CamR) Novagen, Darmstadt, Germany 
   
   
   
   
  
S. cerevisiae   
AH109 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZ 
Dr. Paul Young, UCC 
Y187 MATα, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112, gal4Δ, met-, gal80Δ, 
URA3::GAL1UAS-GAL1TATA-lacz 
Dr. Paul Young, UCC 
1
KO, knockout. 
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Table 19 List of plasmids used for yeast two-hybrid and protein expression 
Plasmids Relevant characteristics Source 
pGEX-6p-3 N-terminally GST-tagged expression vector GE Healthcare, UK 
pDC006 pGEX-6p-3 hp0958 (Caly et al., 2010) 
pFliH01 pGEX-6p-3 fliH 2-258 This study 
pFliH02 pGEX-6p-3 fliH 89-258 This study 
pRpoN01 pGEX-6p-3 rpoN 74-284 This study 
pRpoN02 pGEX-6p-3 rpoN 74-210 This study 
pMut2 pGEX-6p-3 HP0958 mutant T3A This study 
pMut3 pGEX-6p-3 HP0958 mutant H4A This study 
pMut4 pGEX-6p-3 HP0958 mutant H13A This study 
pMut6 pGEX-6p-3 HP0958 mutant L58A This study 
pMut9 pGEX-6p-3 HP0958 mutant R181E This study 
pMut10 pGEX-6p-3 HP0958 mutant R184E This study 
pMut11 pGEX-6p-3 HP0958 mutant K187A This study 
pMut12 pGEX-6p-3 HP0958 mutant K195A This study 
pMut13 pGEX-6p-3 HP0958 mutant F203V This study 
pMut15 pGEX-6p-3 HP0958 mutant R205A This study 
pMut16 pGEX-6p-3 HP0958 mutant R205V This study 
pMut17 pGEX-6p-3 HP0958 mutant K209E This study 
pMut18 pGEX-6p-3 HP0958 mutant T222A This study 
pMut19 pGEX-6p-3 HP0958 mutant Y231F This study 
   
pMAD Em
r
 cassette; β-galactosidase gene under 
constitutive promoter 
(Arnaud et al., 
2004) 
pGBKT7 Kan
r
 for selection in E. coli; Trp1 nutritional 
marker for selection in S. cerevisiae 
Dr. Paul Young 
pGADT7 Amp
r
 for selection in E. coli; Leu2 nutritional 
marker for selection in S. cerevisiae 
Dr. Paul Young 
pCC01 pGBKT7 hp0958 This study 
pCC02 pGADT7 fliH 89-258 This study 
pCC03 pGBKT7 fliH 89-258 This study 
pCC04 pGADT7 hp0958 This study 
pCC05 pGADT7 rpoN 74-284 This study 
pCC06 pGADT7 rpoN 74-210 This study 
pCC07 pGADT7 fliI 2-91 This study 
pMut2k pGBKT7 HP0958 mutant T3A This study 
pMut3k pGBKT7 HP0958 mutant H4A This study 
pMut4k pGBKT7 HP0958 mutant H13A This study 
pMut5k pGBKT7 HP0958 mutant L47A This study 
pMut6k pGBKT7 HP0958 mutant L58A This study 
pMut7k pGBKT7 HP0958 mutant I99A This study 
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pMut8k pGBKT7 HP0958 mutant F161A This study 
pMut9k pGBKT7 HP0958 mutant R181E This study 
pMut10k pGBKT7 HP0958 mutant R184E This study 
pMut11k pGBKT7 HP0958 mutant K187A This study 
pMut12k pGBKT7 HP0958 mutant K195A This study 
pMut13k pGBKT7 HP0958 mutant F203V This study 
pMut14k pGBKT7 HP0958 mutant I204A This study 
pMut17k pGBKT7 HP0958 mutant K209E This study 
pMut18k pGBKT7 HP0958 mutant T222A This study 
pMut19k pGBKT7 HP0958 mutant Y231F This study 
 
  
Table 20 List of plasmids transformed into H. pylori strain P79-0958KO 
Plasmids Relevant characteristics Source 
pIR203K04 Kan
r
 suicide vector (Langford et al., 2006) 
pIR0958 pIR203K04 with the hp0958 gene under the control of the hp1563 promoter (Douillard et al., 2008) 
pIRmut2 pIR0958 mutant T3A This study 
pIRmut3 pIR0958 mutant H4A This study 
pIRmut4 pIR0958 mutant H13A This study 
pIRmut5 pIR0958 mutant L47A This study 
pIRmut6 pIR0958 mutant L58A This study 
pIRmut7 pIR0958 mutant I99A This study 
pIRmut8 pIR0958 mutant F161A This study 
pIRmut9 pIR0958 mutant R181E This study 
pIRmut10 pIR0958 mutant R184E This study 
pIRmut11 pIR0958 mutant K187A This study 
pIRmut12 pIR0958 mutant K195A This study 
pIRmut13 pIR0958 mutant F203V This study 
pIRmut14 pIR0958 mutant I204A This study 
pIRmut15 pIR0958 mutant R205A This study 
pIRmut16 pIR0958 mutant R205V This study 
pIRmut17 pIR0958 mutant K209E This study 
pIRmut18 pIR0958 mutant T222A This study 
pIRmut19 pIR0958 mutant Y231F This study 
  
Table 21 Overview of structure-function analysis of HP0958 by analysis of site-directed mutant proteins 
Compiled results of biochemical assays and complementation data from the current study, with previously published structure-function analysis by Caly et al. 
(Caly et al., 2010) where: (*) positive; (-) negative; empty cells denote no data available; (M) motile; (N) non-motile; (S) swarming. “Location” refers to the 
secondary structure within HP0958 at that residue selected for mutation where: (α) α-helix; (β) β-sheet; (Kn) knuckle co-ordinating zinc atom; (hinge) linker 
region between coiled-coil and Zn-finger domains. 
Mutation Location RpoN interaction flaA interaction Motility assay
*
 TEM 
  (Y2H) (EMSA)  Flagella Multi-bulb Large bulbs Non-polar 
P79 WT    M * - - - 
KO    N - - - - 
Complement    M * - - - 
T3A α1a Increased Little or no effect S - * - - 
H4A α1a Same as WT Little or no effect S - - - - 
H13A α1a Decreased Little or no effect M - * - - 
L47A
+ α1b Decreased Same as WT N - * - * 
L58A α1b  Same as WT M * * - * 
I99A
+ α2a Abolished Same as WT S - - * * 
F161A
+ α2b Increased Same as WT S - * - * 
F178A
+ α3  Observable effect      
Y179A
+ α3        
R181A
+ α3  Observable effect      
R181E α3 Same as WT Abolished S - * - - 
R184A
+ α3  Little or no effect      
R184E α3 Same as WT Abolished M * - - - 
W185A
+ α3  Little or no effect      
K187A hinge Increased Same as WT S - - - - 
T189A
+ hinge  Observable effect      
  
K195A Zn ribbon Decreased Same as WT S - * - * 
K196A
+ Zn ribbon  Little or no effect      
Q197A
+ Zn ribbon  Observable effect      
C199A
+ Zn ribbon, Kn1  Observable effect      
F203V Zn ribbon, Kn1 Same as WT Observable effect M * - - * 
I204A
+  Decreased Observable effect S - * * * 
R205A Zn ribbon  Observable effect M * * - * 
R205V° Zn ribbon  Observable effect M - - - - 
K209A
+ Zn ribbon, α4  Little or no effect      
K209E Zn ribbon, α4 Same as WT Abolished M * * - * 
Y211A
+ Zn ribbon, α4  Little or no effect      
T222A Zn ribbon, Kn2 Same as WT Increased M * - - * 
R228A
+ Zn ribbon, Kn2  Observable effect      
Y231F Zn ribbon, β2  Little or no effect M * - - * 
*
Wild-type and P79 derivative strains. 
+
HP0958 site-directed mutants generated for EMSA screen by Caly et al. (Caly et al., 2010). 
°TEM of this strain will be repeated as images from this culture include artefacts (Appendix 21). 
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Figure 22 GST pull-down assay investigating the previously proposed HP0958-FliH 
interaction. 
GST pull-down assay of HP0958 and FLAG fusion FliH proteins. (A) SDS-PAGE of 
HP0958-FliH (89-258) GST pull-down assay; (B) corresponding immunoblot with anti-
FLAG antibody; (C) SDS-PAGE of HP0958-FliH (89-258) GST pull-down assay; (D) 
corresponding immunoblot with anti-FLAG antibody. Loading was identical for (A - D) 
where: L = Prestained Broad Range protein ladder; 1 = FLAG fusion FliH; 2 = glutathione 
sepharose B incubated with FLAG-FliH; 3 = glutathione sepharose B resin bound GST 
incubated with FLAG-FliH; 4 = glutathione sepharose resin bound GST-HP0958; 5 and 6 = 
glutathione sepharose B resin bound GST-HP0958 incubated with FLAG-FliH. 
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Figure 23 Investigation of previously proposed HP0958 PPIs by yeast two-hybrid assay. 
β-galactosidase activity relative to positive control strain E. coli Top10 harbouring 
the pMAD plasmid for constitutive expression of the enzyme. B = strains possessing 
bait protein expressed as fusion protein with the GAL4 DNA-binding domain; 
P = prey protein expressed as fusion protein with the GAL4 transcription activation 
domain; T = strains possessing both vectors harbouring bait and prey genes for a 
given interaction pair. 
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Figure 24 Flagellum production by H. pylori P79 and derivatives. 
Transmission electron micrographs of H. pylori cells stained with uranyl acetate. In each 
panel, arrows mark flagella and arrowheads mark bulb structures. (A) Wild-type P79; (B) 
detail of P79 wild-type flagella; (C) hp0958-null derivative of P79; (D) complemented 
hp0958-null derivative of P79; (E) detail of complemented derivative; (F) representative 
example of a flagellate cell from HP0958 mutant complemented with mutated allele; (G) 
detail of flagellate cell from HP0958 mutant complemented with mutated allele; (H) 
representative example of a cell with multi-bulb phenotype from HP0958 mutant 
complemented with mutated allele; (I) detail of multi-bulb phenotype; (J) representative 
example of a cell with non-polar bulb phenotype from HP0958 mutant complemented with 
mutated allele; (K) representative example of a cell with large polar bulbs from HP0958 
mutant complemented with mutated allele; (L) representative example of a cell with 
amphitricious flagella from HP0958 mutant complemented with mutated allele. 
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Figure 25 Motility screens of H. pylori P79 and derivatives. 
Cells were inoculated in 0.3% soft agar and incubated for 4 days at 37°C, 5% CO2. 
Halo formation within agar indicates motility while non-motile cells remain at the 
site of inoculation. Growth outwards from the point of inoculation on the surface 
only (not in the agar) results in ring pattern due to swarming. 
 
  
 
 
Figure 26 Western blot analysis of flagellum protein expression in P79 and its derivatives. 
Flagellin and hook protein levels of cells corrected to OD600 1.0 after 20 hrs liquid culture. (L) ColorPlus
TM
 prestained protein ladder, broad range (7 -
 175 kDa); (1) wild-type P79; (2) P79-0958KO; (3) P79-0958KO_pIRWT; (4) P79-0958KO_pIRT3A; (5) P79-0958KO_pIRH4A; (6) P79-
0958KO_pIRH13A; (7) P79-0958KO_pIRL47A; (8) P79-0958KO_pIRL58A; (9) P79-0958KO_pIRI99A; (10) P79-0958KO_pIRF161A; (11) P79-
0958KO_pIRR181E; (12) P79-0958KO_pIRR184E; (13) P79-0958KO_pIRK187A; (14) P79-0958KO_pIRK195A; (15) P79-0958KO_pIRF203V; (16) P79-
0958KO_pIRI204A; (17) P79-0958KO_pIRR205A; (18) P79-0958KO_pIRR205V; (19) P79-0958KO_pIRK209E; (20) P79-0958KO_pIRT222A; (21) P79-
0958KO_pIRY231F. 
  
 
Figure 27 Flagellar gene expression of hp0958-null P79 derivative complemented with mutated alleles. 
mRNA levels of 5 flagellar genes relative to the wild-type P79 transcription profile. Gene names are listed on the y-axis and strains analysed are listed on the 
x-axis by the hp0958 mutant allele they possess. “HP0958KO” is a control for expression in the absence of HP0958 and “complement” is the P79 mutant 
derivative complemented with the wild-type HP0958. 1 = wild-type level; 0.1 = 10 fold reduction in expression; 0.01 = 100 fold reduction in expression. All 
gene expression was normalised to the housekeeping gene, era. Non-motile strains are coloured purple and motile strains are coloured yellow. 
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Figure 28 Identification of residues in HP0958 which are involved in the interaction 
with RpoN (74-284). 
(A) β-galactosidase activity of S. cerevisiae Y187 derivative strains expressing HP0958 site-
directed mutant proteins and RpoN (74-284) represented as a proportion of the signal from 
the derivative strain harbouring wild-type HP0958/RpoN (74-284) interaction. (B) 
Illustration of the structure of wild-type HP0958 protein highlighting residues tested by Y2H 
and β-galactosidase assay. Image generated with Pymol (DeLano Scientific, CA). Colours in 
both (A) and (B) refer to the secondary structure of residues selected for mutation of HP0958 
for each mutant where: red = α-helix; blue = hinge region; green = Zn-finger. Mann-Whitney 
pairwise statistical test was performed for each pair-wise comparison. *P≤0.05; ** P≤0.01; 
***P≤0.001. 
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Figure 29 Predicted secondary structure of the flaA mRNA transcript. 
Predicted secondary structure of flaA mRNA transcript of H. pylori strain 17874. (A) 
Structure generated in Circles based on maximum weight matching; (B) Structure generated 
in RNAdraw based on McCaskill minimum free energy. 
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Figure 30 Gel shift assay of HP0958 binding to full length and shortened derivatives of 
the flaA mRNA transcript. 
15 ng of biotin-labelled riboprobe was incubated with 6 µg wild type HP0958. RNA 
corresponding to truncated flaA transcripts is labelled Region 1, 2 or 3. Arrows indicate the 
position of flaA transcripts after gel electrophoresis and the different migration of the 
HP0958/flaA mRNA complex. Order as follows: full length flaA mRNA (1) RNA load; (2) 
co-incubation with GST control protein; (3) co-incubation with HP0958; region 1 flaA 
mRNA (4) RNA load; (5) co-incubation with GST control protein; (6) co-incubation with 
HP0958; region 2 flaA mRNA (7) RNA load; (8) co-incubation with GST control protein; 
(9) co-incubation with HP0958; region 3 flaA mRNA (10) RNA load; (11) co-incubation 
with GST control protein; (12) co-incubation with HP0958. 
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Figure 31 Mobility shift assay screen of HP0958 mutants. 
15 ng of biotin-labelled full-length flaA riboprobe was incubated with 6 µg HP0958 (wild-
type or site-directed mutants). Arrows indicate the position of flaA transcripts after gel 
electrophoresis and the different migration of the HP0958/flaA mRNA complex. Controls 
and site-directed mutants are labelled on x-axis. 
  
 
Figure 32 Residues within HP0958 protein involved in interactions with RpoN and/or flaA mRNA. 
Residues which are involved in the HP0958-RpoN (74-284) interaction are coloured red; those involved in the HP0958-flaA mRNA interaction are coloured 
blue; residue I204A which is involved in both interactions is coloured magenta. Image generated with Pymol (DeLano Scientific, CA) and includes previously 
published data on the HP0958-flaA mRNA interaction by Caly et al. (Caly et al., 2010). 
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1 General Discussion 
Over the last ~30 years, research into the gastric human pathogen Helicobacter 
pylori has generated major advancements in our understanding of its biology, 
pathogenicity and intimate host associations. The classification of H. pylori as a 
human carcinogen, emerging antibiotic resistances and globally high levels of gastric 
diseases highlight its continuing clinical relevance throughout the decades 
(International Agency for Research on Cancer, 1994; Marshall et al., 1984; Parkin, 
2006). Genome mining has lead to the identification of strain-specific genes, 
biomarkers of disease and provided insights into the regulatory network of gene 
expression in H. pylori. Due to close evolution with its human host, H. pylori has 
developed a genome which is extremely efficient for performing critical processes 
during its ecological cycle such as infection, colonisation and evasion of the host 
immune response (Backert and Clyne, 2011; Linz et al., 2007). The genome of 
H. pylori appears to be in a constant state of flux, with recombination events, phase 
variation and mutation rates enabling the extreme plasticity (Olbermann et al., 2010; 
Suerbaum and Josenhans, 2007). 
In Chapter 2 the draft genome sequences of two H. pylori strains, CCUG 17874 
and P79, were described as a published Genome Announcement (Clancy et al., 
2012). Comparative analysis of strains 17874 and P79 identified key differences in 
predicted pseudogenes, genes encoding outer membrane proteins, restriction 
modification (RM) systems and competence genes. Regarding the difference in 
transformation efficiency between the strains, it is likely that the restriction barrier is 
the main factor which makes plasmid introduction into 17874 more difficult, while 
variations in the comB locus may also contribute. The development of methylomics 
has recently led to the identification of novel recognition sequences for RM systems, 
as well as highlighting remarkable levels of interstrain variation (Krebes et al., 2013; 
Murray et al., 2012). The mere absence or presence of a particular RM gene cannot 
be accepted as sufficient evidence for interstrain variation of biological relevance 
since RM system components have previously been shown to be present but inactive 
in some strains of H. pylori (Xu et al., 2000). The relatively recently described 
derivative strain of 26695 H. pylori which was deficient in type II RM systems had 
increased transformation efficiency, highlighting an exciting new method of 
enhancing the tractability of lab strains which are difficult to transform (Zhang and 
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Blaser, 2012). Application of this strategy to the motile type-strain 17874, together 
with the publically available draft genome sequence for this strain, would greatly 
enhance motility studies requiring genetic manipulations. 
Interestingly, each person infected with H. pylori possesses unique strain(s), with 
the exception of close family members, highlighting the adaptability of this human 
pathogen (Fialho et al., 2010; Raymond et al., 2008; Schwarz et al., 2008). The 
extreme genetic diversity of H. pylori and compounding factors such as host genetics 
and environmental factors have hampered efforts to identify clear disease markers 
(Chung et al., 2010; Kodaman et al., 2014; Neal et al., 2013; Wroblewski et al., 
2010). Presence of cytotoxin associated gene A (cagA) and vacuolating cytotoxin A 
(vacA) gene are two of the best described virulence determinants associated with 
H. pylori-related disease development (Backert and Clyne, 2011). However, strains 
lacking the standard characteristed virulence factors including SabA and BabA have 
been isolated from patients suffering from gastric neoplasia (Thiberge et al., 2010). 
This indicates that H. pylori may harbour virulence determinants which are currently 
unknown. 
Refinement of the core genome and pan-genome of H. pylori will contribute to 
global understanding of the mechanisms of infection and persistence in its host. In 
this study, the core genome of H. pylori was further reduced in comparison to recent 
analyses (Lu et al., 2013). Comparative analyses of the species core genome with the 
core genome of strains isolated from individuals suffering from H. pylori-related 
diseases (“disease-core”) has resulted in a panel of genes which can be probed in 
further analyses. Many of the “disease-core” genes encoded hypothetical proteins 
whose characterisation is warranted based on the potential for these to be novel 
biomarkers of disease or virulence factors. It is likely that these hypothetical proteins 
have functions which are advantageous to these strains either in colonisation or 
induction of disease-onset, as H. pylori is an extremely efficient organism in terms of 
gene conservation. Many of these genes may encode proteins involved in LPS 
biosynthesis, outer membrane proteins or transporter proteins, all of which are 
contributors of virulence, effective colonisation and persistence. For instance, 
HP1286 was originally annotated as encoding a hypothetical protein in the genome 
of strain 26695, but has since been identified as a stress-response factor homologous 
to YceI . The high number of genes encoding hypothetical proteins annotated in the 
genomes of strains 17874 and P79 is striking, considering the relatively small 
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genome size of H. pylori and the large number of strains for which genome sequence 
data is available. Clearly, the presence of so many (often strain-specific) genes 
encoding proteins of unknown function undermines our understanding of the 
complexity of H. pylori as a persistent human pathogen. Systematic characterisation 
of these genes would undoubtedly enhance future studies regarding infection, 
colonisation and the on-set of disease triggered by H. pylori. Furthermore, the 
identification of homopolymeric repeats in the genomes of strains 17874 and P79 
highlights the role of phase variation in H. pylori regulation of gene expression of 
factors such as motility and surface-exposed antigens. The link has been made 
between phase variation and epigenetic regulation of gene expression in H. pylori 
(Srikhanta et al., 2011). This mechanism of regulation adds another layer of 
complexity to the issue of pathogenesis. Therefore, a challenge now exists to develop 
genome data mining tools which are capable of accurately annotating and filtering 
the sequence information to enhance targeted approaches to future analyses. The 
coupling of genomics, transcriptomics and the relatively recent methylomics to 
biological analyses will help to elucidate the intricacies of gene expression and 
regulation, marking an exciting new era in H. pylori research (Murray et al., 2012; 
Sharma et al., 2010). 
In Chapter 3, the focus of this study was shifted from a broad scale genome 
analysis to a detailed structure-function analysis of the essential H. pylori flagellum 
biogenesis protein, HP0958. Although structural elements of the H. pylori flagellum 
are closely conserved when compared to model organisms E. coli and Salmonella, 
regulation of flagellar assembly deviates from these (Anderson et al., 2010; 
Lertsethtakarn et al., 2011; Niehus et al., 2004). Elucidation of the regulatory 
mechanisms of flagellum biogenesis in H. pylori will help to understand this 
complex process and may contribute to knowledge of spatial regulation of flagella in 
motile bacteria as H. pylori are lophotrichously flagellated while the model 
organisms are peritrichously flagellated. 
In this study, the previously proposed interaction of HP0958 with FliH, the 
negative regulator of flagellar ATPase FliI, was found to be a false positive from a 
yeast-two hybrid (Y2H) analysis of the proteome of H. pylori (Rain et al., 2001). 
Confirmation of the HP0958-RpoN (74-284) interaction by Y2H analysis and 
subsequent site-directed mutagenesis identified the involvement of the coiled-coil 
domain of HP0958. HP0958 was previously identified as a chaperone of RpoN 
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(Douillard et al., 2008; Pereira and Hoover, 2005). The HP0958-RpoN interaction 
was identified as a relatively weak interaction compared to FliH-FliI binding. One 
possibility is that the absence of currently unidentified additional interaction partners 
prevents the formation of a stable complex in the Y2H system. Another scenario is 
that the weak, transient nature of the HP0958-RpoN interaction is biologically 
favourable, allowing the interaction of RpoN with the core RNA polymerase 
(residues ~70-200 in Aquifex aeolicus) to stimulate expression of Class II flagellar 
genes (Hong et al., 2009). The role of HP0958 in this case may be to protect RpoN 
from intracellular proteases, prevent aggregation or induce RpoN to take on an 
extended conformation which exposes the core RNA polymerase binding site. While 
it is known that HP0958 improves the stability of RpoN in the cytoplasm, the 
potential involvement of HP0958 in RpoN interactions with the core RNA 
polymerase has yet to be investigated (Pereira and Hoover, 2005). 
Complementation of a non-motile hp0958-null derivative of P79 with HP0958 
mutant alleles by natural transformation revealed that mutations in the coiled-coil 
generally resulted in non-motile cells, while those in the Zn-finger generally restored 
motility either partially or fully. Interestingly, electron microscopy of complemented 
mutant strains revealed presence of flagellar-type extrusions from the cell surface at 
both poles and/or non-polar sites. This suggests that HP0958 may have an additional 
role in localisation of flagellum biogenesis to a single cell pole; this process likely 
involves both the coiled-coil and Zn-finger domains of HP0958. Little is known 
about the mechanism of flagellum localisation in H. pylori. FlhF and FlhG have been 
implicated in localisation of flagellum biogenesis to the bacterial cell pole and 
control of flagellum number in H. pylori, Campylobacter jenuni and Vibrio (Balaban 
and Hendrixson, 2011; Balaban et al., 2009; Lertsethtakarn et al., 2011). Balaban et 
al. proposed that in C. jejuni, FlhF is involved in the activation of RpoN-dependent 
gene expression in an FlgS/R-independent mechanism (Balaban and Hendrixson, 
2011). Recently, a novel role for flagellar-associated autotoxin A (FaaA) has been 
proposed in localising flagellum production to the cell pole in H. pylori (Radin et al., 
2013). Site-directed mutagenesis of HP0958 enabled refinement of the current model 
for HP0958-flaA mRNA interaction. The previously published structure-function 
analysis of the HP0958-flaA mRNA interaction was augmented by analysis of a 
further 14 side-directed mutants combined with analysis of the RNA subdomains 
required for interaction (Caly et al., 2010). The full length transcript of the major 
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flagellin was found to be required for direct full-strength interaction with the Zn-
finger domain of HP0958. 
Given that FliH does not interact with HP0958, the currently accepted model for 
the role of HP0958 during flagellum biogenesis must be re-evaluated (Douillard et 
al., 2008). Components of the basal body and export apparatus may fill the 
previously proposed role of FliH in this model. Elucidation of the role of HP0958 in 
flagellar localisation to the cell pole may be the key. One scenario could involve 
interaction between RpoN-bound HP0958 and FlhF. FlhF has been implicated in 
localising the MS ring components to the cell pole in C. jenuni, in addition to its 
influence on the activity of RpoN (Balaban et al., 2009). Therefore, future studies to 
identify potential interactions between HP0958, RpoN, FlhF and potentially FlhG 
may identify the missing link which targets the HP0958-flaA mRNA complex to the 
export apparatus. Furthermore, together with FaaA, these proteins may be involved 
in a cascade which ensures the tight spatial regulation of flagellum biogenesis at a 
single cell pole. In Vibrio alginolyticus, FlhG has been identified to negatively 
regulate the activity of FlhF (Kusumoto et al., 2008). Elucidation of the potential 
interplay between these flagellar proteins will serve to improve the model of 
flagellum construction in H. pylori. 
Additionally, many of the P79-0958KO derivative strains complemented with 
HP0958 mutant proteins produced truncated flagellar-type structures which 
resembled flagellar distal bulbs. Mutation of the fliD gene also produced mutant cells 
which possessed atypical flagellar sheaths, which are thought to be of similar 
composition to that of the bacterial outer membrane (Geis et al., 1993; Kim et al., 
1999). FaaA localises to the flagellar sheath in H. pylori and deletion of the gene 
resulted in cells with abnormal cell localisation of the flagellum (Radin et al., 2013). 
There have been relatively few developments in our understanding of the 
biosynthesis of the flagellar sheath. Geis et al. found that the sheath contains fatty 
acids, LPS and low molecular weight proteins, and suggested that it is an extension 
of the outer membrane (Geis et al., 1993). In addition, only two proteins have since 
been identified as localising to the flagellar sheath: the autotransporter FaaA and 
HpaA (Jones et al., 1997; Luket and Penn, 1995; Radin et al., 2013). Therefore, the 
panel of derivative strains possessing HP0958 mutant proteins from this study 
provides a platform for analysis of flagellar sheath biogenesis. Future analysis of the 
essential flagellum biogenesis protein HP0958 will provide understanding of the 
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deviations of flagellum construction from the model organisms and potentially 
enhance our understanding of flagellar localisation and sheath production. 
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Appendix 1 List of methylases in the genome of H. pylori CCUG 17874 
Locus tag Contig Product 
HP17_00556 13 Type II adenine methyltransferase 
HP17_00561 13 Cytosine specific DNA methyltransferase 
HP17_00576 13 Adenine/cytosine DNA methyltransferase 
HP17_00811 15 Type II adenine methyltransferase 
HP17_04995 88 Type II DNA modification methyltransferase 
HP17_05010 88 Type II DNA modification (methyltransferase) 
HP17_05065 88 Flagellin N-methylase, FliB 
HP17_05280 91 DNA methylase 
HP17_07432 144 N5-glutamine S-adenosyl-L-methionine-dependent 
methyltransferase 
HP17_07164 140 Type II DNA modification enzyme (methyltransferase) 
HP17_07154 140 Type II DNA modification enzyme 
HP17_05865 100 rRNA methyltransferase 
HP17_05645 99 Adenine-specific DNA methyltransferase 
HP17_06342 110 Putative type II cytosine specific methyltransferase 
HP17_08696 165 N6-adenine-specific methylase 
HP17_02549 41 Adenine-specific DNA methyltransferase 
HP17_02150 35 Ribosomal protein L11 methyltransferase 
HP17_02065 34 Pore-forming cytolysin (rRNA methylase) 
HP17_003479 68 M.HpyAVIII, type II cytosine specific DNA 
methyltransferase 
HP17_04079/84 73/74 Adenine-specific DNA methyltransferase 
HP17_02808 44 Adenine-specific DNA methyltransferase 
HP17_01438 24 DNA adenine methylase 
HP17_01448 24 Adenine-specific DNA methylase 
HP17_01453 24 Adenine-specific DNA methylase 
HP17_07027 133 Adenine-specific DNA methyltransferase 
HP17_06947 131 Type III restriction enzyme M protein 
HP17_06942 131 Adenine-specific DNA methylase 
HP17_03874 72 Ubiquinone/menaquinone biosynthesis methyltransferase 
HP17_03959 73 Type II methylase 
HP17_03964 73 Type II adenine specific DNA methyltransferase 
HP17_04104 75 Type III R-M system modification enzyme 
HP17_04286 80 Putative type II methylase protein  
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Appendix 2 List of endonucleases in the genome of H. pylori CCUG 17874 
Locus tag Contig Product 
HP17_00566 13 Restriction endonuclease 
HP17_05690 99 Endonuclease III 
HP17_05650 99 Type III restriction enzyme R protein (Res) 
HP17_05590 98 3-methyladenine DNA glycosylase 
HP17_08516 164 HP0790-like protein 
HP17_08626 165 Hypothetical protein 
HP17_08144 154 Type I restriction enzyme subunit S 
HP17_03189 59 Putative type I restriction-modification enzyme specificity 
subunit S 
HP17_03354 65 Holliday junction resolvase 
HP17_02464 39 Type I restriction/modification specificity protein 
HP17_02095 34 Similar to archaeal Holliday junction resolvase and Mrr 
protein 
HP17_01888 31 Holliday junction resolvase-like protein 
HP17_06877 130 Putative endonuclease G 
HP17_04169 75 Restriction modification system DNA specificity domain 
protein 
HP17_06677 125 Mulitfunctional nucleoside diphosphate 
kinase/apyrimidinic endonuclease/ 3'-phosphodiesterase 
HP17_05005 88 Type II R-M system restriction endonuclease 
HP17_08484 162 Type II restriction endonuclease 
HP17_07159 140 Type II restriction endonuclease 
HP17_02554 41 Restriction endonuclease Hpy8I 
HP17_01443 24 Type II restriction endonuclease 
HP17_07037 133 Type II R-M system restriction endonuclease 
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Appendix 3 List of all methylases in the genome of H. pylori P79 
Locus tag Contig Product 
HP79_04107 111 tRNA mo(5)U34 methyltransferase 
HP79_04916 128 Adenine-specific DNA methyltransferase 
HP79_04911 128 Cytosine specific DNA methyltransferase 
HP79_04891 128 Adenine/cytosine DNA methyltransferase 
HP79_04677 126 Type II restriction enzyme M protein (hsdM) 
HP79_08238 199 rRNA large subunit methyltransferase 
HP79_08602 203 Adenine-specific DNA methyltransferase 
HP79_08622 204 Adenine-specific DNA methyltransferase 
HP79_08677 204 Flagellin N-methylase, FliB 
HP79_05531 139 N5-glutamine S-adenosyl-L-methionine-dependent 
methyltransferase 
HP79_02349 68 RNA methyltransferase 
HP79_02124 64 Adenine-specific DNA methyltransferase 
HP79_03041 86 N6-adenine-specific methylase 
HP79_01635 43 Adenine-specific DNA methyltransferase 
HP79_07126 173 Ribosomal protein L11 methyltransferase 
HP79_07026 171 Haemolysin (tly), rRNA methylase 
HP79_07151 173 16S rRNA methyltransferase GidB 
HP79_09002 214 Cytosine specific DNA methyltransferase (BSP6IM) 
HP79_03386 95 tRNA (guanine-N(7)-)-methyltransferase 
HP79_03698 102 Adenine-specific DNA methyltransferase 
HP79_05764 142 Adenine-specific DNA methy ltransferase 
HP79_05779 145 Adenine-specific DNA methyltransferase 
HP79_05854 147 Type IIS restriction enzyme M1 protein (mod) 
HP79_05859 147 Type IIS restriction enzyme M2 protein (mod) 
HP79_05864 147 Adenine-specific DNA methyltransferase 
HP79_05869 147 Adenine-specific DNA methyltransferase 
HP79_06346 154 tRNA (guanine-N(1)-)-methyltransferase 
HP79_06411 157 Adenine-specific DNA methyltransferase 
HP79_06976 169 Adenine-specific DNA methyltransferase 
HP79_00105 5 Ribosomal RNA large subunit methyltransferase N 
HP79_00370 14 Methylated-DNA--protein-cysteine methyltransferase 
HP79_00848 23 16S ribosomal RNA methyltransferase RsmE 
HP79_00988 28 Type III DNA modification enzyme (methyltransferase) 
HP79_00995 29 Type III R-M system modification enzyme 
HP79_01020 29 Type IIS restriction enzyme R and M protein (ECO57IR) 
HP79_01200 31 Ubiquinone/menaquinone biosynthesis methyltransferase 
HP79_05511 137 N-6 Adenine-specific DNA methylase 
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Appendix 4 List of endonucleases in the genome of H. pylori P79 
Locus tag Contig Product 
HP79_07645 187 Mulitfunctional nucleoside diphosphate 
kinase/apyrimidinic endonuclease/3'-phosphodiesterase 
HP79_02179 66 Endonuclease III 
HP79_00025 102 Ulcer-associated gene restriction endonuclease (iceA) 
HP79_00617 20 Holliday junction resolvase-like protein 
HP79_04142 113 Type I restriction enzyme S protein (hsdS) 
HP79_02129 64 Type III restriction enzyme R protein (res) 
HP79_02054 61 3-methyladenine DNA glycosylase 
HP79_03146 88 Anti-codon nuclease masking agent (prrB) 
HP79_02956 82 Hypothetical protein 
HP79_02804 78 Type I restriction enzyme S protein (hsdS) 
HP79_07061 172 Similar to archaeal Holliday junction resolvase and Mrr 
protein 
HP79_06089 150 Type I restriction enzyme S protein (hsdS) 
HP79_01000 29 Type III restriction enzyme R protein (res) 
 
  
Appendix 5 List of sequenced genomes used in core genome analysis of H. pylori 
Strain Size (Mbp)* Location Disease Status 
SNT49 1.61 (3.2kb p) India Asymptomatic complete 
26695 1.67 UK Gastritis complete 
HPAG1 1.6 (0.01p) Sweeden Chronic atrophic gastritis complete 
Shi470 1.61 Peru Gastritis complete 
Puno120 1.62 (0.01 p) Peru Gastritis complete 
Puno135 1.65 Peru Gastritis complete 
F16 1.58 Japan Gastritis complete 
v225d 1.59 (0.01 p) Venezuela Acute superficial gastritis complete 
SJM180 1.66 Peru Gastritis complete 
B8 1.67 (0.01p)  Gastric ulcer complete 
B128 1.65  Gastric ulcer 73 contigs 
J99 1.64 USA Duodenal ulcer complete 
51 1.59 South Korea Duodenal ulcer complete 
908 1.55 France Duodenal ulcer complete 
2017 1.55 France Duodenal ulcer complete 
2018 1.56 France Duodenal ulcer complete 
F30 1.57 (0.01 p) Japan Duodenal ulcer complete 
P12 1.67 (0.01 p) Germany Duodenal ulcer complete 
PeCan4 1.63 (0.01p) Peru Gastric cancer complete 
ELS37 1.66 (0.01 p) El Salvador Gastric cancer complete 
F32 1.58 (2.6kb p) Japan Diffuse type gastric cancer complete 
F57 1.61 Japan Diffuse type gastric cancer complete 
PeCan18 1.66 Peru Gastric cancer complete 
XZ274 1.63 (0.02 p) China Gastric cancer complete 
98-10 1.57 Japan Gastric cancer 51 contigs 
B45 1.6 (0.02 phage)+ France MALT lymphoma 63 contigs 
B38 1.58 France MALT lymphoma complete 
G27 1.65 (0.01 p) Italy Endoscopy patient complete 
  
52 1.57 South Korea  complete 
HUP-B14 1.6 (0.01 p) Spain  complete 
35A 1.57   complete 
India7 1.68 India  complete 
83 1.62   complete 
Lithuania75 1.62 (0.02 p) Lithuania  complete 
Gambia94/24 1.71 (2.5kb p) Gambia  complete 
Sat464 1.56 (0.01 p) Peru  complete 
Shi417 1.67 Peru  complete 
Cuz20 1.64 Peru  complete 
SouthAfrica7 1.65 (0.03 p) South Africa  complete 
Shi112 1.66 Peru  complete 
Shi169 1.62 Peru  complete 
*Figures in brackets denote the presence and size (Mb unless otherwise stated) of plasmid DNA (p). 
+
Strain harbours 0.02 Mb phage DNA. 
Strains used in core genome analysis in addition to 17874 and P79 (not listed). Strain and genome information was collected from the National Center for 
Biotechnology Information (NCBI, 2013). 
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Appendix 6 Revised core genome of H. pylori* 
Locus tag Product 
HP17_00015 Phosphoenolpyruvate synthase 
HP17_00025 Threonyl-tRNA synthetase 
HP17_00030 InfC translation initiation factor IF-3 
HP17_00035 RpmI 50S ribosomal protein 
HP17_00040 RplT 50S ribosomal protein L20 
HP17_00045 Outer membrane protein 
HP17_00060 Hypothetical protein 
HP17_00070 L-serine deaminase 
HP17_00075 L-serine transporter 
HP17_00080 Phospho-2-dehydro-3-deoxyheptonate aldolase 
HP17_00090 Bacterioferritin comigratory protein 
HP17_00095 Hypothetical protein 
HP17_00110 Fe-S oxidoreductase 
HP17_00120 L-lactate permease 
HP17_00140 Cbb3-type cytochrome c oxidase subunit I 
HP17_00145 Cbb3-type cytochrome c oxidase subunit II 
HP17_00150 Cytochrome c oxidase, cbb3-type, CcoQ subunit 
HP17_00155 Cytochrome c oxidase, cbb3-type, subunit III 
HP17_00160 Hypothetical protein 
HP17_00170 Hypothetical protein 
HP17_00185 Hypothetical protein 
HP17_00200 Hypothetical protein 
HP17_00205 Hypothetical protein 
HP17_00210 AroK shikimate kinase 
HP17_00215 Hypothetical protein 
HP17_00225 Hypothetical protein 
HP17_00235 Hypothetical protein 
HP17_00240 Delta-aminolevulinic acid dehydratase 
HP17_00255 Response regulator OmpR 
HP17_00260 Hypothetical protein 
HP17_00270 Collagenase 
HP17_00275 Hypothetical protein 
HP17_00285 PrfB peptide chain release factor 2 
HP17_00295 Flagellar biosynthesis protein FliR 
HP17_00300 Hypothetical protein 
HP17_00315 Excinuclease ABC subunit B 
HP17_00325 Adenylosuccinate lyase 
HP17_00335 Pyruvate ferredoxin oxidoreductase, beta subunit 
HP17_00340 PorA pyruvate flavodoxin oxidoreductase subunit alpha 
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HP17_00345 PorD pyruvate flavodoxin oxidoreductase subunit delta 
HP17_00350 Pyruvate flavodoxin oxidoreductase subunit gamma 
HP17_00355 Outer membrane protein HorH; signal peptide 
HP17_00380 Glk glucokinase 
HP17_00385 6-phosphogluconolactonase 
HP17_00390 Glucose-6-phosphate 1-dehydrogenase 
HP17_00395 Phosphogluconate dehydratase 
HP17_00400 Multifunctional KHG/KDPG aldolase 
HP17_00405 Putative beta-lactamase HcpC 
HP17_00415 Putative outer membrane protein 
HP17_00425 UDP-glucose 4-epimerase 
HP17_00430 TruA tRNA pseudouridine synthase A 
HP17_00435 Hypothetical protein 
HP17_00440 Pcm protein-L-isoaspartate O-methyltransferase 
HP17_00445 NrdF ribonucleotide-diphosphate reductase subunit beta 
HP17_00475 Biotin carboxylase 
HP17_00496 Dcd deoxycytidine triphosphate deaminase 
HP17_00506 16S ribosomal RNA methyltransferase RsmE 
HP17_00511 Hypothetical protein 
HP17_00521 Thiol:disulfide interchange protein 
HP17_00541 Hydrogenase expression/formation protein 
HP17_00551 Hypothetical protein 
HP17_00581 Symporter, SSS family (Proline Permease); membrane protein 
HP17_00586 Delta-1-pyrroline-5-carboxylate dehydrogenase 
HP17_00591 Hypothetical protein 
HP17_00676 Urease accessory protein UreH 
HP17_00681 Urease accessory protein UreG 
HP17_00701 Urease accessory protein UreI 
HP17_00721 Urease subunit alpha 
HP17_00726 LspA lipoprotein signal peptidase 
HP17_00731 GlmM phosphoglucosamine mutase 
HP17_00736 RpsT 30S ribosomal protein S20 
HP17_00741 PrfA peptide chain release factor 1 
HP17_00751 Hypothetical protein 
HP17_00761 RpsI 30S ribosomal protein S9 
HP17_00766 RplM 50S ribosomal protein L13 
HP17_00771 Hypothetical protein 
HP17_00776 Hypothetical protein 
HP17_00781 Hypothetical protein 
HP17_00786 RNA polymerase sigma factor RpoD 
HP17_00791 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase 
HP17_00796 Malonyl CoA-acyl carrier protein transacylase 
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HP17_00830 Hypothetical protein 
HP17_00835 2-hydroxyacid dehydrogenase 
HP17_00840 Hypothetical protein 
HP17_00855 Hypothetical protein 
HP17_00865 Hypothetical protein 
HP17_00875 2',3'-cyclic-nucleotide 2'-phosphodiesterase 
HP17_00880 S-ribosylhomocysteinase 
HP17_00885 Cystathionine gamma-synthase/cystathionine beta- lyase 
HP17_00905 DnaK molecular chaperone DnaK 
HP17_00910 Heat shock protein GrpE 
HP17_00920 Hypothetical protein 
HP17_00925 Hypothetical protein 
HP17_00930 Hypothetical protein 
HP17_00935 Flagellin B 
HP17_00950 Hypothetical protein 
HP17_00955 4-oxalocrotonate tautomerase 
HP17_00960 RecR recombination protein RecR 
HP17_00970 Heat shock protein HtpX 
HP17_00975 FolE GTP cyclohydrolase I 
HP17_00980 Geranyltranstransferase (Farnesyl-diphosphate synthase) (FPP synthase) 
HP17_00985 SurE 5'(3')-nucleotidase/polyphosphatase 
HP17_00990 Hypothetical protein 
HP17_00995 6-carboxy-5,6,7,8-tetrahydropterin synthase 
HP17_01000 Hypothetical protein 
HP17_01005 Hypothetical protein 
HP17_01025 Amino acid ABC transporter permease 
HP17_01030 Putative polar amino acid transport system substrate-binding protein 
HP17_01035 Alanine racemase 
HP17_01045 D-alanine glycine permease 
HP17_01050 D-amino acid dehydrogenase 
HP17_01055 Hypothetical protein 
HP17_01128 Nickel cobalt outer membrane efflux protein 
HP17_01133 GlyS glycyl-tRNA synthetase subunit beta 
HP17_01143 Phosphoglyceromutase 
HP17_01148 GatC aspartyl/glutamyl-tRNA amidotransferase subunit C 
HP17_01153 Adenosylmethionine--8-amino-7-oxononanoate transaminase 
HP17_01158 Peptidyl-prolyl cis-trans isomerase D 
HP17_01163 Cell division protein FtsA 
HP17_01168 Cell division protein FtsZ 
HP17_01238 DNA polymerase III subunit delta 
HP17_01243 Ribonuclease R 
HP17_01268 Tryptophanyl-tRNA synthetase 
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HP17_01273 Biotin biosynthesis protein BioC 
HP17_01278 SecG preprotein translocase subunit SecG 
HP17_01283 Frr ribosome recycling factor 
HP17_01288 PyrE orotate phosphoribosyltransferase 
HP17_01293 Conserved hypothetical mitochondrial protein- like protein 4 
HP17_01303 NADH dehydrogenase subunit A 
HP17_01308 NADH dehydrogenase subunit B 
HP17_01313 NADH dehydrogenase subunit C 
HP17_01323 Putative NADH oxidoreductase I 
HP17_01338 NADH:ubiquinone oxidoreductase subunit H 
HP17_01343 NADH dehydrogenase subunit I 
HP17_01348 NADH:ubiquinone oxidoreductase subunit J 
HP17_01353 NADH:ubiquinone oxidoreductase subunit K 
HP17_01358 NADH:ubiquinone oxidoreductase subunit L 
HP17_01368 NADH:ubiquinone oxidoreductase subunit N 
HP17_01398 TrpA tryptophan synthase subunit alpha 
HP17_01403 Tryptophan synthase subunit beta 
HP17_01413 TrpD anthranilate phosphoribosyltransferase 
HP17_01418 Anthranilate synthase component II 
HP17_01423 Anthranilate synthase component I 
HP17_01463 Hypothetical protein 
HP17_01468 Hypothetical protein 
HP17_01478 Transcriptional regulator (tenA) 
HP17_01498 Nicotinamide mononucleotide transporter 
HP17_01513 RplQ 50S ribosomal protein L17 
HP17_01518 DNA-directed RNA polymerase subunit alpha 
HP17_01523 RpsD 30S ribosomal protein S4 
HP17_01528 30S ribosomal protein S11 
HP17_01538 RpsM 30S ribosomal protein S13 
HP17_01548 InfA translation initiation factor IF-1 
HP17_01553 Methionine aminopeptidase 
HP17_01558 SecY preprotein translocase subunit SecY 
HP17_01563 RplO 50S ribosomal protein L15 
HP17_01568 RpsE 30S ribosomal protein S5 
HP17_01573 RplR 50S ribosomal protein L18 
HP17_01578 RplF 50S ribosomal protein L6 
HP17_01583 RpsH 30S ribosomal protein S8 
HP17_01593 RplE 50S ribosomal protein L5 
HP17_01603 RplN 50S ribosomal protein L14 
HP17_01608 RpsQ 30S ribosomal protein S17 
HP17_01613 50S ribosomal protein L29 
HP17_01618 RplP 50S ribosomal protein L16 
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HP17_01623 RpsC 30S ribosomal protein S3 
HP17_01628 RplV 50S ribosomal protein L22 
HP17_01633 RpsS 30S ribosomal protein S19 
HP17_01643 RplB 50S ribosomal protein L2 
HP17_01648 RplW 50S ribosomal protein L23 
HP17_01653 RplD 50S ribosomal protein L4 
HP17_01658 RplC 50S ribosomal protein L3 
HP17_01663 RpsJ 30S ribosomal protein S10 
HP17_01673 Hypothetical protein 
HP17_01683 RnhB ribonuclease HII 
HP17_01698 FumC fumarate hydratase 
HP17_01703 Hypothetical protein 
HP17_01708 Hypothetical protein 
HP17_01713 Putative cobalt-zinc-cadmium resistance protein CzcB 
HP17_01723 Hypothetical protein 
HP17_01728 Branched-chain amino acid transport protein 
HP17_01733 Chaperone protein DnaJ 
HP17_01738 Hypothetical protein 
HP17_01748 MnmA tRNA-specific 2-thiouridylase MnmA 
HP17_01753 Hypothetical protein 
HP17_01763 Nickel responsive regulator 
HP17_01793 Putative heme iron utilization protein 
HP17_01803 ArgS arginyl-tRNA synthetase 
HP17_01813 Gmk guanylate kinase 
HP17_01828 Nuclease NucT 
HP17_01833 Outer membrane protein HorC; signal peptide 
HP17_01838 FlgH flagellar basal body L-ring protein 
HP17_01858 LpxK tetraacyldisaccharide 4'-kinase 
HP17_01863 NAD synthetase 
HP17_01868 Ketol-acid reductoisomerase 
HP17_01873 Cell division inhibitor 
HP17_01878 MinE cell division topological specificity factor MinE 
HP17_01883 Hypothetical protein 
HP17_01888 Holliday junction resolvase-like protein 
HP17_01910 Hypothetical protein 
HP17_01960 HP17_01960 single-stranded-DNA-specific exonuclease 
HP17_01965 PyrG CTP synthetase 
HP17_01970 HP17_01970 hypothetical protein 
HP17_01980 FliG flagellar motor switch protein G 
HP17_01985 FliH flagellar assembly protein H 
HP17_01990 1-deoxy-D-xylulose-5-phosphate synthase 
HP17_01995 GTP-binding protein LepA 
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HP17_02025 Flagellar basal-body rod protein 
HP17_02030 General substrate transporter, MFS superfamily 
HP17_02050 Transketolase  
HP17_02060 Bifunctional riboflavin kinase/FMN adenylyltransferase 
HP17_02070 Hypothetical protein 
HP17_02075 PyrB aspartate carbamoyltransferase catalytic subunit 
HP17_02095 Similar to archaeal Holliday junction resolvase 
HP17_02100 High-affinity nickel-transport protein 
HP17_02105 Hypothetical protein 
HP17_02130 CDP-diacylglycerol--serine O- phosphatidyltransferase 
HP17_02145 Cell division protein FtsH 
HP17_02150 PrmA ribosomal protein L11 methyltransferase 
HP17_02160 Outer membrane protein HorD 
HP17_02165 Hypothetical protein 
HP17_02175 GidB 16S rRNA methyltransferase GidB 
HP17_02180 QueA S-adenosylmethionine:tRNA ribosyltransferase- isomerase 
HP17_02185 Sec-independent protein translocase protein tat 
HP17_02190 Sec-independent translocase 
HP17_02195 RuvB Holliday junction DNA helicase RuvB 
HP17_02200 PanB 3-methyl-2-oxobutanoate hydroxymethyltransferase 
HP17_02210 Hypothetical protein 
HP17_02215 Hypothetical protein 
HP17_02225 MinC septum formation inhibitor 
HP17_02230 LpxC UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase 
HP17_02235 Hypothetical protein 
HP17_02240 Homoserine kinase 
HP17_02262 RbfA ribosome-binding factor A 
HP17_02267 Ribosome maturation factor rimP 
HP17_02277 Phosphodiesterase domain-containing protein 
HP17_02282 Transcriptional regulator 
HP17_02292 Hypothetical protein 
HP17_02297 FlhA flagellar biosynthesis protein FlhA 
HP17_02302 RpsO 30S ribosomal protein S1 
HP17_02312 3-dehydroquinate dehydratase 
HP17_02317 X-Pro aminopeptidase 
HP17_02322 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine 
pyrophosphokinase 
HP17_02327 FlhF flagellar biosynthesis regulator FlhF 
HP17_02332 Flagellar biosynthesis protein FlhG 
HP17_02342 FliA flagellar biosynthesis sigma factor 
HP17_02347 FliM flagellar motor switch protein FliM 
HP17_02352 Flagellar motor switch protein FliY 
HP17_02357 Hypothetical protein 
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HP17_02362 Hypothetical protein 
HP17_02367 Ferric uptake regulation protein 
HP17_02372 Recombination factor protein RarA 
HP17_02377 Putative transcriptional regulator, MerR family protein 
HP17_02397 Response regulator 
HP17_02402 IspDF bifunctional 2-C-methyl-D-erythritol 4-phosphate 
cytidylyltransferase/2-C-methyl-D-erythritol 2,4- cyclodiphosphate 
synthase protein 
HP17_02407 Protease DO 
HP17_02422 Phosphatidylglycerophosphate synthase 
HP17_02427 Hypothetical protein 
HP17_02432 7-alpha-hydroxysteroid dehydrogenase 
HP17_02437 Dihydrodipicolinate synthase 
HP17_02447 Putative zinc protease 
HP17_02452 Dihydroorotate dehydrogenase 
HP17_02457 Polyphosphate kinase 
HP17_02484 Glyceraldehyde-3-phosphate dehydrogenase 
HP17_02489 Integral membrane protein 
HP17_02499 Hypothetical protein 
HP17_02524 Outer membrane protein HopB 
HP17_02529 Outer membrane porin and adhesin HopC; signal peptide 
HP17_02564 FlgD flagellar basal body rod modification protein 
HP17_02594 Hypothetical protein 
HP17_02638 Hypothetical protein 
HP17_02648 Maf-like protein 
HP17_02668 Carbamoyl phosphate synthase small subunit 
HP17_02673 Hypothetical protein 
HP17_02678 Integral membrane protein 
HP17_02683 Membrane transport protein 
HP17_02688 Hypothetical protein 
HP17_02703 Hypothetical protein 
HP17_02708 Aspartate kinase 
HP17_02713 RNA pyrophosphohydrolase 
HP17_02723 Cytochrome c-553 
HP17_02728 Coproporphyrinogen III oxidase 
HP17_02733 Camphor resistance protein CrcB 
HP17_02738 HemD uroporphyrinogen-III synthase 
HP17_02743 Hypothetical protein 
HP17_02758 Undecaprenyl pyrophosphate synthase 
HP17_02768 Glycinamide ribonucleotide synthetase 
HP17_02773 Hypothetical protein 
HP17_02778 Organic solvent tolerance protein 
HP17_02783 Phosphoribosyltransferase 
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HP17_02788 Polynucleotide phosphorylase/polyadenylase 
HP17_02793 F0F1 ATP synthase subunit C 
HP17_02798 Serine acetyltransferase 
HP17_02808 Site-specific DNA-methyltransferase 
HP17_02813 Hypothetical protein 
HP17_02818 ABC transporter ATP-binding protein 
HP17_02823 Elongation factor Tu 
HP17_02833 SecE preprotein translocase subunit SecE  
HP17_02838 nusG transcription antitermination protein NusG 
HP17_02843 rplK 50S ribosomal protein L11 
HP17_02848 rplA 50S ribosomal protein L1 
HP17_02853 rplJ 50S ribosomal protein L10 
HP17_02858 rplL 50S ribosomal protein L7/L12 
HP17_02887 rpsL 30S ribosomal protein S12 
HP17_02892 HP17_02892 30S ribosomal protein S7 
HP17_02902 HP17_02902 elongation factor G 
HP17_02932 HP17_02932 ADP-heptose--LPS heptosyltransferase II 
HP17_02947 HP17_02947 aspartate-semialdehyde dehydrogenase 
HP17_02967 GltX glutamyl-tRNA synthetase 
HP17_02992 Hypothetical protein 
HP17_03002 Oligoendopeptidase F 
HP17_03007 Hypothetical protein 
HP17_03012 Hypothetical protein 
HP17_03022 Hypothetical protein 
HP17_03027 Hypothetical protein 
HP17_03042 Alpha-carbonic anhydrase 
HP17_03047 Putative arabinose transporter 
HP17_03052 Hypothetical protein 
HP17_03057 Na+/H+ antiporter 
HP17_03067 Putative PP-loop family ATPase 
HP17_03072 Multidrug-efflux transporter 
HP17_03077 Nucleoside transporter 
HP17_03087 Purine-nucleoside phosphorylase 
HP17_03114 Hypothetical protein 
HP17_03129 tRNA-dihydrouridine synthase B 
HP17_03134 Hypothetical protein 
HP17_03204 Integral membrane protein 
HP17_03214 ABC transporter, ATP-binding protein 
HP17_03229 Phosphoheptose isomerase 
HP17_03239 ADP-heptose synthase 
HP17_03244 ADP-L-glycero-D-manno-heptose-6-epimerase 
HP17_03249 D,D-heptose 1,7-bisphosphate phosphatase 
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HP17_03254 Hypothetical protein 
HP17_03259 Pantothenate kinase 
HP17_03269 Hypothetical protein 
HP17_03274 Dut deoxyuridine 5'-triphosphate nucleotidohydrolase 
HP17_03279 GreA transcription elongation factor GreA 
HP17_03284 Ipid-A-disaccharide synthase 
HP17_03289 Hypothetical protein 
HP17_03294 HypA hydrogenase nickel incorporation protein 
HP17_03319 CDP-diacylglycerol pyrophosphatase 
HP17_03324 Alkylphosphonate uptake protein 
HP17_03329 Hypothetical protein 
HP17_03334 Hypothetical protein 
HP17_03339 Catalase 
HP17_03344 Iron-regulated outer membrane protein 
HP17_03354 RuvC Holliday junction resolvase 
HP17_03384 RuvA Holliday junction DNA helicase RuvA 
HP17_03389 Hypothetical protein 
HP17_03399 CysS cysteinyl-tRNA synthetase 
HP17_03409 Iron(III) dicitrate transport system ATP-binding protein 
HP17_03414 Iron(III) dicitrate ABC transporter permease protein 
HP17_03419 Short-chain oxidoreductase 
HP17_03424 Hypothetical protein 
HP17_03454 Cysteine-rich protein X 
HP17_03464 Gamma-glutamyltranspeptidase 
HP17_03469 FlgK flagellar hook-associated protein FlgK 
HP17_03474 Hypothetical protein 
HP17_03479 M. HpyAVIII, a type II cytosine specific DNA methyltransferase 
HP17_03484 Hypothetical protein 
HP17_03494 FKBP-type peptidyl-prolyl cis-trans isomerase slyD 
HP17_03499 Hypothetical protein 
HP17_03504 Peptidoglycan-associated lipoprotein precursor 
HP17_03509 TolB translocation protein TolB 
HP17_03519 Biopolymer transport protein ExbD/TolR 
HP17_03524 Biopolymer transport protein 
HP17_03529 AtpC F0F1 ATP synthase subunit epsilon 
HP17_03534 F0F1 ATP synthase subunit beta 
HP17_03539 F0F1 ATP synthase subunit gamma 
HP17_03544 F0F1 ATP synthase subunit alpha 
HP17_03549 F0F1 ATP synthase subunit delta 
HP17_03554 F0F1 ATP synthase subunit B 
HP17_03559 F0F1 ATP synthase subunit B' 
HP17_03564 Plasmid replication-partition-like protein 
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HP17_03579 Biotin--protein ligase 
HP17_03624 Hypothetical protein 
HP17_03629 Peptidyl-prolyl cis-trans isomerase B, cyclosporine-type rotamase (ppi) 
HP17_03634 Carbon storage regulator 
HP17_03639 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase 
HP17_03644 SmpB SsrA-binding protein 
HP17_03669 Hypothetical protein 
HP17_03674 HP17_03674 membrane protein insertase 
HP17_03684 TrmE tRNA modification GTPase TrmE 
HP17_03709 Hypothetical protein 
HP17_03714 Hypothetical protein 
HP17_03719 Membrane-associated lipoprotein 
HP17_03724 Collagen-binding surface adhesin SpaP 
HP17_03729 Thioredoxin 
HP17_03734 Ribosomal large subunit pseudouridine synthase 
HP17_03744 Cytochrome c551 peroxidase 
HP17_03759 Hypothetical protein 
HP17_03764 ABC transport system substrate binding protein 
HP17_03784 Outer membrane protein; signal peptide 
HP17_03794 Branched-chain amino acid aminotransferase 
HP17_03799 Outer membrane protein HorJ; signal peptide 
HP17_03804 DNA polymerase I 
HP17_03819 Hypothetical protein 
HP17_03824 Tmk thymidylate kinase 
HP17_03829 CoaD phosphopantetheine adenylyltransferase 
HP17_03834 3-octaprenyl-4-hydroxybenzoate carboxy-lyase 
HP17_03844 FlgA flagellar basal body P-ring biosynthesis protein FlgA 
HP17_03849 DNA helicase II (UvrD) 
HP17_03854 hypothetical protein 
HP17_03859 seryl-tRNA synthetase 
HP17_03864 Hypothetical protein 
HP17_03869 Exodeoxyribonuclease VII small subunit 
HP17_03874 UbiE ubiquinone/menaquinone biosynthesis methyltransferase 
HP17_03879 Hypothetical protein 
HP17_03884 X-Pro dipeptidase 
HP17_03889 Antibiotic transport system permease protein 
HP17_03894 Hypothetical protein 
HP17_03899 Hypothetical protein 
HP17_03904 Lipase-like protein 
HP17_03909 Hemolysin domain-containing protein 
HP17_03924 Putative nifU-like protein 
HP17_03929 Hypothetical protein 
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HP17_03934 MurE UDP-N-acetylmuramoylalanyl-D-glutamate--2, 6- 
diaminopimelate ligase 
HP17_03939 Transaldolase 
HP17_03944 50S ribosomal protein L25/general stress protein Ctc 
HP17_03949 Peptidyl-tRNA hydrolase 
HP17_03954 Permease; membrane protein 
HP17_03999 Hypothetical protein 
HP17_04004 Riboflavin biosynthesis protein 
HP17_04009 Sodium/glutamate symport carrier protein/glutamate permease 
HP17_04014 Saccharopine dehydrogenase 
HP17_04024 Putative glycerol-3-phosphate acyltransferase PlsY 
HP17_04029 Hypothetical protein 
HP17_04034 FrpB-like protein 
HP17_04049 Selenocysteine synthase 
HP17_04054 NusA transcription elongation factor NusA 
HP17_04109 ATP-dependent DNA helicase RecG 
HP17_04114 Hypothetical protein 
HP17_04119 Hypothetical protein 
HP17_04124 Exodeoxyribonuclease III 
HP17_04129 Hypothetical protein 
HP17_04149 Hypothetical protein 
HP17_04154 Glucosamine--fructose-6-phosphate aminotransferase 
HP17_04184 Hypothetical protein 
HP17_04199 Arginase 
HP17_04204 Alanine dehydrogenase 
HP17_04226 Outer membrane protein 
HP17_04251 Hypothetical protein 
HP17_04256 Hypothetical protein 
HP17_04276 Fructose-1,6-bisphosphatase 
HP17_04281 Hypothetical protein 
HP17_04296 Ubiquinol cytochrome c oxidoreductase, cytochrome c1 subunit 
HP17_04301 Ubiquinol-cytochrome c reductase cytochrome b subunit 
HP17_04306 Ubiquinol-cytochrome c reductase, iron-sulfur subunit 
HP17_04311 Transcription-repair coupling factor 
HP17_04326 Hypothetical protein 
HP17_04331 Folylpolyglutamate synthase 
HP17_04336 Hypothetical protein 
HP17_04341 LeuS leucyl-tRNA synthetase 
HP17_04346 Integral membrane protein 
HP17_04351 SecF preprotein translocase subunit SecF 
HP17_04356 SecD preprotein translocase subunit SecD 
HP17_04371 YajC preprotein translocase subunit YajC 
HP17_04376 NhaA pH-dependent sodium/proton antiporter 
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HP17_04381 Putative recombination protein RecB  
HP17_04386 RpsB 30S ribosomal protein S2 
HP17_04391 Tsf elongation factor Ts 
HP17_04396 HP17_04396 cell division protein 
HP17_04401 FliE flagellar hook-basal body protein FliE 
HP17_04406 FlgC flagellar basal body rod protein FlgC 
HP17_04411 FlgB flagellar basal body rod protein FlgB 
HP17_04431 Alkyl hydroperoxide reductase 
HP17_04436 Outer membrane protein 
HP17_04441 Penicillin-binding protein 2 
HP17_04446 Hypothetical protein 
HP17_04451 EngB GTP-binding protein YsxC 
HP17_04456 Hypothetical protein 
HP17_04461 Hypothetical protein 
HP17_04466 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase 
HP17_04471 Rare lipoprotein A 
HP17_04476 Regulatory protein DniR 
HP17_04481 DNAse 
HP17_04486 Riboflavin synthase subunit alpha 
HP17_04511 Hypothetical protein 
HP17_04536 Pyridoxine 5'-phosphate synthase 
HP17_04541 PdxA 4-hydroxythreonine-4-phosphate dehydrogenase 
HP17_04556 FlgG flagellar basal body rod protein FlgG 
HP17_04581 Hypothetical protein 
HP17_04596 NusB transcription antitermination protein NusB 
HP17_04606 2-dehydro-3-deoxyphosphooctonate aldolase 
HP17_04616 Orotidine 5'-phosphate decarboxylase 
HP17_04621 PanC pantoate--beta-alanine ligase 
HP17_04646 GroEL chaperonin GroEL 
HP17_04651 GroES co-chaperonin GroES 
HP17_04656 DnaG DNA primase 
HP17_04666 Hypothetical protein 
HP17_04671 Hypothetical protein 
HP17_04676 Hypothetical protein 
HP17_04681 ATPase/DNA transfer protein 
HP17_04691 Chemotaxis protein 
HP17_04696 Carboxynorspermidine decarboxylase 
HP17_04701 Lipid A 1-phosphatase 
HP17_04706 Lipid A phosphoethanolamine transferase 
HP17_04731 Isocitrate dehydrogenase 
HP17_04741 Dethiobiotin synthetase 
HP17_04751 Putative universal stress global response regulator UspA 
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HP17_04756 ATP-dependent Clp protease adapter protein ClpS 
HP17_04761 ATP-dependent C1p protease (clpA) 
HP17_04776 Hypothetical protein 
HP17_04791 Hypothetical protein 
HP17_04796 ComB9 competence protein 
HP17_04801 ComB10 competence protein 
HP17_04806 Mannose-1-phosphate guanyltransferase 
HP17_04811 GDP-D-mannose dehydratase 
HP17_04816 Nodulation protein (nolK) 
HP17_04831 3-deoxy-manno-octulosonate cytidylyltransferase 
HP17_04836 Disulphide isomerase 
HP17_04841 Hypothetical protein 
HP17_04851 Hypothetical protein 
HP17_04856 Cysteine-rich protein E; beta-lactamase HcpE precursor 
HP17_04861 Hypothetical protein 
HP17_04866 HemC porphobilinogen deaminase 
HP17_04871 Prolyl-tRNA synthetase 
HP17_04876 HemA glutamyl-tRNA reductase 
HP17_04881 Octaprenyl-diphosphate synthase (Octaprenyl pyrophosphate synthetase) 
(OPP synthetase) 
HP17_04886 Hypothetical protein 
HP17_04891 Hypothetical protein 
HP17_04896 HP17_04896 Neutrophil activating protein NapA (bacterioferritin) 
HP17_04901 Histidine kinase sensor protein 
HP17_04906 Hypothetical protein 
HP17_04911 FlgI flagellar basal body P-ring protein 
HP17_04916 ATP-dependent RNA helicase 
HP17_04933 Hypothetical protein 
HP17_04938 Oligopeptide permease 
HP17_04965 Hypothetical protein 
HP17_04970 Adenylosuccinate synthetase 
HP17_04975 Hypothetical protein 
HP17_04985 Hypothetical protein 
HP17_04990 XseA exodeoxyribonuclease VII large subunit 
HP17_05015 ATP-dependent protease binding subunit/heat shock protein 
HP17_05025 Dihydroorotase 
HP17_05030 Chlorohydrolase 
HP17_05035 Hypothetical protein 
HP17_05040 (dimethylallyl)adenosine tRNA methylthiotransferase 
HP17_05045 Hypothetical protein 
HP17_05050 Hypothetical protein 
HP17_05055 Hypothetical protein 
HP17_05060 Hypothetical protein 
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HP17_05065 Hypothetical protein 
HP17_05070 ATP-dependent nuclease 
HP17_05075 Hypothetical protein 
HP17_05080 Putative 4Fe-4S ferredoxin-type protein 
HP17_05085 Guanosine pentaphosphate phosphohydrolase 
HP17_05090 Lipopolysaccharide heptosyltransferase-1 
HP17_05095 Lipid A biosynthesis lauroyl acyltransferase 
HP17_05100 Tgt queuine tRNA-ribosyltransferase 
HP17_05115 AroB 3-dehydroquinate synthase 
HP17_05120 hypothetical protein 
HP17_05125 hypothetical protein 
HP17_05130 Cell division protein FtsH; signal peptide 
HP17_05135 Hypothetical protein 
HP17_05140 Hypothetical protein 
HP17_05165 Chorismate mutase 
HP17_05180 AmiE acylamide amidohydrolase 
HP17_05185 FlgL flagellar hook-associated protein FlgL 
HP17_05190 RplU 50S ribosomal protein L21 
HP17_05195 RpmA 50S ribosomal protein L27 
HP17_05200 Peptide ABC transporter substrate-binding protein 
HP17_05205 Peptide ABC transporter permease 
HP17_05230 ObgE GTPase CgtA 
HP17_05240 Hypothetical protein 
HP17_05245 Glutamate-1-semialdehyde aminotransferase 
HP17_05250 Hypothetical protein 
HP17_05255 Hypothetical protein 
HP17_05260 Putative N-carbamoyl-D-amino acid amidohydrolase 
HP17_05285 Hypothetical protein 
HP17_05290 Conserved ATP/GTP binding protein 
HP17_05315 Hypothetical protein 
HP17_05320 AspA aspartate ammonia-lyase 
HP17_05325 UDP-N-acetylglucosamine 1- carboxyvinyltransferase 
HP17_05330 Hypothetical protein 
HP17_05335 UTP--glucose-1-phosphate uridylyltransferase subunit 
HP17_05340 Soluble lytic murein transglycosylase 
HP17_05350 Glutamylglutaminyl-tRNA synthetase 
HP17_05370 Polynucleotide adenylyltransferase; poly(A) polymerase 
HP17_05390 Hypothetical protein 
HP17_05400 Hypothetical protein 
HP17_05405 Quinone-reactive Ni/Fe hydrogenase (hydD) 
HP17_05410 Ni/Fe-hydrogenase, b-type cytochrome subunit 
HP17_05415 Nickel-dependent hydrogenase, large subunit 
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HP17_05425 Hydrogenase (NiFe) small subunit HydA 
HP17_05445 Cysteine-rich protein F 977146:978204 reverse 
HP17_05450 Tetrahydrodipicolinate N-succinyltransferase 
HP17_05455 IspG 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase 
HP17_05460 Hypothetical protein 
HP17_05465 MurC UDP-N-acetylmuramate--L-alanine ligase 
HP17_05470 Hypothetical protein 
HP17_05480 Inorganic pyrophosphatase 
HP17_05495 Adk adenylate kinase 
HP17_05500 AspS aspartyl-tRNA synthetase 
HP17_05505 Chemotaxis protein (cheV) 
HP17_05510 LigA NAD-dependent DNA ligase LigA 
HP17_05515 Hypothetical protein 
HP17_05550 Hypothetical protein 
HP17_05560 Membrane fusion protein (mtrC) 
HP17_05565 Outer-membrane protein of the hefABC efflux system 
HP17_05570 HemE uroporphyrinogen decarboxylase  
HP17_05590 3-methyladenine DNA glycosylase 
HP17_05595 Flagellin A 1013546:1015003 reverse 
HP17_05610 Methyl-accepting chemotaxis transmembrane sensory protein 
HP17_05615 8-amino-7-oxononanoate synthase 
HP17_05625 Tumor necrosis factor alpha-inducing protein 
HP17_05635 Dsbb-like protein 
HP17_05640 Hypothetical protein 
HP17_05660 OorB 2-oxoglutarate-acceptor oxidoreductase subunit OorB 
HP17_05670 OorD 2-oxoglutarate-acceptor oxidoreductase subunit OorD 
HP17_05675 Aminodeoxychorismate lyase (pabC) 
HP17_05680 Hypothetical protein 
HP17_05690 Endonuclease III 
HP17_05695 Flagellar motor switch protein 
HP17_05715 Dihydroorotase 
HP17_05720 Hypothetical protein 
HP17_05725 Hypothetical protein 
HP17_05735 Bifunctional 5,10-methylene-tetrahydrofolate dehydrogenase 
HP17_05740 Signal peptidase I (lepB) 
HP17_05745 Hypothetical protein 
HP17_05750 Ribose-5-phosphate isomerase B 
HP17_05755 Hypothetical protein 
HP17_05760 Adenine phosphoribosyltransferase 
HP17_05765 Hypothetical protein 
HP17_05770 Multifunctional aminopeptidase A 
HP17_05775 GTP-binding protein YchF 
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HP17_05780 Hypothetical protein 
HP17_05790 DapF diaminopimelate epimerase 
HP17_05795 Hypothetical protein 
HP17_05800 Hypothetical protein 
HP17_05805 Hypothetical protein 
HP17_05810 RpsU 30S ribosomal protein S21 
HP17_05815 FabG 3-ketoacyl-(acyl-carrier-protein) reductase 
HP17_05820 AcpP acyl carrier protein 
HP17_05830 3-oxoacyl-(acyl carrier protein) synthase II 
HP17_05865 RNA methyltransferase 
HP17_05875 RpmE 50S ribosomal protein L31 
HP17_05880 Rho transcription termination factor Rho 
HP17_05885 Glutamate racemase 
HP17_05990 Hypothetical protein 
HP17_05995 Bifunctional phosphopantothenoylcysteine decarboxylase 
HP17_06010 Hypothetical protein 
HP17_06015 Hypothetical protein 
HP17_06025 DNA-binding protein HU 
HP17_06035 Hypothetical protein 
HP17_06040 SpeE spermidine synthase 
HP17_06045 CoaE dephospho-CoA kinase 
HP17_06057 GatA aspartyl/glutamyl-tRNA amidotransferase subunit A 
HP17_06062 Inosine 5'-monophosphate dehydrogenase 
HP17_06067 F0F1 ATP synthase subunit A 
HP17_06152 Phosphoserine phosphatase 
HP17_06157 Ferritin 
HP17_06162 Hypothetical protein 
HP17_06177 Hypothetical protein 
HP17_06182 Processing zinc-metalloprotease 
HP17_06187 GatB aspartyl/glutamyl-tRNA amidotransferase subunit B 
HP17_06207 RnhA ribonuclease H 
HP17_06212 Rnc ribonuclease III 
HP17_06217 Chorismate synthase 
HP17_06222 Hypothetical protein 
HP17_06227 Coproporphyrinogen III oxidase 
HP17_06232 Glycerol-3-phosphate dehydrogenase 
HP17_06247 Outer membrane protein 
HP17_06252 Aspartate aminotransferase 
HP17_06262 Phage integrase family site specific recombinase 
HP17_06267 Methylated-DNA--protein-cysteine methyltransferase 
HP17_06282 Oxidoreductase 
HP17_06287 Ribonucleotide-diphosphate reductase subunit 
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HP17_06312 GlmU bifunctional N-acetylglucosamine-1-phosphate 
uridyltransferase/glucosamine-1-phosphate acetyltransferase 
HP17_06337 Hypothetical protein 
HP17_06357 Acetyl-CoA acetyltransferase 
HP17_06362 Succinyl-CoA-transferase subunit A 
HP17_06387 Outer membrane protein 
HP17_06407 Acetone carboxylase subunit alpha 
HP17_06412 Hypothetical protein 
HP17_06417 Hypothetical protein 
HP17_06422 Diacylglycerol kinase 
HP17_06437 DNA gyrase subunit A 
HP17_06442 Hypothetical protein 
HP17_06472 Outer membrane protein HopE 
HP17_06482 16S rRNA m(4)C1402 methyltranserfase 
HP17_06487 Hypothetical protein 
HP17_06492 Hypothetical protein 
HP17_06507 Hypothetical protein 
HP17_06522 RNA polymerase factor sigma-54 1186162:1187406 
HP17_06527 ABC-type transport system, ATP binding protein 
HP17_06562 Hypothetical protein 
HP17_06597 LysS lysyl-tRNA synthetase 
HP17_06602 Serine hydroxymethyltransferase 
HP17_06607 Hypothetical protein 
HP17_06612 Hypothetical protein 
HP17_06627 Hypothetical protein 
HP17_06637 FrdB fumarate reductase iron-sulfur subunit 
HP17_06642 Fumarate reductase flavoprotein subunit 
HP17_06647 Fumarate reductase cytochrome b-556 subunit 
HP17_06652 TpiA triosephosphate isomerase 
HP17_06657 Enoyl-(acyl carrier protein) reductase 
HP17_06662 LpxD UDP-3-O-[3-hydroxymyristoyl] glucosamine N- acyltransferase 
HP17_06667 S-adenosylmethionine synthetase 
HP17_06677 Ndk mulitfunctional nucleoside diphosphate kinase/apyrimidinic 
endonuclease/3'-phosphodiesterase 
HP17_06682 Hypothetical protein 
HP17_06697 3-oxoacyl-(acyl carrier protein) synthase III 
HP17_06702 Hypothetical protein 
HP17_06707 Hypothetical protein 
HP17_06722 ATP-binding protein (mpr) 
HP17_06737 Outer membrane protein 
HP17_06742 Heat shock protein 90 
HP17_06747 Cysteine-rich protein A 
HP17_06752 Succinyl-diaminopimelate desuccinylase 
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HP17_06762 Sodium-dependent transporter (huNaDC-1) 
HP17_06772 1-deoxy-D-xylulose 5-phosphate reductoisomerase 
HP17_06782 Hypothetical protein 
HP17_06787 Hypothetical protein 
HP17_06792 Cysteine desulfurase 
HP17_06797 NifU-like protein 
HP17_06812 DNA repair protein RadA 
HP17_06817 Bifunctional methionine sulfoxide reductase A/B protein 
HP17_06832 Hypothetical protein 
HP17_06882 Prephenate dehydrogenase 
HP17_06887 ATP-dependent protease L 
HP17_06902 Flagellar assembly protein FliW 
HP17_06907 FabZ (3R)-hydroxymyristoyl-ACP dehydratase 
HP17_06912 UDP-N-acetylglucosamine acyltransferase 
HP17_06917 ClpX ATP-dependent protease ATP-binding subunit ClpX 
HP17_06922 Rod shape-determining protein MreB 
HP17_06932 Rod shape-determining protein MreC 
HP17_06967 Replicative DNA helicase 
HP17_06977 UbiA prenyltransferase 
HP17_06992 Hypothetical protein 
HP17_06997 Phosphatidylserine decarboxylase 
HP17_07002 Quinolinate synthetase 
HP17_07007 Nicotinate-nucleotide pyrophosphorylase 
HP17_07042 Carboxyl-terminal protease 
HP17_07047 Hypothetical protein 
HP17_07052 1-acyl-sn-glycerol-3-phosphate acyltransferase 
HP17_07057 Uracil-DNA glycosylase 
HP17_07067 Glyceraldehyde-3-phosphate dehydrogenase 
HP17_07072 Pgk phosphoglycerate kinase 
HP17_07077 Magnesium and cobalt transport protein 
HP17_07082 Hypothetical protein 
HP17_07129 Outer membrane protein HofD; signal peptide 
HP17_07134 Outer membrane protein HofC 
HP17_07169 GTP-binding protein TypA 
HP17_07214 Arginine decarboxylase 
HP17_07219 Polysaccharide biosynthesis protein 
HP17_07229 Hypothetical protein 
HP17_07239 Hypothetical protein 
HP17_07249 Cyclopropane fatty acid synthase 
HP17_07259 Hypothetical protein 
HP17_07264 Putative neuraminyllactose-binding hemagglutinin- like protein 
HP17_07274 GuaA GMP synthase 
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HP17_07279 Hypothetical protein 
HP17_07289 Hypothetical protein 
HP17_07294 Cysteine desulfurase  
HP17_07304 PheS phenylalanyl-tRNA synthetase subunit alpha 
HP17_07322 PheT phenylalanyl-tRNA synthetase subunit beta 
HP17_07327 3-phosphoshikimate 1-carboxyvinyltransferase 
HP17_07332 IspH 4-hydroxy-3-methylbut-2-enyl diphosphate reductase 
HP17_07337 RpsA 30S ribosomal protein S1 
HP17_07342 Hypothetical protein  
HP17_07347 D-3-phosphoglycerate dehydrogenase 
HP17_07352 3-octaprenyl-4-hydroxybenzoate carboxy-lyase 
HP17_07357 Hypothetical protein 
HP17_07367 CheA-MCP interaction modulator 
HP17_07372 Autophosphorylating histidine kinase 
HP17_07377 Purine-binding chemotaxis protein CheW 
HP17_07382 Adhesin-thiol peroxidase 
HP17_07392 Hypothetical protein 
HP17_07402 Hypothetical protein 
HP17_07407 Hypothetical protein 
HP17_07412 Hypothetical protein 
HP17_07417 Hypothetical protein 
HP17_07432 N5-glutamine S-adenosyl-L-methionine-dependent 
methyltransferase 
HP17_07447 Putative potassium channel protein 
HP17_07457 Flagellar sheath adhesin 
HP17_07462 MraY phospho-N-acetylmuramoyl-pentapeptide- transferase 
HP17_07477 Hypothetical protein 
HP17_07502 DNA polymerase III subunit beta 
HP17_07507 GyrB DNA gyrase subunit B 
HP17_07532 Hypothetical protein 
HP17_07537 UDP-sugar diphosphatase 
HP17_07557 Dihydrodipicolinate reductase 
HP17_07572 Glutamine synthetase 
HP17_07587 RplI 50S ribosomal protein L9 
HP17_07592 ATP-dependent protease subunit HslV 
HP17_07602 Era GTPase Era 
HP17_07607 Hypothetical protein 
HP17_07722 KsgA 16S ribosomal RNA methyltransferase KsgA/Dim1 family 
protein 
HP17_07727 Ribonuclease J 
HP17_07732 Polysialic acid capsule expression protein 
HP17_07737 Ribosomal RNA large subunit methyltransferase N 
HP17_07747 Hypothetical protein 
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HP17_07762 Type IV secretion system ATPase 
HP17_07772 FliQ flagellar biosynthesis protein FliQ 
HP17_07777 MurB UDP-N-acetylenolpyruvoylglucosamine reductase 
HP17_07807 7-cyano-7-deazaguanine reductase 
HP17_07842 Hypothetical protein 
HP17_07847 Putative nucleotide phosphoribosyltransferase 
HP17_07852 Putative aminotransferase 
HP17_07857 Phosphatidyl glycerophosphatase A 
HP17_07867 2-hydroxy-6-oxohepta-2,4-dienoate hydrolase 
HP17_07872 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D- alanine ligase; 
putative membrane protein 
HP17_07877 Hypothetical protein 
HP17_07882 Ribose-phosphate pyrophosphokinase 
HP17_07902 Hypothetical protein 
HP17_07907 Hypothetical protein 
HP17_07912 tRNA (guanine-N(7)-)-methyltransferase 1 2 
HP17_07917 Cell division protein 
HP17_07927 Hypothetical protein 
HP17_07932 Flagellar protein FlaG 
HP17_07937 FliD flagellar capping protein 
HP17_07942 FliS flagellar protein FliS  
HP17_07947 Hypothetical protein 
HP17_07952 Molybdopterin biosynthesis protein 
HP17_07962 Carbon-nitrogen hydrolase  
HP17_07967 Hypothetical protein 
HP17_07972 Hypothetical protein 
HP17_07987 Hypothetical protein 
HP17_07992 Signal recognition particle-docking protein FtsY 
HP17_08049 2-nitropropane dioxygenase 
HP17_08054 Tyrosyl-tRNA synthetase 
HP17_08059 Guanosine-3', 5'-bis(diphosphate)3'- pyrophosphohydrolase 
/Guanosine-3',5'-Bis(diphosphate) synthetase II (ppGpp-3'-
pyrophosphohydrolase/ppGpp synthetase II)  
HP17_08064 RpoZ DNA-directed RNA polymerase subunit omega 
HP17_08069 PyrH uridylate kinase 
HP17_08074 Hypothetical protein 
HP17_08104 Hypothetical protein 
HP17_08109 LolA lipoprotein chaperone 
HP17_08114 Preprotein translocase subunit SecA 
HP17_08119 Hypothetical protein 
HP17_08124 Hypothetical protein  
HP17_08164 Glucose/galactose transporter 
HP17_08169 Hypothetical protein  
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HP17_08174 Glutamine ABC transporter periplasmic glutamine- binding 
protein  
HP17_08179 Phosphate ABC transporter ATP-binding protein 
HP17_08184 Glutamine ABC transporter, permease protein 
HP17_08189 Glutamine ABC transporter permease 
HP17_08199 Outer membrane protein HofH 
HP17_08219 Thioredoxin reductase 
HP17_08224 Cation transport subunit for cbb3-type oxidase 
HP17_08229 Hypothetical protein 
HP17_08234 Flavodoxin FldA 
HP17_08239 Metal-binding heat shock protein 
HP17_08249 Pyrroline-5-carboxylate reductase 
HP17_08264 Outer membrane protein HopI 
HP17_08269 MurG undecaprenyldiphospho-muramoylpentapeptide beta- N- 
acetylglucosaminyltransferase 
HP17_08274 Flagellar assembly protein FliW 
HP17_08279 ValS valyl-tRNA synthetase 
HP17_08284 Signal recognition particle protein 
HP17_08289 RpsP 30S ribosomal protein S16 
HP17_08294 Hypothetical protein 
HP17_08299 RimM 16S rRNA-processing protein RimM 
HP17_08304 TrmD tRNA (guanine-N(1)-)-methyltransferase 
HP17_08309 RplS 50S ribosomal protein L19 
HP17_08334 Peptidyl-prolyl cis-trans isomerase C 
HP17_08339 Fructose-bisphosphate aldolase 
HP17_08344 Elongation factor P 
HP17_08384 Sialic acid synthase 
HP17_08389 ABC transporter 
HP17_08394 Apolipoprotein N-acyltransferase 
HP17_08404 Hypothetical protein 
HP17_08419 Hypothetical protein 
HP17_08521 Cadmium, zinc and cobalt-transporting ATPase 
HP17_08536 Mg chelatase-related protein; ComM protein 
HP17_08541 Def peptide deformylase 
HP17_08546 ClpP ATP-dependent Clp protease proteolytic subunit 
HP17_08551 Tig trigger factor 
HP17_08556 Outer membrane protein HorG 
HP17_08561 Neuraminyllactose-binding hemagglutinin HpaA 
HP17_08566 MoaC molybdenum cofactor biosynthesis protein MoaC 
HP17_08576 Molybdopterin converting factor, subunit  
HP17_08586 RibA GTP cyclohydrolase II 
HP17_08606 Bifunctional 3,4-dihydroxy-2-butanone 4- phosphate 
synthase/GTP cyclohydrolase II protein 
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HP17_08611 Lipooligosaccharide 5G8 epitope biosynthesis- associated protein 
HP17_08621 Thioredoxin 
HP17_08626 Hypothetical protein 
HP17_08631 Homoserine dehydrogenase 
HP17_08636 UvrC excinuclease ABC subunit C 
HP17_08641 Hypothetical protein 
HP17_08661 Hypothetical protein 
HP17_08666 MotB flagellar motor protein MotB 
HP17_08671 Flagellar motor protein MotA 
HP17_08676 Thiamin biosynthesis protein (thiF) 
HP17_08681 Hydrolase 
HP17_08686 Hypothetical protein 
HP17_08691 Hypothetical protein 
HP17_08701 FliL flagellar basal body-associated protein FliL 
HP17_08706 AcpS 4'-phosphopantetheinyl transferase  
HP17_08716 Hydrolase 
HP17_08726 Hypothetical protein  
HP17_08731 rRNA large subunit methyltransferase  
HP17_08736 Acetyl-CoA carboxylase subunit beta 
HP17_08741 Putative recombination protein RecO  
HP17_08746 Putative competence/damage-inducible protein CinA  
HP17_08751 Hypothetical protein 
HP17_08761 Prolipoprotein diacylglyceryl transferase 
HP17_08766 Hypothetical protein 
HP17_08781 Hypothetical protein 
HP17_08786 GlyQ glycyl-tRNA synthetase subunit alpha 
*17874 annotation. 
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Appendix 7 List of “disease core”-specific genes* 
Locus tag Product 
HP0018 Hypothetical protein 
HP0026 Type II citrate synthase 
HP0048 Transcriptional regulator (hypF) 
HP0069 Urease accessory protein UreF 
HP0070 Urease accessory protein UreE 
HP0072 Urease subunit beta 
HP0092 Type II restriction enzyme M protein (hsdM) 
HP0116 DNA topoisomerase I 
HP0135 Hypothetical protein 
HP0138 Iron-sulfur protein 
HP0141 L-lactate permease (lctP) 
HP0150 Hypothetical protein 
HP0153 Recombinase A 
HP0200 50S ribosomal protein L32 
HP0213 tRNA uridine 5-carboxymethylaminomethyl modification enzyme GidA 
HP0215 CDP-diglyceride synthetase (cdsA) 
HP0228 Hypothetical protein 
HP0229 Hypothetical protein 
HP0282 Hypothetical protein 
HP0290 Diaminopimelate decarboxylase 
HP0320 Hypothetical protein 
HP0351 Flagellar MS-ring protein 
HP0380 Glutamate dehydrogenase 
HP0471 Glutathione-regulated potassium-efflux system protein (kefB) 
HP0498 Sodium- and chloride-dependent transporter 
HP0509 Glycolate oxidase subunit (glcD) 
HP0555 Hypothetical protein 
HP0567 Hypothetical protein 
HP0582 Hypothetical protein 
HP0607 Acriflavine resistance protein (acrB) 
HP0610 Toxin-like outer membrane protein 
HP0655 Protective surface antigen D15 
HP0686 Iron(III) dicitrate transport protein (fecA) 
HP0705 Excinuclease ABC subunit A 
HP0717 DNA polymerase III subunits gamma and tau 
HP0718 Hypothetical protein 
HP0738 D-alanyl-alanine synthetase A 
HP0761 Hypothetical protein 
HP0779 Bifunctional aconitate hydratase 2/2-methylisocitrate dehydratase 
HP0781 Hypothetical protein 
HP0782 Hypothetical protein 
Appendices 
~ 232 ~ 
HP0818 Osmoprotection protein (proWX) 
HP0826 Lipooligosaccharide 5G8 epitope biosynthesis-associated protein (lex2B) 
HP0834 GTP-binding protein EngA 
HP0839 Outer membrane protein P1 (ompP1) 
HP0879 Hypothetical protein 
HP0887 Vacuolating cytotoxin 
HP0908 Flagellar hook protein FlgE 
HP0911 Rep helicase, single-stranded DNA-dependent ATPase (rep) 
HP1017 Amino acid permease 
HP1022 Hypothetical protein 
HP1023 Hypothetical protein 
HP1039 Hypothetical protein 
HP1054 Hypothetical protein 
HP1057 Hypothetical protein 
HP1073 Copper ion binding protein (copP) 
HP1083 Hypothetical protein 
HP1106 Hypothetical protein 
HP1157 Hypothetical protein 
HP1159 Cell filamentation protein (fic) 
HP1166 Glucose-6-phosphate isomerase 
HP1168 Carbon starvation protein (cstA) 
HP1179 Phosphopentomutase 
HP1190 Histidyl-tRNA synthetase 
HP1222 D-lactate dehydrogenase (dld) 
HP1232 Dihydropteroate synthase (folP) 
HP1272 NADH dehydrogenase subunit M 
HP1275 Phosphomannomutase 
HP1286 Hypothetical protein 
HP1337 Hypothetical protein 
HP1359 Hypothetical protein 
HP1414 Hypothetical protein 
HP1416 Lipopolysaccharide 1,2-glucosyltransferase (rfaJ) 
HP1422 Isoleucyl-tRNA synthetase 
HP1460 DNA polymerase III subunit alpha 
HP1465 ABC transporter ATP-binding protein 
HP1502 Hypothetical protein 
HP1503 Cation-transporting ATPase, P-type (copA) 
HP1584 DNA-binding/iron metalloprotein/AP endonuclease 
*26695 annotation. 
Appendices 
~ 233 ~ 
Appendix 8 List of “gastritis core”-specific genes* 
Locus tag Product 
HP0002 6,7-dimethyl-8-ribityllumazine synthase 
HP0004 Carbonic anhydrase (icfA) 
HP0013 Hypothetical protein 
HP0018 Hypothetical protein 
HP0025 Hypothetical protein 
HP0026 Type II citrate synthase 
HP0028 Hypothetical protein 
HP0034 Aspartate alpha-decarboxylase 
HP0035 Hypothetical protein 
HP0037 NADH-ubiquinone oxidoreductase subunit 
HP0048 Transcriptional regulator (hypF) 
HP0050 Adenine-specific DNA methyltransferase 
HP0051 Cytosine specific DNA methyltransferase (DDEM) 
HP0064 Hypothetical protein 
HP0065 Hypothetical protein 
HP0069 Urease accessory protein UreF 
HP0070 Urease accessory protein UreE 
HP0072 Urease subunit beta 
HP0079 Hypothetical protein 
HP0082 Methyl-accepting chemotaxis transducer (tlpC) 
HP0092 Type II restriction enzyme M protein (hsdM) 
HP0098 Threonine synthase 
HP0101 Hypothetical protein 
HP0103 Methyl-accepting chemotaxis protein (tlpB) 
HP0107 Cysteine synthetase (cysK) 
HP0111 Heat-inducible transcription repressor 
HP0116 DNA topoisomerase I 
HP0135 Hypothetical protein 
HP0138 Iron-sulfur protein 
HP0141 L-lactate permease (lctP) 
HP0142 DNA glycosylase MutY 
HP0150 Hypothetical protein 
HP0151 Hypothetical protein 
HP0153 Recombinase A 
HP0154 Phosphopyruvate hydratase 
HP0159 Lipopolysaccharide 1,2-glucosyltransferase (rfaJ) 
HP0168 Hypothetical protein 
HP0172 Molybdopterin biosynthesis protein (moeA) 
HP0200 50S ribosomal protein L32 
HP0201 Glycerol-3-phosphate acyltransferase PlsX 
HP0213 tRNA uridine 5-carboxymethylaminomethyl modification enzyme GidA 
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HP0215 CDP-diglyceride synthetase (cdsA) 
HP0222 Hypothetical protein 
HP0228 Hypothetical protein 
HP0229 Hypothetical protein 
HP0233 Hypothetical protein 
HP0248 Hypothetical protein 
HP0252 Hypothetical protein 
HP0263 Adenine-specific DNA methyltransferase 
HP0265 Cytochrome c biogenesis protein (ccdA) 
HP0282 Hypothetical protein 
HP0290 Diaminopimelate decarboxylase 
HP0292 Hypothetical protein 
HP0293 Para-aminobenzoate synthetase (pabB) 
HP0300 Dipeptide ABC transporter permease (dppC) 
HP0302 Dipeptide ABC transporter ATP-binding protein (dppF) 
HP0304 Hypothetical protein 
HP0320 Hypothetical protein 
HP0322 Poly E-rich protein 
HP0326 CMP-N-acetylneuraminic acid synthetase 
HP0337 Hypothetical protein 
HP0347 Hypothetical protein 
HP0351 Flagellar MS-ring protein 
HP0367 Hypothetical protein 
HP0369 Hypothetical protein 
HP0371 Biotin carboxyl carrier protein (fabE) 
HP0373 Hypothetical protein 
HP0376 Ferrochelatase 
HP0380 Glutamate dehydrogenase 
HP0389 Iron-dependent superoxide dismutase 
HP0404 Protein kinase C inhibitor (SP:P16436) 
HP0407 Biotin sulfoxide reductase (bisC) 
HP0463 Type I restriction enzyme M protein (hsdM) 
HP0471 Glutathione-regulated potassium-efflux system protein (kefB) 
HP0473 
Molybdenum ABC transporter periplasmic molybdate-binding protein 
(modA) 
HP0474 Molybdenum ABC transporter permease (modB) 
HP0475 Molybdenum ABC transporter ATP-binding protein (modD) 
HP0482 Hypothetical protein 
HP0485 Catalase-like protein 
HP0491 50S ribosomal protein L28 
HP0497 Sodium- and chloride-dependent transporter 
HP0498 Sodium- and chloride-dependent transporter 
HP0509 Glycolate oxidase subunit (glcD) 
HP0516 ATP-dependent protease ATP-binding subunit HslU 
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HP0520 Cag pathogenicity island protein (cag1) 
HP0522 Cag pathogenicity island protein (cag3) 
HP0523 Cag pathogenicity island protein (cag4) 
HP0525 VirB11-like protein 
HP0526 Cag pathogenicity island protein (cag6) 
HP0527 Cag pathogenicity island protein (cag7) 
HP0528 Cag pathogenicity island protein (cag8) 
HP0529 Cag pathogenicity island protein (cag9) 
HP0530 Cag pathogenicity island protein (cag10) 
HP0531 Cag pathogenicity island protein (cag11) 
HP0532 Cag pathogenicity island protein (cag12) 
HP0534 Cag pathogenicity island protein (cag13) 
HP0537 Cag pathogenicity island protein (cag16) 
HP0538 Cag pathogenicity island protein (cag17) 
HP0539 Cag pathogenicity island protein (cag18) 
HP0540 Cag pathogenicity island protein (cag19) 
HP0541 Cag pathogenicity island protein (cag20) 
HP0542 Cag pathogenicity island protein (cag21) 
HP0543 Cag pathogenicity island protein (cag22) 
HP0545 Cag pathogenicity island protein (cag24) 
HP0546 Cag pathogenicity island protein (cag25) 
HP0547 Cag pathogenicity island protein (cag26) 
HP0552 Hypothetical protein 
HP0554 Hypothetical protein 
HP0555 Hypothetical protein 
HP0557 Acetyl-CoA carboxylase carboxyltransferase subunit alpha 
HP0567 Hypothetical protein 
HP0578 Hypothetical protein 
HP0582 Hypothetical protein 
HP0583 Hypothetical protein 
HP0589 2-oxoglutarate-acceptor oxidoreductase subunit OorA 
HP0591 2-oxoglutarate-acceptor oxidoreductase subunit OorC 
HP0597 Penicillin-binding protein 1A (PBP-1A) 
HP0607 Acriflavine resistance protein (acrB) 
HP0610 Toxin-like outer membrane protein 
HP0611 Hypothetical protein 
HP0613 ABC transporter ATP-binding protein 
HP0621 Recombination and DNA strand exchange inhibitor protein 
HP0629 Hypothetical protein 
HP0630 Modulator of drug activity (mda66) 
HP0636 Hypothetical protein 
HP0639 Hypothetical protein 
HP0644 Hypothetical protein 
HP0655 Protective surface antigen D15 
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HP0659 Hypothetical protein 
HP0660 Hypothetical protein 
HP0685 Flagellar biosynthesis protein FliP 
HP0686 Iron(III) dicitrate transport protein (fecA) 
HP0687 Iron(II) transport protein (feoB) 
HP0692 3-oxoadipate CoA-transferase subunit B 
HP0693 Short-chain fatty acids transporter 
HP0695 Hydantoin utilization protein A (hyuA) 
HP0703 Response regulator 
HP0705 Excinuclease ABC subunit A 
HP0717 DNA polymerase III subunits gamma and tau 
HP0718 Hypothetical protein 
HP0719 Hypothetical protein 
HP0723 L-asparaginase II 
HP0724 Anaerobic C4-dicarboxylate transporter 
HP0728 Hypothetical protein 
HP0729 Hypothetical protein 
HP0738 D-alanyl-alanine synthetase A 
HP0749 Cell division membrane protein (ftsX) 
HP0760 Phosphodiesterase 
HP0761 Hypothetical protein 
HP0764 Hypothetical protein 
HP0769 Molybdopterin-guanine dinucleotide biosynthesis protein A 
HP0771 Hypothetical protein 
HP0772 N-acetylmuramoyl-L-alanine amidase 
HP0779 Bifunctional aconitate hydratase 2/2-methylisocitrate dehydratase 
HP0781 Hypothetical protein 
HP0782 Hypothetical protein 
HP0799 Molybdenum cofactor biosynthesis protein MogA 
HP0801 Molybdopterin converting factor, subunit 1 (moaD) 
HP0810 Hypothetical protein 
HP0818 Osmoprotection protein (proWX) 
HP0819 Osmoprotection protein (proV) 
HP0825 Thioredoxin reductase 
HP0826 Lipooligosaccharide 5G8 epitope biosynthesis-associated protein (lex2B) 
HP0827 ss-DNA binding protein 12RNP2 precursor 
HP0834 GTP-binding protein EngA 
HP0839 Outer membrane protein P1 (ompP1) 
HP0840 FlaA1 protein 
HP0843 Thiamine-phosphate pyrophosphorylase 
HP0844 Thiamine biosynthesis protein (thi) 
HP0845 Hydroxyethylthiazole kinase 
HP0846 Type I restriction enzyme R protein (hsdR) 
HP0852 Hypothetical protein 
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HP0870 Flagellar hook protein FlgE 
HP0879 Hypothetical protein 
HP0887 Vacuolating cytotoxin 
HP0898 Hydrogenase expression/formation protein (hypD) 
HP0899 Hydrogenase expression/formation protein (hypC) 
HP0900 Hydrogenase expression/formation protein (hypB) 
HP0906 Hypothetical protein 
HP0908 Flagellar hook protein FlgE 
HP0910 Adenine-specific DNA methyltransferase 
HP0911 Rep helicase, single-stranded DNA-dependent ATPase (rep) 
HP0915 Iron-regulated outer membrane protein (frpB) 
HP0919 Carbamoyl phosphate synthase large subunit 
HP0926 tRNA pseudouridine synthase D 
HP0957 3-deoxy-D-manno-octulosonic-acid transferase 
HP0958 Hypothetical protein 
HP0961 NAD(P)H-dependent glycerol-3-phosphate dehydrogenase 
HP0969 Cation efflux system protein (czcA) 
HP0970 Nickel-cobalt-cadmium resistance protein (nccB) 
HP1017 Amino acid permease 
HP1022 Hypothetical protein 
HP1023 Hypothetical protein 
HP1024 Co-chaperone-curved DNA binding protein A (CbpA) 
HP1039 Hypothetical protein 
HP1054 Hypothetical protein 
HP1057 Hypothetical protein 
HP1067 Chemotaxis protein (cheY) 
HP1072 Copper-transporting ATPase, P-type (copA) 
HP1073 Copper ion binding protein (copP) 
HP1082 Multidrug resistance protein (msbA) 
HP1083 Hypothetical protein 
HP1086 Hemolysin (tly) 
HP1090 DNA translocase FtsK 
HP1104 Cinnamyl-alcohol dehydrogenase ELI3-2 (cad) 
HP1106 Hypothetical protein 
HP1113 Hypothetical protein 
HP1127 Hypothetical protein 
HP1139 SpoOJ regulator (soj) 
HP1157 Hypothetical protein 
HP1159 Cell filamentation protein (fic) 
HP1166 Glucose-6-phosphate isomerase 
HP1168 Carbon starvation protein (cstA) 
HP1175 Hypothetical protein 
HP1177 Hypothetical protein 
HP1179 Phosphopentomutase 
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HP1190 Histidyl-tRNA synthetase 
HP1192 Secreted protein involved in flagellar motility 
HP1220 ABC transporter ATP-binding protein 
HP1222 D-lactate dehydrogenase (dld) 
HP1231 DNA polymerase III subunit delta' 
HP1232 Dihydropteroate synthase (folP) 
HP1238 Formamidase 
HP1244 30S ribosomal protein S18 
HP1245 Single-stranded DNA-binding protein 
HP1246 30S ribosomal protein S6 
HP1249 Shikimate 5-dehydrogenase 
HP1250 Hypothetical protein 
HP1252 
Oligopeptide ABC transporter periplasmic oligopeptide-binding protein 
(oppA) 
HP1259 Hypothetical protein 
HP1263 NADH dehydrogenase subunit D 
HP1265 Hypothetical protein 
HP1266 NADH dehydrogenase subunit G 
HP1272 NADH dehydrogenase subunit M 
HP1274 Paralysed flagella protein (pflA) 
HP1275 Phosphomannomutase 
HP1279 
bifunctional indole-3-glycerol phosphate 
synthase/phosphoribosylanthranilate Isomerase 
HP1286 Hypothetical protein 
HP1291 Hypothetical protein 
HP1308 50S ribosomal protein L24 
HP1329 Cation efflux system protein (czcA) 
HP1337 Hypothetical protein 
HP1339 Biopolymer transport protein (exbB) 
HP1340 Biopolymer transport protein (exbD) 
HP1341 Siderophore-mediated iron transport protein (tonB) 
HP1359 Hypothetical protein 
HP1363 Hypothetical protein 
HP1364 Histidine kinase sensor protein 
HP1365 Response regulator 
HP1371 Type III restriction enzyme R protein 
HP1378 Competence lipoprotein (comL) 
HP1382 Hypothetical protein 
HP1387 DNA polymerase III subunit epsilon 
HP1393 DNA repair protein (recN) 
HP1400 Iron(III) dicitrate transport protein (fecA) 
HP1406 Biotin synthase 
HP1407 Ribonuclease N 
HP1414 Hypothetical protein 
HP1416 Lipopolysaccharide 1,2-glucosyltransferase (rfaJ) 
Appendices 
~ 239 ~ 
HP1420 Flagellum-specific ATP synthase 
HP1422 Isoleucyl-tRNA synthetase 
HP1423 Hypothetical protein 
HP1434 Formyltetrahydrofolate hydrolase (purU) 
HP1435 Endopeptidase IV 
HP1436 Hypothetical protein 
HP1439 Hypothetical protein 
HP1445 Biopolymer transport protein (exbB) 
HP1446 Biopolymer transport protein (exbD) 
HP1447 50S ribosomal protein L34 
HP1448 Ribonuclease P, protein component (rnpA) 
HP1451 Hypothetical protein 
HP1453 Hypothetical protein 
HP1460 DNA polymerase III subunit alpha 
HP1462 Secreted protein involved in flagellar motility 
HP1465 ABC transporter ATP-binding protein 
HP1491 Phosphate permease 
HP1502 Hypothetical protein 
HP1503 Cation-transporting ATPase, P-type (copA) 
HP1517 Type IIS restriction enzyme R and M protein (ECO57IR) 
HP1529 Chromosome replication initiator DnaA 
HP1533 FAD-dependent thymidylate synthase 
HP1542 Hypothetical protein 
HP1560 Cell division protein (ftsW) 
HP1575 ABC transporter 
HP1576 DL-methionine transporter ATP-binding subunit 
HP1577 ABC transporter permease (yaeE) 
HP1581 Methicillin resistance protein (llm) 
HP1584 DNA-binding/iron metalloprotein/AP endonuclease 
*26695 annotation. 
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Appendix 9 List of “duodenal ulcer core”-specific genes* 
Locus tag Product 
jhp0004 Carbonic anhydrase 
jhp0016 Hypothetical protein 
jhp0021 Hypothetical protein 
jhp0022 Type II citrate synthase 
jhp0026 Hypothetical protein 
jhp0030 Aspartate alpha-decarboxylase 
jhp0031 Hypothetical protein 
jhp0033 Hypothetical protein 
jhp0041 Transcriptional regulator 
jhp0043 Type II DNA modification enzyme 
jhp0044 Type II DNA modification enzyme 
jhp0064 Urease accessory protein 
jhp0065 Urease accessory protein UreE 
jhp0067 Urease subunit beta 
jhp0085 Type II DNA modification (methyltransferase) 
jhp0090 Threonine synthase 
jhp0091 Methyl-accepting chemotaxis protein (MCP) 
jhp0093 Hypothetical protein 
jhp0095 Methyl-accepting chemotaxis protein (MCP) 
jhp0099 Cysteine synthase 
jhp0103 Heat-inducible transcription repressor 
jhp0108 DNA topoisomerase I 
jhp0112 Hypothetical protein 
jhp0118 Hypothetical protein 
jhp0123 Hypothetical protein 
jhp0126 Iron-sulfur protein 
jhp0129 L-lactate permease 
jhp0130 DNA glycosylase MutY 
jhp0131 Hypothetical protein 
jhp0138 Hypothetical protein 
jhp0139 Hypothetical protein 
jhp0141 Recombinase A 
jhp0142 Phosphopyruvate hydratase 
jhp0147 Lipopolysaccharide biosynthesis protein 
jhp0151 Histidine kinase sensor protein 
jhp0154 Hypothetical protein 
jhp0176 Cardiolipin synthase 
jhp0186 50S ribosomal protein L32 
jhp0187 Glycerol-3-phosphate acyltransferase PlsX 
jhp0191 Hypothetical protein 
jhp0199 TRNA uridine 5-carboxymethylaminomethyl modification enzyme GidA 
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jhp0201 CDP-diacylglycerol synthase 
jhp0208 Hypothetical protein 
jhp0213 Hypothetical protein 
jhp0214 Outer membrane protein/porin 
jhp0218 Hypothetical protein 
jhp0237 Hypothetical protein 
jhp0241 Hypothetical protein 
jhp0244 Type II DNA modification (methyltransferase) 
jhp0245 Hypothetical protein 
jhp0246 Hypothetical protein 
jhp0248 Type II DNA modification (methyltransferase) 
jhp0250 Cytochrome C-type biogenesis protein 
jhp0267 Hypothetical protein 
jhp0275 Diaminopimelate decarboxylase 
jhp0277 Hypothetical protein 
jhp0278 P-aminobenzoate synthetase 
jhp0286 Peptide ABC transporter ATP-binding protein 
jhp0287 Peptide ABC transporter ATP-binding protein 
jhp0295 Hypothetical protein 
jhp0298 Hypothetical protein 
jhp0300 ABC transporter ATP-binding protein 
jhp0303 Hypothetical protein 
jhp0305 Poly E-rich protein 
jhp0310 Flagellar biosynthesis protein 
jhp0319 Hypothetical protein 
jhp0325 Flagellar MS-ring protein 
jhp0330 Hypothetical protein 
jhp0335 Septum formation protein 
jhp0336 Hypothetical protein 
jhp0339 Hemolysin 
jhp0342 Hypothetical protein 
jhp0343 Multi-drug resistance protein 
jhp0344 Hypothetical protein 
jhp0350 Hypothetical protein 
jhp0352 Copper-associated protein 
jhp0353 Copper-transporting P-type ATPase 
jhp0358 Response regulator 
jhp0361 Hypothetical protein 
jhp0368 Hypothetical protein 
jhp0371 Hypothetical protein 
jhp0376 Hypothetical protein 
jhp0377 Translation initiation factor IF-2 
jhp0385 Hypothetical protein 
jhp0400 Co-chaperone with DnaK 
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jhp0401 Hypothetical protein 
jhp0402 Hypothetical protein 
jhp0406 Amino acid permease 
jhp0415 Type I restriction enzyme modification subunit 
jhp0419 Hypothetical protein 
jhp0423 Glutathione-regulated potassium-efflux system protein 
jhp0425 Molybdate ABC transporter periplasmic-binding protein 
jhp0427 Molybdate ABC transporter ATP-binding protein 
jhp0430 Type II DNA modification (methyltransferase 
jhp0431 Hypothetical protein 
jhp0435 Type II DNA modification (methyltransferase 
jhp0437 Hypothetical protein 
jhp0443 50S ribosomal protein L28 
jhp0446 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate synthetase 
jhp0447 Hypothetical protein 
jhp0449 Transporter 
jhp0450 Transporter 
jhp0458 Hypothetical protein 
jhp0459 Glycolate oxidase 
jhp0462 Hypothetical protein 
jhp0465 ATP-dependent protease ATP-binding subunit HslU 
jhp0468 Hypothetical protein 
jhp0469 Cag island protein 
jhp0471 Cag island protein 
jhp0472 Cag island protein 
jhp0473 Cag island protein, DNA transfer protein 
jhp0474 Cag island protein, DNA transfer protein 
jhp0475 Cag island protein 
jhp0476 Cag island protein 
jhp0477 Cag island protein 
jhp0478 Cag island protein 
jhp0479 Cag island protein 
jhp0480 Cag island protein 
jhp0481 Cag island protein 
jhp0482 Cag island protein 
jhp0483 Cag island protein 
jhp0485 Cag island protein 
jhp0486 Cag island protein 
jhp0487 Cag island protein 
jhp0488 Cag island protein 
jhp0489 Cag island protein 
jhp0490 Cag island protein 
jhp0491 Cag island protein 
jhp0492 DNA transfer protein 
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jhp0493 Cag island protein 
jhp0494 Cag island protein 
jhp0495 Cag island protein, cytotoxicity associated immunodominant antigen 
jhp0499 Hypothetical protein 
jhp0502 Hypothetical protein 
jhp0503 Hypothetical protein 
jhp0504 Acetyl-CoA carboxylase carboxyltransferase subunit alpha 
jhp0514 Hypothetical protein 
jhp0525 Hypothetical protein 
jhp0529 Siderophore-mediated IRON transport protein 
jhp0530 Hypothetical protein 
jhp0533 Hypothetical protein 
jhp0537 2-oxoglutarate-acceptor oxidoreductase subunit OorA 
jhp0539 2-oxoglutarate-acceptor oxidoreductase subunit OorC 
jhp0544 Penicillin-binding protein 
jhp0547 Secretion/efflux ABC transporter ATP-binding protein 
jhp0550 Hypothetical protein 
jhp0554 Efflux transporter 
jhp0556 Vacuolating cytotoxin (VacA) paralog 
jhp0563 Lipopolysaccharide biosynthesis protein  
jhp0565 Recombination and DNA strand exchange inhibitor protein 
jhp0572 Hypothetical protein 
jhp0573 Hypothetical protein 
jhp0579 Hypothetical protein 
jhp0581 Hypothetical protein 
jhp0582 Hypothetical protein 
jhp0589 Hypothetical protein 
jhp0596 Alpha (1,3)-fucosyltransferase 
jhp0600 Protective surface antigen D15 
jhp0604 Hypothetical protein 
jhp0605 Hypothetical protein 
jhp0619 Hypothetical protein 
jhp0626 Iron(III) dicitrate transport protein 
jhp0627 Ferrous iron transport protein B 
jhp0635 Short-chain fatty acids transporter 
jhp0636 3-oxoacid CoA-transferase subunit B 
jhp0643 Transcriptional regulator 
jhp0644 Excinuclease ABC subunit A 
jhp0654 Hypothetical protein 
jhp0655 DNA polymerase III subunits gamma/tau 
jhp0656 Hypothetical protein 
jhp0657 Hypothetical protein 
jhp0665 Hypothetical protein 
jhp0666 Hypothetical protein 
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jhp0675 D-alanyl-alanine synthetase A 
jhp0681 Hypothetical protein  
jhp0686 Hypothetical protein 
jhp0697 Phosphodiesterase 
jhp0698 Hypothetical protein 
jhp0706 Molybdopterin-guanine dinucleotide biosynthesis protein A 
jhp0707 Flagellar biosynthesis protein FlhB 
jhp0708 Hypothetical protein 
jhp0709 N-acetylmuramoyl-L-alanine amidase 
jhp0716 Bifunctional aconitate hydratase 2/2-methylisocitrate dehydratase 
jhp0717 Hypothetical protein 
jhp0718 Hypothetical protein 
jhp0719 Hypothetical protein 
jhp0739 Hypothetical protein 
jhp0743 Iron(III) dicitrate transport protein 
jhp0746 Hypothetical protein 
jhp0757 Osmoprotection binding protein 
jhp0758 Osmoprotection ATP-binding protein 
jhp0764 Thioredoxin reductase 
jhp0765 Lipopolysaccharide biosynthesis protein 
jhp0766 Hypothetical protein 
jhp0773 GTP-binding protein EngA 
jhp0777 Hypothetical protein 
jhp0778 Sugar nucleotide biosynthesis protein 
jhp0786 Type I restriction enzyme modification subunit 
jhp0788 Hypothetical protein 
jhp0790 Guanosine 5'-monophosphate oxidoreductase 
jhp0797 Hypothetical protein 
jhp0804 Flagellar hook protein FlgE 
jhp0812 Hypothetical protein 
jhp0817 Hypothetical protein 
jhp0819 Vacuolating cytotoxin 
jhp0835 Hydrogenase expression/formation protein 
jhp0836 Hydrogenase expression/formation protein 
jhp0837 Hydrogenase expression/formation protein 
jhp0842 Hypothetical protein 
jhp0844 Flagellar hook protein FlgE 
jhp0845 Hypothetical protein 
jhp0846 Type II DNA modification (methyltransferase 
jhp0847 ATP-dependent helicase 
jhp0850 Hypothetical protein 
jhp0851 IRON-regulated outer membrane protein 
jhp0853 Carbamoyl phosphate synthase large subunit 
jhp0856 Vacuolating cytotoxin (VacA) paralog 
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jhp0857 Hypothetical protein 
jhp0860 TRNA pseudouridine synthase D 
jhp0871 Proline/betaine transporter 
jhp0880 Hypothetical protein 
jhp0881 Hypothetical protein 
jhp0891 3-deoxy-D-manno-octulosonic-acid transferase 
jhp0892 Hypothetical protein 
jhp0895 NAD(P)H-dependent glycerol-3-phosphate dehydrogenase 
jhp0902 Hypothetical protein 
jhp0903 Cation efflux system protein 
jhp0904 Cation efflux system protein 
jhp0907 Hypothetical protein 
jhp0915 Hypothetical protein 
jhp0954 Hypothetical protein 
jhp0965 Hypothetical protein 
jhp0967 Methionyl-tRNA synthetase 
jhp0974 S/N-oxide reductase 
jhp0977 HIT family protein 
jhp0987 Hypothetical protein 
jhp0992 Iron-dependent superoxide dismutase 
jhp0994 Primosome assembly protein PriA 
jhp0999 Zinc-metallo protease 
jhp1001 Glutamate dehydrogenase 
jhp1003 Cytochrome C-type biogenesis protein 
jhp1005 Ferrochelatase 
jhp1008 Hypothetical protein 
jhp1010 Biotin carboxyl carrier protein 
jhp1012 Type II DNA modification enzyme 
jhp1013 Hypothetical protein 
jhp1014 Hypothetical protein 
jhp1015 Spore coat polysaccharide biosynthesis protein C 
jhp1023 Short chain alcohol dehydrogenase 
jhp1030 Zinc-dependent alcohol dehydrogenase 
jhp1032 Lipopolysaccharide biosynthesis protein 
jhp1033 Hypothetical protein 
jhp1056 Hypothetical protein 
jhp1067 Hypothetical protein 
jhp1069 Methionyl-tRNA formyltransferase 
jhp1084 Hypothetical protein 
jhp1086 CAMP-induced cell filamentation protein 
jhp1092 Hypothetical protein 
jhp1093 Glucose-6-phosphate isomerase 
jhp1095 Hypothetical protein 
jhp1102 Hypothetical protein 
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jhp1103 Outer membrane function 
jhp1105 Phosphopentomutase 
jhp1115 Histidyl-tRNA synthetase 
jhp1117 Motility protein 
jhp1121 DNA-directed RNA polymerase subunit beta/beta' 
jhp1141 ABC transporter ATP-binding protein 
jhp1143 D-lactate dehydrogenase 
jhp1152 DNA polymerase III subunit delta' 
jhp1153 Dihydropteroate synthase 
jhp1162 Alanyl-tRNA synthetase 
jhp1170 Shikimate 5-dehydrogenase 
jhp1172 Peptide ABC transporter ATP-binding protein 
jhp1173 Hypothetical protein 
jhp1180 Hypothetical protein 
jhp1186 NADH oxidoreductase I 
jhp1187 NADH dehydrogenase subunit G 
jhp1193 NADH dehydrogenase subunit M 
jhp1196 Phosphomannomutase 
jhp1200 Bifunctional indole-3-glycerol phosphate 
synthase/phosphoribosylanthranilate isomerase 
jhp1206 Hypothetical protein 
jhp1211 Hypothetical protein 
jhp1228 50S ribosomal protein L24 
jhp1241 Hypothetical protein 
jhp1244 Hypothetical protein 
jhp1249 Cation efflux system protein 
jhp1256 Hypothetical protein 
jhp1258 Biopolymer transport protein 
jhp1259 Biopolymer transport EXBD protein 
jhp1277 Hypothetical protein 
jhp1279 DNA transfer protein 
jhp1281 Hypothetical protein 
jhp1284 Type II DNA modification (methyltransferase 
jhp1285 Type III restriction enzyme R protein 
jhp1292 Hypothetical protein 
jhp1295 Endonuclease 
jhp1296 Type III DNA modification enzyme 
jhp1298 Biotin synthase 
jhp1299 Ribonuclease N 
jhp1309 Hypothetical protein 
jhp1310 TRNA delta(2)-isopentenylpyrophosphate transferase 
jhp1311 Lipopolysaccharide biosynthesis protein 
jhp1315 Flagellum-specific ATP synthase 
jhp1317 Isoleucyl-tRNA synthetase 
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jhp1318 Hypothetical protein 
jhp1338 Biopolymer transport protein 
jhp1339 Biopolymer transport protein 
jhp1341 Ribonuclease P protein component 
jhp1344 Hypothetical protein 
jhp1353 DNA polymerase III subunit alpha 
jhp1355 Motility protein 
jhp1358 ABC transporter ATP-binding protein 
jhp1359 Hypothetical protein 
jhp1365 Type II DNA modification enzyme 
jhp1384 Phosphate permease 
jhp1394 Hypothetical protein 
jhp1395 Hypothetical protein 
jhp1396 Component of cation transport for cbb3-type oxidase 
jhp1401 Ferrodoxin 
jhp1405 Iron-regulated outer membrane protein 
jhp1411 Type III DNA modification enzyme  
jhp1417 Chromosome replication initiator DnaA 
jhp1418 Hypothetical protein 
jhp1421 FAD-dependent thymidylate synthase 
jhp1422 Type I restriction enzyme (specificity subunit) 
jhp1423 Type I restriction enzyme modification subunit 
jhp1433 Hypothetical protein 
jhp1438 DNA polymerase III subunit epsilon 
jhp1439 Ribulose-phosphate 3-epimerase 
jhp1456 Hypothetical protein 
jhp1457 Hypothetical protein 
jhp1468 Rod shape-determining protein 
jhp1483 Flagellar biosynthesis protein 
jhp1485 ABC transporter permease 
jhp1487 Hypothetical protein 
jhp1488 Undecaprenyl-phosphate-alpha-N- acetylglucosaminyltransferase 
jhp1491 DNA-binding/iron metalloprotein/AP endonuclease 
*J99 annotation. 
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Appendix 10 List of “gastric cancer core”-specific genes 
Locus tag Product 
HPF32_0011 Argininosuccinate synthase 
HPF32_0016 Hypothetical protein 
HPF32_0036 Putative transcriptional regulator 
HPF32_0037 Signal-transducing protein, histidine kinase 
HPF32_0040 Competence locus E 
HPF32_0042 Hypothetical protein 
HPF32_0049 Adenine specific DNA methyltransferase 
HPF32_0050 Adenine specific DNA methyltransferase 
HPF32_0067 Hypothetical protein 
HPF32_0071 Hypothetical protein 
HPF32_0079 Urease accessory protein 
HPF32_0080 Urease accessory protein UreE 
HPF32_0082 Urease subunit alpha 
HPF32_0104 Type II restriction enzyme M protein 
HPF32_0110 Threonine synthase 
HPF32_0115 Methyl-accepting chemotaxis protein 
HPF32_0127 DNA topoisomerase I 
HPF32_0137 Hypothetical protein 
HPF32_0143 Hypothetical protein 
HPF32_0146 Hypothetical protein 
HPF32_0149 L-lactate permease 
HPF32_0151 C(4)-dicarboxylates and tricarboxylates/succinate antiporter 
HPF32_0159 Hypothetical protein 
HPF32_0162 Recombinase A 
HPF32_0172 Putative histidine kinase sensor protein 
HPF32_0198 Hypothetical protein 
HPF32_0208 50S ribosomal protein L32 
HPF32_0216 Lipopolysaccharide 1,2-glycosyltransferase 
HPF32_0222 TRNA uridine 5-carboxymethylaminomethyl modification protein 
GidA 
HPF32_0224 CDP-diglyceride synthetase 
HPF32_0232 Hypothetical protein 
HPF32_0237 Putative sulfate permease 
HPF32_0238 Outer membrane protein HopA 
HPF32_0258 Hypothetical protein 
HPF32_0261 Oligopeptide permease integral membrane protein 
HPF32_0266 Hypothetical protein 
HPF32_0291 Hypothetical protein 
HPF32_0300 Diaminopimelate decarboxylase 
HPF32_0314 Hypothetical protein 
HPF32_0320 Hypothetical protein 
HPF32_0323 Nitrite extrusion protein 
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HPF32_0328 Cytochrome c-type biogenesis protein 
HPF32_0330 Glutamate dehydrogenase 
HPF32_0332 Putative zinc-metallo protease 
HPF32_0337 Primosome assembly protein PriA 
HPF32_0367 Methionyl-tRNA synthetase 
HPF32_0380 Hypothetical protein 
HPF32_0393 Hypothetical protein 
HPF32_0412 Hypothetical protein 
HPF32_0434 Putative vacuolating cytotoxin VacA 
HPF32_0439 Iron-regulated outer membrane protein 
HPF32_0440 Putative outer membrane protein 
HPF32_0443 Rep helicase, single-stranded DNA-dependent ATPase 
HPF32_0445 Type II restriction enzyme 
HPF32_0446 Flagellar hook protein FlgE 
HPF32_0462 Vacuolating cytotoxin A 
HPF32_0464 Virulence factor MviN 
HPF32_0470 Hypothetical protein 
HPF32_0475 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate synthetase 
HPF32_0476 Hypothetical protein 
HPF32_0479 Sodium- and chloride-dependent transporter 
HPF32_0480 Phospholipase A1 
HPF32_0488 Plasminogen binding protein 
HPF32_0489 Putative Glycolate oxidase 
HPF32_0491 Urease-enhancing factor 
HPF32_0499 Hypothetical protein 
HPF32_0500 Cag pathogenicity island protein 
HPF32_0501 Cag pathogenicity island protein 
HPF32_0502 Cag island protein 
HPF32_0504 Cag pathogenicity island protein 
HPF32_0505 Cag pathogenicity island protein 
HPF32_0507 Cag pathogenicity island protein 
HPF32_0508 Cag pathogenicity island protein 
HPF32_0509 Cag pathogenicity island protein 
HPF32_0510 Cag pathogenicity island protein 
HPF32_0511 Cag pathogenicity island protein 
HPF32_0512 Cag pathogenicity island protein 
HPF32_0513 Cag pathogenicity island protein 
HPF32_0514 Cag pathogenicity island protein 
HPF32_0515 Cag pathogenicity island protein 
HPF32_0516 Cag pathogenicity island protein 
HPF32_0517 Cag island protein 
HPF32_0518 Cag pathogenicity island protein 
HPF32_0519 Cag pathogenicity island protein 
HPF32_0520 DNA transfer protein 
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HPF32_0521 Cag pathogenicity island protein 
HPF32_0522 Cag pathogenicity island protein 
HPF32_0523 Cag pathogenicity island protein 
HPF32_0531 Hypothetical protein 
HPF32_0542 Membrane protein 
HPF32_0557 Hypothetical protein 
HPF32_0561 Hypothetical protein 
HPF32_0578 Hypothetical protein 
HPF32_0582 Cytoplasmic pump protein of the hefABC efflux system HefC 
HPF32_0584 Putative vacuolating cytotoxin (VacA)-like protein 
HPF32_0595 Putative lipopolysaccharide biosynthesis protein 
HPF32_0607 Modulator of drug activity 
HPF32_0615 Outer membrane protein OipA1/A2 
HPF32_0621 Excinuclease ABC subunit A 
HPF32_0629 Hydantoin utilization protein A 
HPF32_0636 Iron(II) transport protein 
HPF32_0637 Iron(III) dicitrate transport protein FecA1 
HPF32_0664 Putative outer membrane protein 
HPF32_0684 DNA polymerase III subunits gamma and tau 
HPF32_0685 Hypothetical protein 
HPF32_0688 L-asparaginase II 
HPF32_0689 Anaerobic C4-dicarboxylate transporter 
HPF32_0704 D-alanyl-alanine synthetase A 
HPF32_0729 Hypothetical protein 
HPF32_0740 Hypothetical protein 
HPF32_0748 Bifunctional aconitate hydratase 2/2-methylisocitrate dehydratase 
HPF32_0749 Hypothetical protein 
HPF32_0750 Hypothetical protein 
HPF32_0751 Outer membrane protein HofE 
HPF32_0766 Molybdenum cofactor biosynthesis protein 
HPF32_0785 Osmoprotection protein 
HPF32_0794 Lipooligosaccharide 5G8 epitope biosynthesis-associated protein 
HPF32_0802 GTP-binding protein EngA 
HPF32_0806 Outer membrane protein P1 
HPF32_0811 Thiamine biosynthesis protein 
HPF32_0812 Thiamine phosphate pyrophosphorylase 
HPF32_0813 Type I restriction enzyme R protein 
HPF32_0822 Guanosine 5'-monophosphate oxidoreductase 
HPF32_0829 Hypothetical protein 
HPF32_0844 Hypothetical protein 
HPF32_0854 Outer membrane protein HopK 
HPF32_0856 Molybdenum ABC transporter ModD 
HPF32_0861 Glutathione-regulated potassium-efflux system protein 
HPF32_0865 Integral membrane protein 
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HPF32_0879 Amino acid permease 
HPF32_0883 DNA-polymerase I-like 5'-3' exonuclease 
HPF32_0884 Hypothetical protein 
HPF32_0900 Hypothetical protein 
HPF32_0909 Translation initiation factor IF-2 
HPF32_0910 Hypothetical protein 
HPF32_0915 Hypothetical protein 
HPF32_0918 Hypothetical protein 
HPF32_0925 Hypothetical protein 
HPF32_0933 Copper ion binding protein 
HPF32_0935 Hypothetical protein 
HPF32_0942 Outer membrane protein HofB 
HPF32_0958 Flagellar MS-ring protein 
HPF32_0962 Hypothetical protein 
HPF32_0978 CMP-N-acetylneuraminic acid synthetase 
HPF32_0979 CMP-N-acetylneuraminic acid synthetase 
HPF32_0983 Poly E-rich protein 
HPF32_0985 Sec-independent protein translocase protein 
HPF32_1019 Outer membrane protein HomC 
HPF32_1026 Spore coat polysaccharide biosynthesis protein C 
HPF32_1033 Short chain alcohol dehydrogenase 
HPF32_1042 Putative lipopolysaccharide biosynthesis protein 
HPF32_1043 Hypothetical protein 
HPF32_1050 Outer membrane protein HorI 
HPF32_1059 Hypothetical protein 
HPF32_1077 Methionyl-tRNA formyltransferase 
HPF32_1092 Outer membrane protein HopL 
HPF32_1094 Cell filamentation protein 
HPF32_1100 Hypothetical protein 
HPF32_1101 Glucose-6-phosphate isomerase 
HPF32_1103 Carbon starvation protein 
HPF32_1111 Outer membrane protein 
HPF32_1113 Phosphopentomutase 
HPF32_1123 Histidyl-tRNA synthetase 
HPF32_1125 Hypothetical protein 
HPF32_1129 DNA-directed RNA polymerase subunit beta/beta' 
HPF32_1151 D-lactate dehydrogenase 
HPF32_1160 DNA polymerase III subunit delta' 
HPF32_1161 Dihydropteroate synthase 
HPF32_1167 Formamidase 
HPF32_1168 Hypothetical protein 
HPF32_1170 Alanyl-tRNA synthetase 
HPF32_1174 30S ribosomal protein S18 
HPF32_1176 30S ribosomal protein S6 
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HPF32_1180 Hypothetical protein 
HPF32_1181 Putative peptide ABC transporter ATP-binding protein 
HPF32_1193 NADH dehydrogenase subunit D 
HPF32_1202 NADH dehydrogenase subunit M 
HPF32_1204 Paralysed flagella protein 
HPF32_1205 Phosphomannomutase 
HPF32_1208 Bifunctional indole-3-glycerol phosphate synthase/ 
phosphoribosylanthranilate isomerase 
HPF32_1214 Hypothetical protein 
HPF32_1247 ATP-binding protein 
HPF32_1263 Hypothetical protein 
HPF32_1270 Transcriptional regulator 
HPF32_1281 Aspartate alpha-decarboxylase 
HPF32_1287 Hypothetical protein 
HPF32_1289 Type II citrate synthase 
HPF32_1291 Putative type III restriction enzyme M protein 
HPF32_1292 Putative type III restriction enzyme 
HPF32_1296 Hypothetical protein 
HPF32_1300 Hypothetical protein 
HPF32_1302 Lipopolysaccharide 1,2-glucosyltransferase 
HPF32_1309 Isoleucyl-tRNA synthetase 
HPF32_1319 Formyltetrahydrofolate hydrolase 
HPF32_1320 Protease IV 
HPF32_1321 Hypothetical protein 
HPF32_1334 50S ribosomal protein L34 
HPF32_1340 Outer membrane protein HomD 
HPF32_1347 DNA polymerase III subunit alpha 
HPF32_1352 ABC transporter ATP-binding protein 
HPF32_1353 Hypothetical protein 
HPF32_1378 Phosphate permease 
HPF32_1390 Putative outer membrane protein 
HPF32_1391 Hypothetical protein 
HPF32_1392 Putative cation transporting P-type ATPase 
HPF32_1397 Ferrodoxin-like protein 
HPF32_1401 Putative IRON-regulated outer membrane protein 
HPF32_1406 Type III restriction enzyme 
HPF32_1415 Purine nucleoside phosphorylase 
HPF32_1423 Iron(III) dicitrate transport protein 
HPF32_1430 DNA repair protein 
HPF32_1437 Ribulose-phosphate 3-epimerase 
HPF32_1468 Hypothetical protein 
HPF32_1482 ABC transporter ATP-binding protein 
HPF32_1485 Hypothetical protein 
HPF32_1489 O-sialoglycoprotein endopeptidase 
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Appendix 11 List of “MALT lymphoma core”-specific genes* 
Locus tag Product 
HELPY_0002 6,7-dimethyl-8-ribityllumazine synthase 
HELPY_0004 Beta-carbonic anhydrase 
HELPY_0007 Outer membrane protein HopZ 
HELPY_0011 Hypothetical protein 
HELPY_0016 Hypothetical protein 
HELPY_0021 Hypothetical protein 
HELPY_0022 Outer membrane protein HopD 
HELPY_0024 Type II citrate synthase 
HELPY_0026 Hypothetical protein 
HELPY_0028 Hypothetical protein 
HELPY_0032 Aspartate alpha-decarboxylase 
HELPY_0033 Hypothetical protein 
HELPY_0035 Hypothetical protein 
HELPY_0043 Hydrogenase maturation protein HypF 
HELPY_0045 Type II adenine methyltransferase 
HELPY_0051 Hypothetical protein 
HELPY_0052 Hypothetical protein 
HELPY_0055 Hypothetical protein 
HELPY_0056 Hypothetical protein 
HELPY_0057 Hypothetical protein 
HELPY_0058 Hypothetical protein 
HELPY_0059 Hypothetical protein 
HELPY_0065 Urease accessory protein UreF 
HELPY_0066 Urease accessory protein UreE 
HELPY_0068 Urease subunit beta 
HELPY_0078 Methyl-accepting chemotaxis protein 
HELPY_0090 Type II adenine methyltransferase 
HELPY_0091 Alpha-1,2-fucosyltransferase 
HELPY_0095 Threonine synthase 
HELPY_0097 Methyl-accepting chemotaxis protein 
HELPY_0099 Outer membrane protein 
HELPY_0101 Methyl-accepting chemotaxis protein tlpB 
HELPY_0106 Cysteine synthase 
HELPY_0111 Heat-inducible transcription repressor 
HELPY_0116 DNA topoisomerase I 
HELPY_0121 Hypothetical protein 
HELPY_0128 Hypothetical protein 
HELPY_0136 Hypothetical protein 
HELPY_0139 Iron-sulfur cluster binding protein 
HELPY_0143 L-lactate permease, LctP family; membrane protein 
HELPY_0144 DNA glycosylase MutY 
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HELPY_0145 Sodium/sulfate symporter 
HELPY_0154 Hypothetical protein 
HELPY_0155 Hypothetical protein 
HELPY_0157 Recombinase A 
HELPY_0158 Phosphopyruvate hydratase 
HELPY_0163 LPS 1,2-glycosyltransferase 
HELPY_0168 Histidine kinase sensor protein 
HELPY_0171 Hypothetical protein 
HELPY_0175 Molybdopterin biosynthesis protein MoeA 
HELPY_0193 Phospholipase D 
HELPY_0203 50S ribosomal protein L32 
HELPY_0204 Glycerol-3-phosphate acyltransferase PlsX 
HELPY_0211 LPS 1,2-glycosyltransferase 
HELPY_0216 TRNA uridine 5-carboxymethylaminomethyl modification protein 
GidA 
HELPY_0218 Phosphatidate cytidylyltransferase 
HELPY_0232 Sulfate permease 
HELPY_0233 Outer membrane protein HopA 
HELPY_0237 Glutathionylspermidine synthase 
HELPY_0253 Hypothetical protein 
HELPY_0258 Outer membrane protein HopF 
HELPY_0262 Hypothetical protein 
HELPY_0265 TCGA site-specific m6A methyltransferase 
HELPY_0266 Hypothetical protein 
HELPY_0269 Non-functional cytosine methyltransferase 
HELPY_0271 Cytochrome C biogenesis protein; membrane protein 
HELPY_0288 Hypothetical protein 
HELPY_0295 Toxin-like outer membrane protein/vacuolating cytotoxin VacA 
HELPY_0296 Diaminopimelate decarboxylas (DAP decarboxylase) 
HELPY_0298 Hypothetical protein 
HELPY_0299 Para-aminobenzoate (PABA)-synthetase 
HELPY_0306 ABC transporter permease; dipeptide transporter protein 3; 
membrane protein 
HELPY_0308 ABC transporter ATP-binding protein; dipeptide transporter protein 4 
HELPY_0309 ABC transporter ATP-binding protein; dipeptide transporter protein 5 
HELPY_0311 Hypothetical protein 
HELPY_0317 NodB-like polysaccharide deacetylase 
HELPY_0320 Nitrite extrusion protein, major facilitator family protein; membrane 
protein 
HELPY_0323 Sec-independent protein translocase protein tatA/E-like protein 
HELPY_0325 Hypothetical protein 
HELPY_0331 Flagellar biosynthesis protein 
HELPY_0340 Hypothetical protein 
HELPY_0350 Pseudouridine synthase (RNA-uridine isomerase) (RNA 
pseudouridylate synthase) 
HELPY_0354 Flagellar MS-ring protein 
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HELPY_0360 Hypothetical protein 
HELPY_0363 DNA translocase FtsK; membrane protein 
HELPY_0364 Hypothetical protein 
HELPY_0367 Pore-forming cytolysin 
HELPY_0370 Outer membrane protein HofB 
HELPY_0371 ABC transporter ATP-binding protein; lipid A and 
glycerophospholipid transporter; membrane protein 
HELPY_0372 Hypothetical protein 
HELPY_0376 Hypothetical protein 
HELPY_0378 Copper-associated protein 
HELPY_0379 Copper-transporting ATPase/P-type transporting ATPase; membrane 
protein 
HELPY_0383 Chemotactic response regulator, two-component system 
HELPY_0386 Hypothetical protein 
HELPY_0393 Hypothetical protein 
HELPY_0396 Hypothetical protein 
HELPY_0401 Hypothetical protein 
HELPY_0402 Translation initiation factor IF-2 
HELPY_0405 Acetyl-CoA synthetase 
HELPY_0409 Hypothetical protein 
HELPY_0410 Hypothetical protein 
HELPY_0414 Hypothetical protein 
HELPY_0420 Hypothetical protein 
HELPY_0429 Chaperone protein DnaJ 
HELPY_0430 Hypothetical protein 
HELPY_0431 Hypothetical protein 
HELPY_0436 Transporter; amino-acid transporter, AAT family; membrane protein 
HELPY_0444 Type I restriction/modification specificity protein 
HELPY_0445 Type I restriction enzyme M protein 
HELPY_0450 Hypothetical protein 
HELPY_0455 Sodium/hydrogen exchanger 
HELPY_0457 ABC transporter substrate-binding protein 
HELPY_0458 ABC transporter permease; molybdate transporter; membrane protein 
HELPY_0459 ABC transporter ATP-binding protein; molybdate transporter 
HELPY_0462 Type II adenine methyltransferase 
HELPY_0463 Non-functional type II restriction endonuclease 
HELPY_0465 Type II cytosine specific DNA methyltransferase 
HELPY_0466 Non-functional type II restriction endonuclease 
HELPY_0468 Catalase 
HELPY_0472 Hypothetical protein 
HELPY_0474 Hypothetical protein 
HELPY_0482 Flagellar hook protein FlgE 
HELPY_0489 Plasminogen-binding protein PgbB 
HELPY_0500 Guanosine 5'-monophosphate oxidoreductase 
HELPY_0507 Type I R-M system specificity subunit 
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HELPY_0510 Hydroxyethylthiazole kinase 
HELPY_0511 Phosphomethylpyrimidine kinase (HMP-phosphate kinase) (HMP-P 
kinase) 
HELPY_0512 Thiamine-phosphate pyrophosphorylase 
HELPY_0515 UDP-GlcNAc C6 dehydratase/C5 epimerase 
HELPY_0516 Outer membrane protein P1 
HELPY_0520 GTP-binding protein EngA 
HELPY_0528 Nucleotide binding protein 
HELPY_0529 Glycosyltransferase, family 25 
HELPY_0531 Thioredoxin reductase (TRXR) (TR) 
HELPY_0538 ABC transporter ATP-binding protein; osmoprotection ABC 
transporter involved in glycine/betaine/L-proline transport 
HELPY_0539 ABC transporter permease; betaine/proline/choline transporter; 
membrane protein 
HELPY_0547 N-6 adenine methyltransferase 
HELPY_0557 Hypothetical protein 
HELPY_0559 Molybdopterin-converting factor subunit 1 
HELPY_0561 Molybdenum cofactor biosynthesis protein MogA 
HELPY_0582 Outermembrane protein HofE 
HELPY_0583 Hypothetical protein 
HELPY_0584 Hypothetical protein 
HELPY_0585 Bifunctional aconitate hydratase 2/2-methylisocitrate dehydratase 
HELPY_0592 N-acetylmuramoyl-L-alanine amidase 
HELPY_0593 Hypothetical protein 
HELPY_0594 Flagellar biosynthesis protein FlhB 
HELPY_0595 Molybdopterin-guanine dinucleotide biosynthesis protein A 
HELPY_0596 Molybdenum cofactor biosynthesis protein A 
HELPY_0599 Hypothetical protein 
HELPY_0604 Hypothetical protein 
HELPY_0605 Phosphodiesterase 
HELPY_0616 ABC transporter permease 
HELPY_0624 Rod shape-determining protein RodA; membrane protein 
HELPY_0629 D-alanyl-alanine synthetase A 
HELPY_0636 LeoA protein 
HELPY_0638 Hypothetical protein 
HELPY_0639 TRNA(Ile)-lysidine synthase 
HELPY_0642 Outer membrane protein HopP 
HELPY_0643 Anaerobic C4-dicarboxylate transporter 
HELPY_0644 L-asparaginase 
HELPY_0647 Hypothetical protein 
HELPY_0648 L-lysine exporter; membrane protein 
HELPY_0649 DNA polymerase III subunits gamma and tau 
HELPY_0650 ATPase 
HELPY_0656 Outer membrane protein HomA 
HELPY_0661 Excinuclease ABC subunit A 
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HELPY_0662 Hypothetical protein 
HELPY_0666 Transcriptional activator 
HELPY_0671 Hypothetical protein 
HELPY_0679 Short-chain fatty acid transport protein, scFAT family; membrane 
protein 
HELPY_0681 Succinyl-CoA-transferase subunit B 
HELPY_0685 Ferrous iron transport protein B; membrane protein 
HELPY_0686 Iron(III) dicitrate transport protein FecA 
HELPY_0687 Flagellar biosynthesis protein FliP 
HELPY_0690 Hypothetical protein 
HELPY_0693 Hypothetical protein 
HELPY_0711 Hypothetical protein 
HELPY_0712 Hypothetical protein 
HELPY_0716 Surface antigen protein 
HELPY_0727 Hypothetical protein 
HELPY_0729 NAD(P)H-flavin oxidoreductase 
HELPY_0730 3-hydroxyacid dehydrogenase 
HELPY_0732 Hypothetical protein 
HELPY_0733 Outer membrane protein HopH 
HELPY_0735 Hypothetical protein 
HELPY_0741 NAD(P)H oxidoreductase (NADPH quinone reductase) 
HELPY_0750 Recombination and DNA strand exchange inhibitor protein 
HELPY_0763 Vacuolating cytotoxin VacA-like 
HELPY_0765 Cytoplasmic pump proteins of the hefABC efflux system 
HELPY_0769 Hypothetical protein 
HELPY_0772 ABC transporter permease and ATP-binding protein; membrane 
protein 
HELPY_0775 Penicillin-binding protein 1 (peptidoglycan glycosyltransferase) 
HELPY_0783 2-oxoglutarate-acceptor oxidoreductase subunit OorC 
HELPY_0785 2-oxoglutarate-acceptor oxidoreductase subunit OorA 
HELPY_0789 Hypothetical protein 
HELPY_0792 Hypothetical protein 
HELPY_0793 Siderophore-mediated iron transport protein 
HELPY_0798 Hypothetical protein 
HELPY_0810 Hypothetical protein 
HELPY_0819 Acetyl-CoA carboxylase carboxyltransferase subunit alpha 
HELPY_0820 Hypothetical protein 
HELPY_0821 Hypothetical protein 
HELPY_0822 Hypothetical protein 
HELPY_0824 Methylase 
HELPY_0828 Hypothetical protein 
HELPY_0831 ATP-dependent protease ATP-binding subunit HslU 
HELPY_0842 Urease-enhancing factor Lpp 
HELPY_0844 Glycolate oxidase subunit 
HELPY_0845 Hypothetical protein 
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HELPY_0850 Hypothetical protein 
HELPY_0855 Sodium-and chloride-dependent transporter; membrane protein 
HELPY_0856 Sodium-and chloride-dependent transporter; membrane protein 
HELPY_0858 Hypothetical protein 
HELPY_0859 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate synthetase 
HELPY_0862 50S ribosomal protein L28 
HELPY_0865 Hypothetical protein 
HELPY_0870 Virulence factor MviN protein; membrane protein 
HELPY_0872 Vacuolating cytotoxin 
HELPY_0878 Hypothetical protein 
HELPY_0879 Hypothetical protein 
HELPY_0882 Hydrogenase expression/formation protein HypD 
HELPY_0883 Hydrogenase expression/formation protein (HUPF/HYPC) 
HELPY_0884 Hydrogenase and urease maturation protein 
HELPY_0885 Hypothetical protein 
HELPY_0889 Phosphotransacetylase 
HELPY_0890 Flagellar control protein 
HELPY_0892 Flagellar hook protein FlgE 
HELPY_0893 Type II restriction endonuclease Hpy8I 
HELPY_0894 Type II m6A methylase 
HELPY_0895 ATP-dependent single-stranded DNA helicase 
HELPY_0900 Outer membrane protein 
HELPY_0901 Iron-regulated outer membrane protein 
HELPY_0903 Carbamoyl phosphate synthase large subunit 
HELPY_0906 Toxin-like outer membrane protein/vacuolating cytotoxin VacA 
HELPY_0907 Outer membrane protein HopK 
HELPY_0910 TRNA pseudouridine synthase D 
HELPY_0924 Hypothetical protein 
HELPY_0931 Cation antiporter; membrane protein 
HELPY_0932 Hypothetical protein 
HELPY_0933 Hypothetical protein 
HELPY_0940 NAD(P)H-dependent nitroreductase 
HELPY_0943 3-deoxy-D-manno-octulosonic-acid transferase 
HELPY_0944 Hypothetical protein 
HELPY_0947 NAD(P)H-dependent glycerol-3-phosphate dehydrogenase 
HELPY_0949 ATPase 
HELPY_0955 Hypothetical protein 
HELPY_0956 Cobalt-zinc-cadmium resistance protein, CzcA family; membrane 
protein 
HELPY_0957 Cobalt-zinc-cadmium resistance protein, CzcB family 
HELPY_0960 Hypothetical protein 
HELPY_0976 Small-conductance mechanosensitive channel; membrane protein 
HELPY_1001 Hypothetical protein 
HELPY_1002 Hypothetical protein 
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HELPY_1009 Hypothetical protein 
HELPY_1011 Methionyl-tRNA synthetase 
HELPY_1021 Hydrolase 
HELPY_1031 Hypothetical protein 
HELPY_1036 Superoxide dismutase 
HELPY_1038 Primosome assembly protein PriA 
HELPY_1043 Metalloprotease; membrane protein 
HELPY_1045 Glutamate dehydrogenase 
HELPY_1046 Alpha1,3-fucosyltransferase 
HELPY_1047 Cytochrome c biogenesis protein; membrane protein 
HELPY_1049 Ferrochelatase 
HELPY_1054 Biotin carboxyl carrier protein of acetyl-CoA carboxylase 
HELPY_1056 Adenine methyltransferase 
HELPY_1057 Type II restriction endonuclease 
HELPY_1058 Hypothetical protein 
HELPY_1059 UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase 
HELPY_1066 Short chain dehydrogenase 
HELPY_1073 Zinc-containing alcohol dehydrogenase 
HELPY_1074 Lipopolysaccharide 1,3-galactosyltransferase 
HELPY_1075 Hypothetical protein 
HELPY_1083 Outer membrane protein 
HELPY_1095 Hypothetical protein 
HELPY_1100 Hypothetical protein 
HELPY_1111 SpoOJ regulator 
HELPY_1113 Methionyl-tRNA formyltransferase 
HELPY_1114 Hypothetical protein 
HELPY_1119 Hypothetical protein 
HELPY_1131 Outer membrane protein HopL 
HELPY_1133 CAMP-induced cell filamentation protein 
HELPY_1139 Permease, MFS superfamily; membrane protein 
HELPY_1140 Glucose-6-phosphate isomerase 
HELPY_1142 Carbon starvation protein A; membrane protein 
HELPY_1149 Permease; membrane protein 
HELPY_1150 Outer membrane protein HopQ 
HELPY_1152 Phosphopentomutase 
HELPY_1160 Hypothetical protein 
HELPY_1162 Histidyl-tRNA synthetase 
HELPY_1164 Hypothetical protein 
HELPY_1166 Aldo-keto reductase 
HELPY_1170 DNA-directed RNA polymerase subunit beta/beta' 
HELPY_1178 50S ribosomal protein L33 
HELPY_1195 ABC transporter ATP-binding protein 
HELPY_1197 D-lactate dehydrogenase 
HELPY_1206 DNA polymerase III subunit delta' 
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HELPY_1207 Dihydropteroate synthase (DHPS) (Dihydropteroate 
pyrophosphorylase) 
HELPY_1213 Formamidase 
HELPY_1214 Hypothetical protein 
HELPY_1216 Alanyl-tRNA synthetase 
HELPY_1220 30S ribosomal protein S18 
HELPY_1221 Single-stranded DNA-binding protein 
HELPY_1222 30S ribosomal protein S6 
HELPY_1225 Shikimate 5-dehydrogenase 
HELPY_1226 Hypothetical protein 
HELPY_1227 ABC transporter permease 
HELPY_1228 ABC transporter substrate-binding protein 
HELPY_1235 NAD+-dependent deacetylase, Sir2 family 
HELPY_1239 NADH dehydrogenase subunit D 
HELPY_1241 NADH-ubiquinone oxidoreductase subunit F 
HELPY_1242 NADH dehydrogenase subunit G 
HELPY_1248 NADH dehydrogenase subunit M 
HELPY_1250 Paralysed flagella protein PflA 
HELPY_1252 Phosphomannomutase (PMM) 
HELPY_1253 Hypothetical protein 
HELPY_1256 Bifunctional indole-3-glycerol phosphate 
synthase/phosphoribosylanthranilate isomerase 
HELPY_1262 Hypothetical protein 
HELPY_1264 Pantothenate kinase (type III) 
HELPY_1265 Hypothetical protein 
HELPY_1267 Thiamine pyrophosphokinase 
HELPY_1283 50S ribosomal protein L24 
HELPY_1297 Hypothetical protein 
HELPY_1305 Heavy metal efflux pump CzcA 
HELPY_1312 Nicotinate-nucleotide adenyltransferase 
HELPY_1314 Biopolymer transport accessory protein; membrane protein 
HELPY_1315 Biopolymer transport protein ExbD 
HELPY_1316 Siderophore-mediated iron transport protein 
HELPY_1317 Outer membrane protein HopM 
HELPY_1340 Type II restriction endonuclease 
HELPY_1341 Type II m6A methylase 
HELPY_1349 Hypothetical protein 
HELPY_1351 DNA competence protein; membrane protein 
HELPY_1353 Hypothetical protein 
HELPY_1354 Hypothetical protein 
HELPY_1355 Transcriptional regulatory protein 
HELPY_1358 Type III restriction enzyme R protein 
HELPY_1365 Hypothetical protein 
HELPY_1369 DNA/RNA endonuclease G (nucG) 
HELPY_1370 Type III restriction enzyme M protein 
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HELPY_1371 Type III restriction enzyme R protein 
HELPY_1372 Biotin synthase 
HELPY_1373 Ribonuclease N 
HELPY_1380 Hypothetical protein 
HELPY_1382 Hypothetical protein 
HELPY_1383 TRNA delta(2)-isopentenylpyrophosphate transferase 
HELPY_1384 Lipopolysaccharide biosynthesis protein; LPS glycosyltransferase 
HELPY_1389 Flagellum-specific ATP synthase 
HELPY_1391 Isoleucyl-tRNA synthetase 
HELPY_1392 RNA binding protein 
HELPY_1401 Hypothetical protein 
HELPY_1402 Type I restriction enzyme specificity protein 
HELPY_1403 Formyltetrahydrofolate deformylase 
HELPY_1404 Signal peptide protease IV (Protease IV) (Endopeptidase IV) 
HELPY_1405 Hypothetical protein 
HELPY_1406 Hypothetical protein 
HELPY_1407 Hypothetical protein 
HELPY_1408 Hypothetical protein 
HELPY_1416 Biopolymer transport protein ExbD/TolR; membrane protein 
HELPY_1417 Biopolymer transport accessory protein ExbD/TolR 
HELPY_1418 Ribonuclease P 
HELPY_1421 Hypothetical protein 
HELPY_1423 Outer membrane protein HomD 
HELPY_1431 DNA polymerase III subunit alpha 
HELPY_1434 Hypothetical protein 
HELPY_1437 ABC transporter ATP-binding protein 
HELPY_1438 ABC transporter permease 
HELPY_1464 Transporter; phosphate transporter; membrane protein 
HELPY_1473 Hypothetical protein 
HELPY_1474 Outer membrane protein HorK 
HELPY_1475 Hypothetical protein 
HELPY_1476 ATPase, P-type copper-transporter; membrane protein 
HELPY_1481 Ferredoxin-like protein 
HELPY_1485 Iron-regulated outer membrane protein 
HELPY_1491 Type IIS restriction-modification protein 
HELPY_1492 Type III R-M system restriction enzyme 
HELPY_1500 Chromosomal replication initiation protein 
HELPY_1501 Purine nucleoside phosphorylase PunB 
HELPY_1504 FAD-dependent thymidylate synthase 
HELPY_1505 Hypothetical protein 
HELPY_1507 Type I restriction-modification enzyme subunit M 
HELPY_1508 Type I restriction-modification enzyme subunit R 
HELPY_1510 Iron(III) dicitrate transport protein FecA 
HELPY_1514 Hypothetical protein 
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HELPY_1516 Inorganic polyphosphate/ATP-NAD kinase (Poly(P)/ATP NAD 
kinase) 
HELPY_1517 DNA repair protein 
HELPY_1520 Hac prophage II protein 
HELPY_1521 Hac prophage II integrase 
HELPY_1522 Hac prophage II protein 
HELPY_1523 Hac prophage II protein 
HELPY_1525 Hac prophage II protein 
HELPY_1527 Hac prophage II protein 
HELPY_1531 Hypothetical protein 
HELPY_1532 Hypothetical protein 
HELPY_1534 Hypothetical protein 
HELPY_1535 DNA polymerase III subunit epsilon 
HELPY_1536 Ribulose-phosphate 3-epimerase 
HELPY_1539 N-6 Adenine-specific DNA methylase 
HELPY_1540 Hypothetical protein 
HELPY_1545 Hypothetical protein 
HELPY_1546 Zn-metallopeptidase, M23 family 
HELPY_1563 Cell division protein FtsW 
HELPY_1564 ABC transporter substrate-binding protein 
HELPY_1578 Hypothetical protein 
HELPY_1579 DL-methionine transporter ATP-binding subunit 
HELPY_1580 ABC transporter permease; D-and L-methionine transport protein; 
membrane protein 
HELPY_1584 Hypothetical protein 
HELPY_1585 UDP-phosphate N-acetylgalactosaminyl-1-phosphate transferase 
HELPY_1588 DNA-binding/iron metalloprotein/AP endonuclease 
HELPY_1590 Hypothetical protein 
HELPY_1591 Hypothetical protein 
HELPY_CDS127
4156R 
50S ribosomal protein L36 
*HELPY annotation. 
  
Appendix 12 List of unique genes present in the genome of H. pylori CCUG 17874 when compared to a number of H. pylori strains 
Unique 17874 Size (aa) 26695 J99 P79 Product 
HP17_00065 34 Absent Absent Absent Hypothetical protein 
HP17_00165 35 Absent Absent HP79_07905 Hypothetical protein 
HP17_00230 93 Absent Absent HP79_07835 Hypothetical protein 
HP17_00245 >26 Absent Absent Absent Hypothetical protein 
HP17_00536 32 Absent Absent Absent Hypothetical protein 
HP17_01178 40 Absent Absent Absent Hypothetical protein 
HP17_01508 44 HP_0091  Absent HP79_04682 Type II restriction enzyme R protein (hsdR) 
HP17_01533 41 Absent Absent Absent Hypothetical protein 
HP17_01783 31 Absent jhp0915 Absent Hypothetical protein 
HP17_01823 41 Absent Absent Absent Hypothetical protein 
HP17_01893 >37 Absent Absent Absent Hypothetical protein 
HP17_01925 31 HP_0341 Absent HP79_00662 Hypothetical protein 
HP17_01930 42 Absent Absent Absent Hypothetical protein 
HP17_01945 74 HP_0345 Absent HP79_00682 Hypothetical protein 
HP17_02539 52 Absent Absent Absent Hypothetical protein 
HP17_02624 >46 Absent Absent Absent Hypothetical protein 
HP17_03092 30 HP_0024 Absent HP79_06174 Hypothetical protein 
HP17_03459 66 Absent Absent Absent Hypothetical protein 
HP17_03594 30 HP_0502 Absent HP79_01809  Hypothetical protein 
HP17_03699 38 Absent jhp0884 HP79_06976 Hypothetical protein 
HP17_03704 33 Absent Absent Absent Hypothetical protein 
HP17_03749 35 Absent jhp0274 Absent Hypothetical protein 
  
HP17_03779 42 Absent Absent Absent Hypothetical protein 
HP17_04044 31 Absent Absent HP79_01040 Hypothetical protein 
HP17_04074 39 Absent Absent Absent Hypothetical protein 
HP17_04164 30 HP_0024 Absent HP79_06174 Hypothetical protein 
HP17_04194 47 Absent Absent HP79_06059 Hypothetical protein 
HP17_04626 46 HP_1366 Absent HP79_05849 Hypothetical protein 
HP17_04948 30 Absent Absent HP79_08555  Hypothetical protein 
HP17_05630 39 Absent Absent HP79_02099 Hypothetical protein 
HP17_05825 35 HP_0081 Absent Absent Hypothetical protein 
HP17_06092 102 Absent Absent Absent Hypothetical protein 
HP17_06122 42 Absent Absent Absent Hypothetical protein 
HP17_06777 37 Absent Absent Absent Hypothetical protein 
HP17_06822 36 HP_0225 Absent HP79_07001 Hypothetical protein 
HP17_06837 >38 Absent Absent Absent Hypothetical protein 
HP17_07124 >44 HP_1208 Absent HP79_08967 Hypothetical protein 
HP17_07269 36 Absent Absent HP79_05686 Hypothetical protein 
HP17_07512 71 HP_0502  jhp0454  Absent Hypothetical protein 
HP17_07662 42 Absent Absent Absent Hypothetical protein 
HP17_07712 30 HP_0024 Absent HP79_06174 Hypothetical protein 
HP17_07717 90 Absent Absent HP79_00130 Hypothetical protein 
HP17_07742 73 Absent jhp0110 HP79_00100 Hypothetical protein 
HP17_07957 48 Absent Absent Absent Hypothetical protein 
HP17_08134 40 HP_0761 Absent HP79_03311 Hypothetical protein 
HP17_08429 >63 Absent Absent HP79_09132  Hypothetical protein 
  
HP17_08454 64 HP_0453 Absent HP79_04457 Hypothetical protein 
HP17_08504 38 HP_0063 Absent HP79_04844 Hypothetical protein 
HP17_08596 43 Absent Absent HP79_06391 Hypothetical protein 
HP17_08601 45 Absent Absent Absent Hypothetical protein 
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Appendix 13 List of unique genes present in the genome of H. pylori 26695 when 
compared to H. pylori CCUG 17874 and P79 
Unique 
26695 
Size 
(aa) 17874 P79 Product 
HP_0081 40 HP17_05825 Absent Hypothetical protein 
HP_0151 270 Absent HP79_07890 Hypothetical protein 
HP_0161 36 Absent Absent Hypothetical protein 
HP_0314 39 Absent Absent Hypothetical protein 
HP_0412 32 Absent Absent Hypothetical protein 
HP_0450 44 Absent HP79_04472 Hypothetical protein 
HP_0504 49 Absent Absent Hypothetical protein 
HP_0756 48 Absent Absent Hypothetical protein 
HP_0881 31 Absent HP79_02604 Hypothetical protein 
HP_0945 98 Absent HP79_07570  Hypothetical protein 
HP_1033 131 Absent HP79_05066  Hypothetical protein 
HP_1176 34 Absent Absent Hypothetical protein 
HP_1194 28 Absent Absent Hypothetical protein 
HP_1239 29 Absent Absent Hypothetical protein 
HP_1381 77 Absent HP79_05939 Hypothetical protein 
HP_1405 34 HP17_08079 Absent Hypothetical protein 
HP_1427 60 Absent Absent 
Histidine-rich metal-binding 
polypeptide 
HP_1432 72 Absent Absent 
Histidine and glutamine-rich 
protein 
HP_0007 23 Absent Absent Hypothetical protein 
HP_0008 27 Absent HP79_05151 Hypothetical protein 
HP_0225 22 HP17_06822 Absent Hypothetical protein 
HP_0359 21 Absent Absent Hypothetical protein 
HP_0429 12 HP17_08444 Absent Hypothetical protein 
HP_0533 29 Absent Absent Hypothetical protein 
HP_0560 26 Absent Absent Hypothetical protein 
HP_0767 24 Absent Absent Hypothetical protein 
HP_1093 28 Absent Absent Hypothetical protein 
HP_1500 23 Absent Absent Hypothetical protein 
HP_1536 18 HP17_07512 Absent Hypothetical protein 
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Appendix 14 List of unique genes present in the genome of H. pylori J99 when 
compared to a number of H. pylori strains 
Unique 
J99 
Size 
(aa) 17874 P79 Product 
jhp0693 48 Absent Absent Hypothetical protein 
jhp0916 64 HP17_03604 Absent Hypothetical protein, periplasmic 
competence-like protein 
jhp0952 63 Absent Absent Hypothetical protein 
jhp0970 32 Absent Absent Hypothetical protein 
jhp1049 250 Absent HP79_02664 Hypothetical protein 
jhp1320 60 Absent Absent Hypothetical protein 
jhp1321 77 Absent Absent Hypothetical metal-binding 
protein 
jhp1393 26 Absent HP79_05661 Hypothetical protein 
  
Appendix 15 List of unique genes present in the genome of H. pylori P79 when compared to a number of H. pylori strains 
Unique P79 Size (aa) 26695 J99 17874 Product 
HP79_00100 >58 Absent Absent HP17_07742 Hypothetical protein 
HP79_00125 45 Absent Absent Absent Hypothetical protein 
HP79_00130 84 Absent Absent HP17_07717 Hypothetical protein 
HP79_00662 31 HP_0341 Absent HP17_01925 Hypothetical protein 
HP79_00667 130 HP_0342 Absent HP17_01935  Hypothetical protein 
HP79_00682 111 HP_0345 Absent HP17_01945 Hypothetical protein 
HP79_00913 30 HP_1366 jhp1442 Absent Hypothetical protein 
HP79_01025 179 HP_1516 Absent HP17_07159  Hypothetical protein 
HP79_01040 31 Absent Absent HP17_04044 Hypothetical protein 
HP79_01110 44 Absent Absent Absent Hypothetical protein 
HP79_01550 31 HP_1097 Absent HP17_02633  Hypothetical protein 
HP79_01734 40 Absent jhp0659 Absent Hypothetical protein 
HP79_02099 39 Absent Absent HP17_05630 Hypothetical protein 
HP79_02389 75 Absent Absent HP17_05900 Cag pathogenicity island protein B 
HP79_02594 42 Absent Absent Absent Hypothetical protein 
HP79_02604 31 HP_0881 Absent Absent Hypothetical protein 
HP79_02779 >31 Absent Absent Absent Hypothetical protein 
HP79_02931 31 HP_1328 Absent Absent Hypothetical protein 
HP79_03341 48 Absent Absent Absent Hypothetical protein 
HP79_03523 >40 Absent Absent HP17_01025  Hypothetical protein 
HP79_04072 31 HP_1017 Absent Absent Hypothetical protein 
HP79_04147 59 Absent jhp0415 HP17_02469 Hypothetical protein 
  
HP79_04162 44 Absent Absent Absent Hypothetical protein 
HP79_04472 44 HP_0450 Absent Absent Hypothetical protein 
HP79_04602 39 Absent Absent Absent Hypothetical protein 
HP79_04607 44 Absent Absent Absent Hypothetical protein 
HP79_04617 >36 Absent jhp0698 Absent Hypothetical protein 
HP79_04737 34 HP_0174 Absent Absent Hypothetical protein 
HP79_04941 45 HP_0881 Absent HP17_04471 Hypothetical protein 
HP79_05151 27 HP_0008 Absent Absent Hypothetical protein 
HP79_05221 46 Absent Absent HP17_04576 Hypothetical protein 
HP79_05251 45 Absent Absent Absent Hypothetical protein 
HP79_05516 >38 Absent Absent Absent Hypothetical protein 
HP79_05646 39 Absent Absent Absent Hypothetical protein 
HP79_05671 37 Absent Absent Absent Hypothetical protein 
HP79_05686 33 Absent Absent HP17_07269  Hypothetical protein 
HP79_05704 >31 Absent Absent Absent Hypothetical protein 
HP79_05939 77 HP_1381 Absent Absent Hypothetical protein 
HP79_06114 36 Absent Absent Absent Hypothetical protein 
HP79_06154 40 Absent Absent Absent Hypothetical protein 
HP79_06174 30 HP_0024 Absent HP17_03092 Hypothetical protein 
HP79_06236 36 HP_1424 Absent HP17_03884 Hypothetical protein 
HP79_06371 39 Absent Absent Absent Hypothetical protein 
HP79_06376 31 Absent Absent Absent Hypothetical protein 
HP79_06406 34 Absent jhp0953 Absent Hypothetical protein 
HP79_06671 37 Absent Absent Absent Hypothetical protein 
  
HP79_06701 44 HP_0237  Absent HP17_04866 Hypothetical protein 
HP79_07373 53 Absent Absent Absent Hypothetical protein 
HP79_07418 35 Absent Absent Absent Hypothetical protein 
HP79_07453 >27 HP_0461 Absent Absent Hypothetical protein 
HP79_07770 72 Absent Absent HP17_00305 Hypothetical protein 
HP79_07835 36 Absent Absent HP17_00230 Hypothetical protein 
HP79_07890 255 HP_0151 jhp0139 Absent Hypothetical membrane protein 
HP79_07905 35 Absent Absent HP17_00165 Hypothetical protein 
HP79_08218 31 Absent jhp0931 Absent Hypothetical protein 
HP79_08228 40 HP_0592 Absent Absent Hypothetical protein 
HP79_08383 32 Absent Absent Absent Hypothetical protein 
HP79_08555 30 Absent Absent HP17_04948 Hypothetical protein 
HP79_08967 >40 Absent Absent HP17_03449 Hypothetical protein 
HP79_08977 29 Absent Absent Absent Hypothetical protein 
HP79_09132 >73 Absent Absent Absent Hypothetical protein 
 
  
Appendix 16 List of oligonucleotide primers used for cloning and expression 
Primer Sequence (5' - 3') Source 
HP0958-F CGCCGCGGATCCAACACCCACCTCAAACAATTG (Caly et al., 2010) 
HP0958-R CCGCCGGAATTCTTACTAAACTAATTCTTGGCTTTCTTCTTG (Caly et al., 2010) 
FLAG_FliH-F CGCCGCGGATCCGATTATAAAGATGATGATGATAAATCATTGAATAGCCGCAAAAAT This study 
FLAG_FliH 89-F CGCCGCGGATCCGATTATAAAGATGATGATGATAAAAGCAAAGCTTTGATTGAAAAC This study 
FliH258-R CCGCCGGAATTCTTACTACACCTTAAAATTTTCCAACAC This study 
pGBKT7 MCS-F TTCATCGGAAGAGAGTAGTAAC This study 
pGBKT7 MCS-R AAGAGTCACTTTAAAATTTGTATACAC This study 
pGADT7 MCS-F CTATTCGATGATGAAGATACCCCACC This study 
pGADT7 MCS-R AGATGGTGCACGATGCACAGTTG This study 
HP0958_Eco-F CGCCGCGAATTCAACACCCACCTCAAACAATTG This study 
HP0958_Bam-R CCGCCGGGATCCTCAAACTAATTCTTGGCTTTCTTC This study 
Mut2_Eco-F CGCCGCGAATTCAACGCCCACCTCAAACAATTG This study 
Mut3_Eco-F CGCCGCGAATTCAACACCGCCCTCAAACAATTG This study 
FliH 89-258_Eco-F CGCCGCGAATTCAGCAAAGCTTTGATTGAAAACGC This study 
FliH 89-258_Bam-R CCGCCGGGATCCTCACACCTTAAAATTTTCCAACAC This study 
RpoN 74-F CGCCGCGAATTCATCGCATCTAAAAGCCTTTTTG This study 
RpoN 284-R CCGCCGGGATCCAAGCATCAGACCGATTTTATAAATC This study 
RpoN 210-R CCGCCGGGATCCCTCAATGGCTGGGGGGTTTTTAAAGG This study 
  
Appendix 17 List of primers used for site-directed mutagenesis of hp0958 
Primer Sequence (5' - 3') Source 
Mut2-F CCCTGGGATCCAACGCCCACCTCAAACAATTG This study 
Mut2-R CAATTGTTTGAGGTGGGCGTTGGATCCCAGGG  This study 
Mut3-F CCCCTGGGATCCAACACCGCCCTCAAACAATTG This study 
Mut3-R CAATTGTTTGAGGGCGGTGTTGGATCCCAGGGG This study 
Mut4-F GATTGAAATTTCGGCTTTGGATAAAGAAATTGACTCCTTAGAGCCG This study 
Mut4-R CGGCTCTAAGGAGTCAATTTCTTTATCCAAAGCCGAAATTTCAATC This study 
Mut6-F GGAAAAATTAGCCCTAAAAGCACAGGTTTCTAAAAACGAGCAAACCC This study 
Mut6-R GGGTTTGCTCGTTTTTAGAAACCTGTGCTTTTAGGGCTAATTTTTCC This study 
Mut9-F CGAGCCTAAAATCTATAGCTTTTATGAAGAGATCAGAAGATGGGCG This study 
Mut9-R CGCCCATCTTCTGATCTCTTCATAAAAGCTATAGATTTTAGGCTCG This study 
Mut10-F GCTTTTATGAAAGGATCAGAGAATGGGCGAAAAACACGAGC This study 
Mut10-R GCTCGTGTTTTTCGCCCATTCTCTGATCCTTTCATAAAAGC This study 
Mut11-F GGATCAGAAGATGGGCGGCAAACACGAGCATTGTAACG This study 
Mut11-R CGTTACAATGCTCGTGTTTGCCGCCCATCTTCTGATCC This study 
Mut12-F CGAGCATTGTAACGATCGCAAAACAGGCTTGTGGGGG This study 
Mut12-R CCCCCACAAGCCTGTTTTGCGATCGTTACAATGCTCG This study 
Mut13-F CAGGCTTGTGGGGGTTGTGTTATTAGACTAAATGATAAG This study 
Mut13-R CTTATCATTTAGTCTAATAACACAACCCCCACAAGCCTG This study 
Mut17-F GGTTGTTTTATTAGACTAAATGATGAGATTTATACTGAAGTGCTAACG This study 
Mut17-R CGTTAGCACTTCAGTATAAATCTCATCATTTAGTCTAATAAAACAACC This study 
Mut18-F GGGGATATGATCGCGTGCCCGTATTGCGGGCG This study 
  
Mut18-R CGCCCGCAATACGGGCACGCGATCATATCCCC This study 
Mut19-F GGGCGTATTTTAGCCGCTGAGGGCGCGTATGAAAGTAACGC This study 
Mut19-R GCGTTACTTTCATACGCGCCCTCAGCGGCTAAAATACGCCC This study 
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Appendix 18 Selection of targets for site-directed mutagenesis of HP0958. 
Rationale behind selection of residues for site-directed mutagenesis. Multiple alignment of 
amino acid sequences of HP0958 homologues identified 3 highly conserved regions: an N-
terminal hydrophobic region which forms part of the coiled-coil in close contact with the Zn-
ribbon (coloured yellow); hydrophobic residues in the coiled-coil flanked by charged 
residues (coloured green) and the Zn-ribbon which is associated with nucleic acid 
interactions (coloured blue). Residues which were conserved, solvent exposed and not 
critical in maintaining the structure of HP0958 were selected for mutagenesis. Image of 
HP0958 structure was generated using Pymol (DeLano Scientific, CA). 
 
  
 
Appendix 19 List of oligonucleotide primers used for qPCR 
Primer Sequence (5' - 3') Comments Source 
qflaA-F CCGATAGTGTCAGTAATGGGC Forward primer for real time PCR of flaA This study 
qflaA-R GATTCCCAAAACCAATCGCTGTG Reverse primer for real time PCR of flaA This study 
qflgE-F GGCTAACGAGCGTGGATAAG Forward primer for real time PCR of flgE (Douillard et al., 2008) 
qflgE-R GAGCGAGCGCTAAAGTCCTA Reverse primer for real time PCR of flgE (Douillard et al., 2008) 
qflaB-F ACCAGAACCGACGCTAGAGA Forward primer for real time PCR of flaB (Douillard et al., 2008) 
qflaB-R CCACATTCGCATCAAAAATG Reverse primer for real time PCR of flaB (Douillard et al., 2008) 
qropN-F AGCACGATTTCAAGGGCCAT Forward primer for real time PCR of rpoN This study 
qropN-R CACAGCGTTTGAAGTCTCGC Reverse primer for real time PCR of rpoN This study 
qfliA-F GAATGCCCAAAGGAATTCAA Forward primer for real time PCR of fliA (Douillard et al., 2008) 
qfliA-R AGCGAGATCGTCTTGATGGT Reverse primer for real time PCR of fliA (Douillard et al., 2008) 
qera-F AAGGCTAATGCGACCAGAAA Forward primer for real time PCR of era (Douillard et al., 2008) 
qera-R GGAGCCCTGGTGTGTCTAAA Reverse primer for real time PCR of era (Douillard et al., 2008) 
 
  
Appendix 20 List of flaA oligonucleotide primers 
Primer Sequence (5' - 3') Source 
FlaFL-F TGTAATACGACTCACTATAGGTCCAACCAAAAGCAAGGATG (Douillard et al., 2008) 
FlaFL-R AGCCCCATACAAACACCTTTCTTAAAA (Douillard et al., 2008) 
Reg1.1-F TGTAATACGACTCACTATAGGTTCAACCAAAAGCAAGGATGCC This study 
Reg1.1-R GACATTAGCGTTAAAATTCCCATAAGATTTTCAACTGCTCATCCATAGC This study 
Reg1.2-F TATGGATGAGCAGTTGAAATCTTATGGGAATTTTAACGCTAATGTC This study 
Reg1.2-R GCCAACGCTTAAAGCGTTAGCC This study 
Reg2-F TGTAATACGACTCACTATAGGTAAGGTTAAAGCGACTCAAGC This study 
Reg2-R CCATTTAAGGTTAAATTACTCAAACTTCC This study 
Reg3-F TGTAATACGACTCACTATAGGATTGGTTGCAGCGATCAATGCG This study 
Reg3-R ACATCGCGCAAATTCACCGTG This study 
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Appendix 21 EM analysis of flagellum production by H. pylori P79 and derivatives. 
Transmission electron micrographs of H. pylori cells stained with uranyl acetate; 3 images 
per strain. 
  
 
Appendix 22 ClustalW multiple sequence alignment of HP0958 and orthologues in the genus Helicobacter. 
Multiple alignment of the amino acid sequences of HP0958 homologues in the genus Helicobacter where arrows indicate conserved aspartic acid residues 
(D208 and D219 of strain 17874) in the zinc-finger. 
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Motility is an essential feature of Helicobacter pylori infection. H. pylori flagellum 
biogenesis differs from the well-characterised model organism E. coli by lacking the 
master regulator, FlhD4C2. A yeast two hybrid study investigating the proteome of H. 
pylori 26695 previously identified that HP0958 interacts with the flagellar proteins 
FliH and RpoN (σ54). We hypothesised that HP0958 may have a regulatory role in 
flagellum construction, possibly in the switch between expression of Class II and 
Class III flagellar genes. The nature of the interaction between HP0958 and FliH 
(full length and 89-258) was investigated to expand upon the yeast two hybrid data. 
However, pull-down assay failed to identify an interaction between HP0958 and 
FliH. Yeast two hybrid was performed with HP0958 and FliH 89-258, but this also 
indicated that there is no detectable interaction between these proteins. Additionally, 
the HP0958/RpoN interaction was confirmed as a relatively weak interaction by 
yeast two hybrid analysis. The HP0958/FliH interaction appears to be a false positive 
within a large scale analysis identifying over 1,200 interactions. 
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Helicobacter pylori was the first species to have more than one genome sequenced. 
To date, there are 46 genome sequences of H. pylori strains available. Earlier this 
year, we published the draft genome sequences of CCUG 17874 and P79. H. pylori 
17874 is the type strain for the species, often used in motility studies. P79 is a readily 
transformable derivative of the strain P1 and hence is useful for bacterial motility 
studies. Initial inspection of the sequences of 17874 and P79 revealed that the major 
flagellar and outer membrane proteins are conserved when compared to 26695 and 
J99. Core genome analysis of 43 sequenced genomes allowed a more conservative 
estimation of the core genome of the species than previously estimated. Phylogenetic 
analysis of these 43 strains revealed the evolutionary relationship of 17874 and P79 
to the other sequenced strains. 
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Helicobacter pylori is a gastric pathogen which currently infects approximately 50% 
of the global population. Infection can lead to the development of gastric and 
duodenal ulcers, gastric cancer and MALT lymphoma. Motility is an essential feature 
of Helicobacter pylori infection. H. pylori flagellum biogenesis differs from the well-
characterised model organism E. coli by lacking the master regulator, FlhD4C2. A 
yeast two-hybrid study investigating the proteome of H. pylori 26695 previously 
identified that HP0958 interacts with the flagellar proteins FliH and RpoN (σ54). We 
hypothesised that HP0958 may have a regulatory role in flagellum construction, 
possibly in the switch between expression of Class II and Class III flagellar genes. 
The nature of the interaction between HP0958 and FliH (full length and residues 89-
258) was investigated to expand upon the yeast two hybrid data. However, pull-down 
assay failed to identify an interaction between HP0958 and FliH. Yeast two-hybrid 
was performed with HP0958 and FliH 89-258, but this also failed to detect 
interaction between these proteins. The HP0958/RpoN interaction was confirmed as 
a relatively weak interaction by yeast two-hybrid analysis and PXG assay. The 
HP0958/FliH interaction appears to be a false positive within a large scale analysis 
identifying over 1,200 interactions. The C-terminus of RpoN is essential for the 
interaction with HP0958. A panel of site-directed HP0958 mutants were generated to 
further investigate the nature of the HP0958/RpoN interaction. 
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Background: Motility is an important feature of Helicobacter pylori infection. 
HP0958 is a flagellar biosynthesis protein which is essential for motility. HP0958 
stabilises RpoN (σ54), the sigma factor controlling expression of the Class II flagellar 
genes. HP0958 also interacts with the flaA mRNA transcript, encoding the major 
flagellin protein, FlaA. The crystal structure of HP0958 revealed two structural 
domains: an N-terminal anti-parallel, α-helical coiled-coil and a C-terminal Zn-finger 
domain. This structural data has provided information that has informed our design 
of mutations to test interactions with protein and mRNA. 
Materials and Methods: Site-directed mutagenesis of HP0958 was performed to 
identify potential residues involved in interactions with the flaA mRNA transcript 
and RpoN. The HP0958/flaA mRNA interaction was investigated by electrophoretic 
mobility shift assay (EMSAs). The HP0958/RpoN interaction was investigated by 
yeast two-hybrid assay followed by enzyme assay. A panel of hp0958 mutants were 
re-introduced into a hp0958-null mutant strain of P79 by homologous recombination 
and effects on expression of Class II and Class III flagellar genes were monitored by 
western blot. 
Results: A panel of HP0958 mutants were generated based on their potential role in 
protein-protein/protein-RNA interactions. A number of candidates have been 
identified as involved in the interaction of HP0958 with RpoN and the flaA mRNA 
transcript. 
Impact of research: Construction of the bacterial flagellum is a complex, 
hierarchical process involving over 40 proteins; regulation in Helicobacter differs 
from the well-studied model organisms, E. coli and S. enterica serovar 
Typhimurium. Understanding the mechanism by which HP0958 contributes to this 
complex process will improve our understanding of these differences. 
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